Project
SARS-CoV-2 Analysis Results (GEO series: GSE147507)
Navigation
Downloads
Results for WRNIP1
Z-value: 3.06
Motif logo
Transcription factors associated with WRNIP1
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
WRNIP1
|
ENSG00000124535.11 | WRN helicase interacting protein 1 |
Activity-expression correlation:
| Gene | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| WRNIP1 | hg19_v2_chr6_+_2765595_2765797 | 0.61 | 4.2e-03 | Click! |
Activity profile of WRNIP1 motif
Sorted Z-values of WRNIP1 motif
| Promoter | Log-likelihood | Transcript | Gene | Gene Info |
|---|---|---|---|---|
| chr19_-_51504852 | 19.84 |
ENST00000391806.2
ENST00000347619.4 ENST00000291726.7 ENST00000320838.5 |
KLK8
|
kallikrein-related peptidase 8 |
| chr1_-_153588334 | 18.79 |
ENST00000476873.1
|
S100A14
|
S100 calcium binding protein A14 |
| chr12_-_6484376 | 16.55 |
ENST00000360168.3
ENST00000358945.3 |
SCNN1A
|
sodium channel, non-voltage-gated 1 alpha subunit |
| chr1_-_153538292 | 16.21 |
ENST00000497140.1
ENST00000368708.3 |
S100A2
|
S100 calcium binding protein A2 |
| chr1_-_153588765 | 15.43 |
ENST00000368701.1
ENST00000344616.2 |
S100A14
|
S100 calcium binding protein A14 |
| chrX_-_48326764 | 14.70 |
ENST00000413668.1
ENST00000441948.1 |
SLC38A5
|
solute carrier family 38, member 5 |
| chr12_-_6483969 | 14.65 |
ENST00000396966.2
|
SCNN1A
|
sodium channel, non-voltage-gated 1 alpha subunit |
| chr17_-_7166500 | 13.19 |
ENST00000575313.1
ENST00000397317.4 |
CLDN7
|
claudin 7 |
| chr4_-_90758227 | 13.07 |
ENST00000506691.1
ENST00000394986.1 ENST00000506244.1 ENST00000394989.2 ENST00000394991.3 |
SNCA
|
synuclein, alpha (non A4 component of amyloid precursor) |
| chr19_-_51456344 | 12.73 |
ENST00000336334.3
ENST00000593428.1 |
KLK5
|
kallikrein-related peptidase 5 |
| chr3_-_195538760 | 12.68 |
ENST00000475231.1
|
MUC4
|
mucin 4, cell surface associated |
| chr1_-_209979465 | 12.51 |
ENST00000542854.1
|
IRF6
|
interferon regulatory factor 6 |
| chr1_-_28503693 | 12.11 |
ENST00000373857.3
|
PTAFR
|
platelet-activating factor receptor |
| chr1_-_59043166 | 12.00 |
ENST00000371225.2
|
TACSTD2
|
tumor-associated calcium signal transducer 2 |
| chr1_-_209979375 | 11.67 |
ENST00000367021.3
|
IRF6
|
interferon regulatory factor 6 |
| chr14_+_23305760 | 11.63 |
ENST00000311852.6
|
MMP14
|
matrix metallopeptidase 14 (membrane-inserted) |
| chr19_-_36004543 | 11.58 |
ENST00000339686.3
ENST00000447113.2 ENST00000440396.1 |
DMKN
|
dermokine |
| chrX_-_48326683 | 11.37 |
ENST00000440085.1
|
SLC38A5
|
solute carrier family 38, member 5 |
| chr17_+_7344057 | 11.08 |
ENST00000575398.1
ENST00000575082.1 |
FGF11
|
fibroblast growth factor 11 |
| chr19_-_51472031 | 11.04 |
ENST00000391808.1
|
KLK6
|
kallikrein-related peptidase 6 |
| chr1_+_32042131 | 11.02 |
ENST00000271064.7
ENST00000537531.1 |
TINAGL1
|
tubulointerstitial nephritis antigen-like 1 |
| chr15_+_31508174 | 10.99 |
ENST00000559292.2
ENST00000557928.1 |
RP11-16E12.1
|
RP11-16E12.1 |
| chr1_-_153363452 | 10.79 |
ENST00000368732.1
ENST00000368733.3 |
S100A8
|
S100 calcium binding protein A8 |
| chr19_-_51587502 | 10.64 |
ENST00000156499.2
ENST00000391802.1 |
KLK14
|
kallikrein-related peptidase 14 |
| chr17_-_39677971 | 10.49 |
ENST00000393976.2
|
KRT15
|
keratin 15 |
| chr17_-_7164410 | 10.32 |
ENST00000574070.1
|
CLDN7
|
claudin 7 |
| chr14_+_24867992 | 10.28 |
ENST00000382554.3
|
NYNRIN
|
NYN domain and retroviral integrase containing |
| chr19_-_42947121 | 9.90 |
ENST00000601181.1
|
CXCL17
|
chemokine (C-X-C motif) ligand 17 |
| chr19_-_51487071 | 9.71 |
ENST00000391807.1
ENST00000593904.1 |
KLK7
|
kallikrein-related peptidase 7 |
| chr1_-_95007193 | 9.44 |
ENST00000370207.4
ENST00000334047.7 |
F3
|
coagulation factor III (thromboplastin, tissue factor) |
| chr16_+_55522536 | 9.35 |
ENST00000570283.1
|
MMP2
|
matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) |
| chr5_-_41870621 | 9.09 |
ENST00000196371.5
|
OXCT1
|
3-oxoacid CoA transferase 1 |
| chr12_-_6484715 | 8.99 |
ENST00000228916.2
|
SCNN1A
|
sodium channel, non-voltage-gated 1 alpha subunit |
| chr3_-_195538728 | 8.76 |
ENST00000349607.4
ENST00000346145.4 |
MUC4
|
mucin 4, cell surface associated |
| chr7_-_41740181 | 8.66 |
ENST00000442711.1
|
INHBA
|
inhibin, beta A |
| chr3_-_185542761 | 8.41 |
ENST00000457616.2
ENST00000346192.3 |
IGF2BP2
|
insulin-like growth factor 2 mRNA binding protein 2 |
| chr19_-_51487282 | 8.39 |
ENST00000595820.1
ENST00000597707.1 ENST00000336317.4 |
KLK7
|
kallikrein-related peptidase 7 |
| chr1_+_35247859 | 8.36 |
ENST00000373362.3
|
GJB3
|
gap junction protein, beta 3, 31kDa |
| chr8_+_124194752 | 8.31 |
ENST00000318462.6
|
FAM83A
|
family with sequence similarity 83, member A |
| chr19_+_52901094 | 8.30 |
ENST00000391788.2
ENST00000436397.1 ENST00000391787.2 ENST00000360465.3 ENST00000494167.2 ENST00000493272.1 |
ZNF528
|
zinc finger protein 528 |
| chr19_+_39687596 | 8.29 |
ENST00000339852.4
|
NCCRP1
|
non-specific cytotoxic cell receptor protein 1 homolog (zebrafish) |
| chr12_-_52887034 | 8.20 |
ENST00000330722.6
|
KRT6A
|
keratin 6A |
| chr19_+_35606777 | 8.16 |
ENST00000604404.1
ENST00000435734.2 ENST00000603181.1 |
FXYD3
|
FXYD domain containing ion transport regulator 3 |
| chr19_-_51456321 | 8.14 |
ENST00000391809.2
|
KLK5
|
kallikrein-related peptidase 5 |
| chr17_-_74582191 | 8.14 |
ENST00000225276.5
|
ST6GALNAC2
|
ST6 (alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3)-N-acetylgalactosaminide alpha-2,6-sialyltransferase 2 |
| chr6_+_30851840 | 8.01 |
ENST00000511510.1
ENST00000376569.3 ENST00000376575.3 ENST00000376570.4 ENST00000446312.1 ENST00000504927.1 |
DDR1
|
discoidin domain receptor tyrosine kinase 1 |
| chr19_-_51471381 | 8.01 |
ENST00000594641.1
|
KLK6
|
kallikrein-related peptidase 6 |
| chr3_-_13921594 | 7.89 |
ENST00000285018.4
|
WNT7A
|
wingless-type MMTV integration site family, member 7A |
| chr19_-_51529849 | 7.79 |
ENST00000600362.1
ENST00000453757.3 ENST00000601671.1 |
KLK11
|
kallikrein-related peptidase 11 |
| chr17_-_39781054 | 7.77 |
ENST00000463128.1
|
KRT17
|
keratin 17 |
| chr20_-_44540686 | 7.73 |
ENST00000477313.1
ENST00000542937.1 ENST00000372431.3 ENST00000354050.4 ENST00000420868.2 |
PLTP
|
phospholipid transfer protein |
| chr1_+_32042105 | 7.67 |
ENST00000457433.2
ENST00000441210.2 |
TINAGL1
|
tubulointerstitial nephritis antigen-like 1 |
| chr17_-_7167279 | 7.64 |
ENST00000571932.2
|
CLDN7
|
claudin 7 |
| chr6_+_30848771 | 7.60 |
ENST00000503180.1
|
DDR1
|
discoidin domain receptor tyrosine kinase 1 |
| chr17_-_5487277 | 7.57 |
ENST00000572272.1
ENST00000354411.3 ENST00000577119.1 |
NLRP1
|
NLR family, pyrin domain containing 1 |
| chr15_-_75017711 | 7.54 |
ENST00000567032.1
ENST00000564596.1 ENST00000566503.1 ENST00000395049.4 ENST00000395048.2 ENST00000379727.3 |
CYP1A1
|
cytochrome P450, family 1, subfamily A, polypeptide 1 |
| chr12_+_4382917 | 7.53 |
ENST00000261254.3
|
CCND2
|
cyclin D2 |
| chr19_-_54676846 | 7.52 |
ENST00000301187.4
|
TMC4
|
transmembrane channel-like 4 |
| chr11_+_130029457 | 7.50 |
ENST00000278742.5
|
ST14
|
suppression of tumorigenicity 14 (colon carcinoma) |
| chr11_+_117947782 | 7.46 |
ENST00000522307.1
ENST00000523251.1 ENST00000437212.3 ENST00000522824.1 ENST00000522151.1 |
TMPRSS4
|
transmembrane protease, serine 4 |
| chr15_+_41136216 | 7.42 |
ENST00000562057.1
ENST00000344051.4 |
SPINT1
|
serine peptidase inhibitor, Kunitz type 1 |
| chr21_-_28217721 | 7.36 |
ENST00000284984.3
|
ADAMTS1
|
ADAM metallopeptidase with thrombospondin type 1 motif, 1 |
| chr1_-_153538011 | 7.22 |
ENST00000368707.4
|
S100A2
|
S100 calcium binding protein A2 |
| chr2_-_113594279 | 7.20 |
ENST00000416750.1
ENST00000418817.1 ENST00000263341.2 |
IL1B
|
interleukin 1, beta |
| chr9_-_21994344 | 7.18 |
ENST00000530628.2
ENST00000361570.3 |
CDKN2A
|
cyclin-dependent kinase inhibitor 2A |
| chr10_-_105845536 | 7.16 |
ENST00000393211.3
|
COL17A1
|
collagen, type XVII, alpha 1 |
| chr16_-_31147020 | 7.14 |
ENST00000568261.1
ENST00000567797.1 ENST00000317508.6 |
PRSS8
|
protease, serine, 8 |
| chrX_+_102469997 | 7.13 |
ENST00000372695.5
ENST00000372691.3 |
BEX4
|
brain expressed, X-linked 4 |
| chr18_+_47088401 | 7.08 |
ENST00000261292.4
ENST00000427224.2 ENST00000580036.1 |
LIPG
|
lipase, endothelial |
| chr5_-_141257954 | 7.05 |
ENST00000456271.1
ENST00000394536.3 ENST00000503492.1 ENST00000287008.3 |
PCDH1
|
protocadherin 1 |
| chrX_-_48328631 | 7.03 |
ENST00000429543.1
ENST00000317669.5 |
SLC38A5
|
solute carrier family 38, member 5 |
| chr9_+_130911723 | 6.97 |
ENST00000277480.2
ENST00000373013.2 ENST00000540948.1 |
LCN2
|
lipocalin 2 |
| chr1_+_209602156 | 6.97 |
ENST00000429156.1
ENST00000366437.3 ENST00000603283.1 ENST00000431096.1 |
MIR205HG
|
MIR205 host gene (non-protein coding) |
| chr6_+_41606176 | 6.96 |
ENST00000441667.1
ENST00000230321.6 ENST00000373050.4 ENST00000446650.1 ENST00000435476.1 |
MDFI
|
MyoD family inhibitor |
| chr3_-_185542817 | 6.96 |
ENST00000382199.2
|
IGF2BP2
|
insulin-like growth factor 2 mRNA binding protein 2 |
| chr11_-_119999611 | 6.95 |
ENST00000529044.1
|
TRIM29
|
tripartite motif containing 29 |
| chr11_-_111783919 | 6.88 |
ENST00000531198.1
ENST00000533879.1 |
CRYAB
|
crystallin, alpha B |
| chr19_+_35645817 | 6.88 |
ENST00000423817.3
|
FXYD5
|
FXYD domain containing ion transport regulator 5 |
| chr7_-_143991230 | 6.87 |
ENST00000543357.1
|
ARHGEF35
|
Rho guanine nucleotide exchange factor (GEF) 35 |
| chr12_-_52912901 | 6.83 |
ENST00000551188.1
|
KRT5
|
keratin 5 |
| chr9_-_21995300 | 6.79 |
ENST00000498628.2
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A |
| chr16_+_68679193 | 6.76 |
ENST00000581171.1
|
CDH3
|
cadherin 3, type 1, P-cadherin (placental) |
| chr19_+_35645618 | 6.76 |
ENST00000392218.2
ENST00000543307.1 ENST00000392219.2 ENST00000541435.2 ENST00000590686.1 ENST00000342879.3 ENST00000588699.1 |
FXYD5
|
FXYD domain containing ion transport regulator 5 |
| chr9_-_21994597 | 6.74 |
ENST00000579755.1
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A |
| chr12_-_28122980 | 6.72 |
ENST00000395868.3
ENST00000534890.1 |
PTHLH
|
parathyroid hormone-like hormone |
| chr19_-_51472823 | 6.70 |
ENST00000310157.2
|
KLK6
|
kallikrein-related peptidase 6 |
| chr1_-_155162658 | 6.67 |
ENST00000368389.2
ENST00000368396.4 ENST00000343256.5 ENST00000342482.4 ENST00000368398.3 ENST00000368390.3 ENST00000337604.5 ENST00000368392.3 ENST00000438413.1 ENST00000368393.3 ENST00000457295.2 ENST00000338684.5 ENST00000368395.1 |
MUC1
|
mucin 1, cell surface associated |
| chr16_+_55512742 | 6.61 |
ENST00000568715.1
ENST00000219070.4 |
MMP2
|
matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) |
| chr10_-_105845674 | 6.60 |
ENST00000353479.5
ENST00000369733.3 |
COL17A1
|
collagen, type XVII, alpha 1 |
| chr1_-_209824643 | 6.58 |
ENST00000391911.1
ENST00000415782.1 |
LAMB3
|
laminin, beta 3 |
| chr19_-_36001286 | 6.53 |
ENST00000602679.1
ENST00000492341.2 ENST00000472252.2 ENST00000602781.1 ENST00000402589.2 ENST00000458071.1 ENST00000436012.1 ENST00000443640.1 ENST00000450261.1 ENST00000467637.1 ENST00000480502.1 ENST00000474928.1 ENST00000414866.2 ENST00000392206.2 ENST00000488892.1 |
DMKN
|
dermokine |
| chr11_+_57365150 | 6.48 |
ENST00000457869.1
ENST00000340687.6 ENST00000378323.4 ENST00000378324.2 ENST00000403558.1 |
SERPING1
|
serpin peptidase inhibitor, clade G (C1 inhibitor), member 1 |
| chr5_-_138861926 | 6.45 |
ENST00000510817.1
|
TMEM173
|
transmembrane protein 173 |
| chr11_-_119993979 | 6.44 |
ENST00000524816.3
ENST00000525327.1 |
TRIM29
|
tripartite motif containing 29 |
| chr5_-_151066514 | 6.43 |
ENST00000538026.1
ENST00000522348.1 ENST00000521569.1 |
SPARC
|
secreted protein, acidic, cysteine-rich (osteonectin) |
| chr19_+_35606692 | 6.40 |
ENST00000406242.3
ENST00000454903.2 |
FXYD3
|
FXYD domain containing ion transport regulator 3 |
| chrX_+_56259316 | 6.40 |
ENST00000468660.1
|
KLF8
|
Kruppel-like factor 8 |
| chr6_+_30848829 | 6.40 |
ENST00000508317.1
|
DDR1
|
discoidin domain receptor tyrosine kinase 1 |
| chr19_-_11689752 | 6.38 |
ENST00000592659.1
ENST00000592828.1 ENST00000218758.5 ENST00000412435.2 |
ACP5
|
acid phosphatase 5, tartrate resistant |
| chr22_+_24322322 | 6.36 |
ENST00000215780.5
ENST00000402588.3 |
GSTT2
|
glutathione S-transferase theta 2 |
| chr19_-_51472222 | 6.36 |
ENST00000376851.3
|
KLK6
|
kallikrein-related peptidase 6 |
| chr2_+_210288760 | 6.35 |
ENST00000199940.6
|
MAP2
|
microtubule-associated protein 2 |
| chr6_+_30852738 | 6.29 |
ENST00000508312.1
ENST00000512336.1 |
DDR1
|
discoidin domain receptor tyrosine kinase 1 |
| chr8_+_95653302 | 6.29 |
ENST00000423620.2
ENST00000433389.2 |
ESRP1
|
epithelial splicing regulatory protein 1 |
| chr19_-_54984354 | 6.26 |
ENST00000301200.2
|
CDC42EP5
|
CDC42 effector protein (Rho GTPase binding) 5 |
| chr16_-_2908155 | 6.19 |
ENST00000571228.1
ENST00000161006.3 |
PRSS22
|
protease, serine, 22 |
| chr1_+_209602609 | 6.18 |
ENST00000458250.1
|
MIR205HG
|
MIR205 host gene (non-protein coding) |
| chr9_-_21974820 | 6.18 |
ENST00000579122.1
ENST00000498124.1 |
CDKN2A
|
cyclin-dependent kinase inhibitor 2A |
| chr19_+_45281118 | 6.15 |
ENST00000270279.3
ENST00000341505.4 |
CBLC
|
Cbl proto-oncogene C, E3 ubiquitin protein ligase |
| chr1_+_13910479 | 6.14 |
ENST00000509009.1
|
PDPN
|
podoplanin |
| chr1_-_27480973 | 6.12 |
ENST00000545949.1
ENST00000374086.3 |
SLC9A1
|
solute carrier family 9, subfamily A (NHE1, cation proton antiporter 1), member 1 |
| chr19_-_53636125 | 6.09 |
ENST00000601493.1
ENST00000599261.1 ENST00000597503.1 ENST00000500065.4 ENST00000243643.4 ENST00000594011.1 ENST00000455735.2 ENST00000595193.1 ENST00000448501.1 ENST00000421033.1 ENST00000440291.1 ENST00000595813.1 ENST00000600574.1 ENST00000596051.1 ENST00000601110.1 |
ZNF415
|
zinc finger protein 415 |
| chr6_+_41604747 | 6.09 |
ENST00000419164.1
ENST00000373051.2 |
MDFI
|
MyoD family inhibitor |
| chr16_+_68678892 | 6.07 |
ENST00000429102.2
|
CDH3
|
cadherin 3, type 1, P-cadherin (placental) |
| chr19_-_51522955 | 6.07 |
ENST00000358789.3
|
KLK10
|
kallikrein-related peptidase 10 |
| chrX_+_48367338 | 6.06 |
ENST00000359882.4
ENST00000537758.1 ENST00000367574.4 ENST00000355961.4 ENST00000489940.1 ENST00000361988.3 |
PORCN
|
porcupine homolog (Drosophila) |
| chr19_+_50084561 | 6.06 |
ENST00000246794.5
|
PRRG2
|
proline rich Gla (G-carboxyglutamic acid) 2 |
| chr2_+_233925064 | 6.05 |
ENST00000359570.5
ENST00000538935.1 |
INPP5D
|
inositol polyphosphate-5-phosphatase, 145kDa |
| chr1_-_27481401 | 6.05 |
ENST00000263980.3
|
SLC9A1
|
solute carrier family 9, subfamily A (NHE1, cation proton antiporter 1), member 1 |
| chr1_+_13910757 | 6.02 |
ENST00000376061.4
ENST00000513143.1 |
PDPN
|
podoplanin |
| chr8_+_95653373 | 6.01 |
ENST00000358397.5
|
ESRP1
|
epithelial splicing regulatory protein 1 |
| chr15_-_45422056 | 6.01 |
ENST00000267803.4
ENST00000559014.1 ENST00000558851.1 ENST00000559988.1 ENST00000558996.1 ENST00000558422.1 ENST00000559226.1 ENST00000558326.1 ENST00000558377.1 ENST00000559644.1 |
DUOXA1
|
dual oxidase maturation factor 1 |
| chr3_+_40428647 | 6.01 |
ENST00000301825.3
ENST00000439533.1 ENST00000456402.1 |
ENTPD3
|
ectonucleoside triphosphate diphosphohydrolase 3 |
| chr1_-_182361327 | 5.98 |
ENST00000331872.6
ENST00000311223.5 |
GLUL
|
glutamate-ammonia ligase |
| chr19_-_12912601 | 5.97 |
ENST00000334482.5
|
PRDX2
|
peroxiredoxin 2 |
| chr9_-_21975088 | 5.97 |
ENST00000304494.5
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A |
| chr11_+_5710919 | 5.90 |
ENST00000379965.3
ENST00000425490.1 |
TRIM22
|
tripartite motif containing 22 |
| chr22_-_37640456 | 5.87 |
ENST00000405484.1
ENST00000441619.1 ENST00000406508.1 |
RAC2
|
ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2) |
| chr4_+_4387983 | 5.87 |
ENST00000397958.1
|
NSG1
|
Homo sapiens neuron specific gene family member 1 (NSG1), transcript variant 3, mRNA. |
| chrX_-_48325857 | 5.86 |
ENST00000376875.1
|
SLC38A5
|
solute carrier family 38, member 5 |
| chr8_+_124194875 | 5.82 |
ENST00000522648.1
ENST00000276699.6 |
FAM83A
|
family with sequence similarity 83, member A |
| chr19_+_10736183 | 5.82 |
ENST00000590857.1
ENST00000588688.1 ENST00000586078.1 |
SLC44A2
|
solute carrier family 44 (choline transporter), member 2 |
| chr7_-_143892748 | 5.81 |
ENST00000378115.2
|
ARHGEF35
|
Rho guanine nucleotide exchange factor (GEF) 35 |
| chr7_+_144052381 | 5.79 |
ENST00000498580.1
ENST00000056217.5 |
ARHGEF5
|
Rho guanine nucleotide exchange factor (GEF) 5 |
| chr11_-_111783595 | 5.78 |
ENST00000528628.1
|
CRYAB
|
crystallin, alpha B |
| chr11_+_44587206 | 5.74 |
ENST00000525210.1
ENST00000527737.1 ENST00000524704.1 |
CD82
|
CD82 molecule |
| chr17_-_39780819 | 5.73 |
ENST00000311208.8
|
KRT17
|
keratin 17 |
| chr19_-_54676884 | 5.71 |
ENST00000376591.4
|
TMC4
|
transmembrane channel-like 4 |
| chr3_+_99357319 | 5.70 |
ENST00000452013.1
ENST00000261037.3 ENST00000273342.4 |
COL8A1
|
collagen, type VIII, alpha 1 |
| chrX_+_115567767 | 5.68 |
ENST00000371900.4
|
SLC6A14
|
solute carrier family 6 (amino acid transporter), member 14 |
| chr11_-_119999539 | 5.63 |
ENST00000541857.1
|
TRIM29
|
tripartite motif containing 29 |
| chr2_+_113875466 | 5.63 |
ENST00000361779.3
ENST00000259206.5 ENST00000354115.2 |
IL1RN
|
interleukin 1 receptor antagonist |
| chr19_-_51523275 | 5.62 |
ENST00000309958.3
|
KLK10
|
kallikrein-related peptidase 10 |
| chr6_+_106959718 | 5.61 |
ENST00000369066.3
|
AIM1
|
absent in melanoma 1 |
| chr17_+_1665345 | 5.60 |
ENST00000576406.1
ENST00000571149.1 |
SERPINF1
|
serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 1 |
| chr8_+_22437664 | 5.59 |
ENST00000436754.1
ENST00000426493.1 ENST00000429812.1 |
PDLIM2
|
PDZ and LIM domain 2 (mystique) |
| chr1_+_156030937 | 5.59 |
ENST00000361084.5
|
RAB25
|
RAB25, member RAS oncogene family |
| chr19_-_51523412 | 5.57 |
ENST00000391805.1
ENST00000599077.1 |
KLK10
|
kallikrein-related peptidase 10 |
| chr17_-_39743139 | 5.57 |
ENST00000167586.6
|
KRT14
|
keratin 14 |
| chr1_-_17307173 | 5.55 |
ENST00000438542.1
ENST00000375535.3 |
MFAP2
|
microfibrillar-associated protein 2 |
| chr11_+_18287801 | 5.52 |
ENST00000532858.1
ENST00000405158.2 |
SAA1
|
serum amyloid A1 |
| chr8_+_120220561 | 5.50 |
ENST00000276681.6
|
MAL2
|
mal, T-cell differentiation protein 2 (gene/pseudogene) |
| chr22_-_37640277 | 5.48 |
ENST00000401529.3
ENST00000249071.6 |
RAC2
|
ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2) |
| chr6_-_10413112 | 5.48 |
ENST00000465858.1
|
TFAP2A
|
transcription factor AP-2 alpha (activating enhancer binding protein 2 alpha) |
| chr6_+_41604620 | 5.48 |
ENST00000432027.1
|
MDFI
|
MyoD family inhibitor |
| chr1_-_209825674 | 5.47 |
ENST00000367030.3
ENST00000356082.4 |
LAMB3
|
laminin, beta 3 |
| chr11_+_34642656 | 5.47 |
ENST00000257831.3
ENST00000450654.2 |
EHF
|
ets homologous factor |
| chr11_-_441964 | 5.46 |
ENST00000332826.6
|
ANO9
|
anoctamin 9 |
| chr1_-_207206092 | 5.43 |
ENST00000359470.5
ENST00000461135.2 |
C1orf116
|
chromosome 1 open reading frame 116 |
| chr11_+_117947724 | 5.42 |
ENST00000534111.1
|
TMPRSS4
|
transmembrane protease, serine 4 |
| chr5_-_138862326 | 5.41 |
ENST00000330794.4
|
TMEM173
|
transmembrane protein 173 |
| chr10_+_20105157 | 5.41 |
ENST00000377242.3
ENST00000377252.4 |
PLXDC2
|
plexin domain containing 2 |
| chr4_-_102268708 | 5.39 |
ENST00000525819.1
|
PPP3CA
|
protein phosphatase 3, catalytic subunit, alpha isozyme |
| chr8_+_95653427 | 5.36 |
ENST00000454170.2
|
ESRP1
|
epithelial splicing regulatory protein 1 |
| chr12_+_7072354 | 5.35 |
ENST00000537269.1
|
U47924.27
|
U47924.27 |
| chr11_-_321050 | 5.32 |
ENST00000399808.4
|
IFITM3
|
interferon induced transmembrane protein 3 |
| chr9_-_22009297 | 5.30 |
ENST00000276925.6
|
CDKN2B
|
cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4) |
| chr19_-_45908292 | 5.26 |
ENST00000360957.5
ENST00000592134.1 |
PPP1R13L
|
protein phosphatase 1, regulatory subunit 13 like |
| chr16_-_68269971 | 5.26 |
ENST00000565858.1
|
ESRP2
|
epithelial splicing regulatory protein 2 |
| chr15_+_41136734 | 5.25 |
ENST00000568580.1
|
SPINT1
|
serine peptidase inhibitor, Kunitz type 1 |
| chr14_+_23305783 | 5.25 |
ENST00000547279.1
|
MMP14
|
matrix metallopeptidase 14 (membrane-inserted) |
| chr7_-_127672146 | 5.21 |
ENST00000476782.1
|
LRRC4
|
leucine rich repeat containing 4 |
| chr5_+_150400124 | 5.16 |
ENST00000388825.4
ENST00000521650.1 ENST00000517973.1 |
GPX3
|
glutathione peroxidase 3 (plasma) |
| chr11_-_57194550 | 5.16 |
ENST00000528187.1
ENST00000524863.1 ENST00000533051.1 ENST00000529494.1 ENST00000395124.1 ENST00000533524.1 ENST00000533245.1 ENST00000530316.1 |
SLC43A3
|
solute carrier family 43, member 3 |
| chr2_+_17721920 | 5.14 |
ENST00000295156.4
|
VSNL1
|
visinin-like 1 |
| chr14_-_23834411 | 5.13 |
ENST00000429593.2
|
EFS
|
embryonal Fyn-associated substrate |
| chr19_-_12912657 | 5.12 |
ENST00000301522.2
|
PRDX2
|
peroxiredoxin 2 |
| chrX_-_48328551 | 5.11 |
ENST00000376876.3
|
SLC38A5
|
solute carrier family 38, member 5 |
| chr1_-_26680570 | 5.10 |
ENST00000475866.2
|
AIM1L
|
absent in melanoma 1-like |
| chr17_-_39928106 | 5.10 |
ENST00000540235.1
|
JUP
|
junction plakoglobin |
| chr2_-_46385 | 5.09 |
ENST00000327669.4
|
FAM110C
|
family with sequence similarity 110, member C |
| chr11_-_111784005 | 5.07 |
ENST00000527899.1
|
CRYAB
|
crystallin, alpha B |
| chr11_+_18287721 | 5.07 |
ENST00000356524.4
|
SAA1
|
serum amyloid A1 |
| chr1_+_35220613 | 5.06 |
ENST00000338513.1
|
GJB5
|
gap junction protein, beta 5, 31.1kDa |
| chr16_-_65155833 | 5.05 |
ENST00000566827.1
ENST00000394156.3 ENST00000562998.1 |
CDH11
|
cadherin 11, type 2, OB-cadherin (osteoblast) |
| chr10_+_112631699 | 5.05 |
ENST00000444997.1
|
PDCD4
|
programmed cell death 4 (neoplastic transformation inhibitor) |
| chr4_+_4388245 | 5.03 |
ENST00000433139.2
|
NSG1
|
Homo sapiens neuron specific gene family member 1 (NSG1), transcript variant 3, mRNA. |
| chr6_-_31846744 | 5.01 |
ENST00000414427.1
ENST00000229729.6 ENST00000375562.4 |
SLC44A4
|
solute carrier family 44, member 4 |
| chr17_+_7348658 | 5.01 |
ENST00000570557.1
ENST00000536404.2 ENST00000576360.1 |
CHRNB1
|
cholinergic receptor, nicotinic, beta 1 (muscle) |
| chr6_+_30848740 | 5.00 |
ENST00000505534.1
|
DDR1
|
discoidin domain receptor tyrosine kinase 1 |
| chr11_+_71846764 | 4.99 |
ENST00000456237.1
ENST00000442948.2 ENST00000546166.1 |
FOLR3
|
folate receptor 3 (gamma) |
| chr11_+_5711010 | 4.98 |
ENST00000454828.1
|
TRIM22
|
tripartite motif containing 22 |
| chr7_+_145813453 | 4.98 |
ENST00000361727.3
|
CNTNAP2
|
contactin associated protein-like 2 |
| chr11_-_125365435 | 4.98 |
ENST00000524435.1
|
FEZ1
|
fasciculation and elongation protein zeta 1 (zygin I) |
| chr9_+_130911770 | 4.96 |
ENST00000372998.1
|
LCN2
|
lipocalin 2 |
| chr1_-_159915386 | 4.95 |
ENST00000361509.3
ENST00000368094.1 |
IGSF9
|
immunoglobulin superfamily, member 9 |
| chr17_-_39769005 | 4.93 |
ENST00000301653.4
ENST00000593067.1 |
KRT16
|
keratin 16 |
| chr15_+_41136586 | 4.92 |
ENST00000431806.1
|
SPINT1
|
serine peptidase inhibitor, Kunitz type 1 |
| chr19_-_43969796 | 4.91 |
ENST00000244333.3
|
LYPD3
|
LY6/PLAUR domain containing 3 |
| chr1_+_117452669 | 4.89 |
ENST00000393203.2
|
PTGFRN
|
prostaglandin F2 receptor inhibitor |
Network of associatons between targets according to the STRING database.
First level regulatory network of WRNIP1
Gene Ontology Analysis
Gene overrepresentation in biological_process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 7.1 | 42.7 | GO:0002803 | positive regulation of antimicrobial peptide production(GO:0002225) positive regulation of antimicrobial humoral response(GO:0002760) positive regulation of antibacterial peptide production(GO:0002803) |
| 6.0 | 17.9 | GO:1904316 | positive regulation of neutrophil degranulation(GO:0043315) cellular response to gravity(GO:0071258) positive regulation of neutrophil activation(GO:1902565) regulation of transcytosis(GO:1904298) positive regulation of transcytosis(GO:1904300) regulation of maternal process involved in parturition(GO:1904301) positive regulation of maternal process involved in parturition(GO:1904303) response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904316) cellular response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904317) |
| 5.7 | 17.0 | GO:1904328 | regulation of myofibroblast contraction(GO:1904328) myofibroblast contraction(GO:1990764) |
| 5.1 | 5.1 | GO:0043491 | protein kinase B signaling(GO:0043491) |
| 4.7 | 9.4 | GO:0002541 | activation of plasma proteins involved in acute inflammatory response(GO:0002541) |
| 4.6 | 13.9 | GO:0046586 | regulation of calcium-dependent cell-cell adhesion(GO:0046586) |
| 4.6 | 18.3 | GO:0051796 | regulation of monophenol monooxygenase activity(GO:0032771) positive regulation of monophenol monooxygenase activity(GO:0032773) negative regulation of catagen(GO:0051796) regulation of hair cycle by canonical Wnt signaling pathway(GO:0060901) positive regulation of melanosome transport(GO:1902910) |
| 4.4 | 13.1 | GO:1904784 | NLRP1 inflammasome complex assembly(GO:1904784) |
| 4.1 | 20.3 | GO:0051622 | negative regulation of dopamine uptake involved in synaptic transmission(GO:0051585) norepinephrine uptake(GO:0051620) regulation of norepinephrine uptake(GO:0051621) negative regulation of norepinephrine uptake(GO:0051622) negative regulation of catecholamine uptake involved in synaptic transmission(GO:0051945) regulation of glutathione peroxidase activity(GO:1903282) positive regulation of glutathione peroxidase activity(GO:1903284) positive regulation of hydrogen peroxide catabolic process(GO:1903285) positive regulation of peroxidase activity(GO:2000470) |
| 4.0 | 28.3 | GO:1903575 | cornified envelope assembly(GO:1903575) |
| 3.7 | 14.6 | GO:0006542 | glutamine biosynthetic process(GO:0006542) |
| 3.5 | 10.6 | GO:0061193 | sensory organ boundary specification(GO:0008052) formation of organ boundary(GO:0010160) taste bud development(GO:0061193) |
| 3.3 | 39.3 | GO:0035986 | senescence-associated heterochromatin focus assembly(GO:0035986) |
| 3.2 | 9.6 | GO:1904761 | negative regulation of myofibroblast differentiation(GO:1904761) |
| 3.1 | 6.1 | GO:0001300 | chronological cell aging(GO:0001300) |
| 3.0 | 12.2 | GO:0086092 | regulation of the force of heart contraction by cardiac conduction(GO:0086092) |
| 3.0 | 15.0 | GO:0021623 | optic cup structural organization(GO:0003409) oculomotor nerve morphogenesis(GO:0021622) oculomotor nerve formation(GO:0021623) |
| 3.0 | 56.8 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
| 3.0 | 5.9 | GO:2000646 | positive regulation of receptor catabolic process(GO:2000646) |
| 2.9 | 20.1 | GO:0031642 | negative regulation of myelination(GO:0031642) |
| 2.8 | 2.8 | GO:0023019 | signal transduction involved in regulation of gene expression(GO:0023019) |
| 2.8 | 2.8 | GO:0032461 | positive regulation of protein oligomerization(GO:0032461) |
| 2.8 | 16.6 | GO:0042335 | cuticle development(GO:0042335) |
| 2.7 | 8.2 | GO:0060054 | positive regulation of epithelial cell proliferation involved in wound healing(GO:0060054) |
| 2.7 | 10.8 | GO:0007499 | ectoderm and mesoderm interaction(GO:0007499) |
| 2.6 | 7.8 | GO:0043449 | cellular alkene metabolic process(GO:0043449) |
| 2.5 | 7.6 | GO:0002585 | positive regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002582) positive regulation of antigen processing and presentation of peptide antigen(GO:0002585) positive regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002588) |
| 2.5 | 10.0 | GO:0051710 | regulation of cytolysis in other organism(GO:0051710) |
| 2.5 | 2.5 | GO:0045807 | positive regulation of endocytosis(GO:0045807) |
| 2.4 | 7.2 | GO:0045360 | regulation of interleukin-1 biosynthetic process(GO:0045360) positive regulation of interleukin-1 biosynthetic process(GO:0045362) |
| 2.4 | 7.2 | GO:0060915 | fibroblast growth factor receptor signaling pathway involved in negative regulation of apoptotic process in bone marrow(GO:0035602) fibroblast growth factor receptor signaling pathway involved in hemopoiesis(GO:0035603) fibroblast growth factor receptor signaling pathway involved in positive regulation of cell proliferation in bone marrow(GO:0035604) fibroblast growth factor receptor signaling pathway involved in mammary gland specification(GO:0060595) mammary gland bud formation(GO:0060615) branch elongation involved in salivary gland morphogenesis(GO:0060667) mesenchymal cell differentiation involved in lung development(GO:0060915) |
| 2.4 | 16.6 | GO:0071461 | cellular response to redox state(GO:0071461) |
| 2.3 | 7.0 | GO:0098736 | regulation of cellular amine catabolic process(GO:0033241) negative regulation of cellular amine catabolic process(GO:0033242) negative regulation of the force of heart contraction(GO:0098736) regulation of arginine catabolic process(GO:1900081) negative regulation of arginine catabolic process(GO:1900082) regulation of citrulline biosynthetic process(GO:1903248) negative regulation of citrulline biosynthetic process(GO:1903249) negative regulation of cellular amino acid biosynthetic process(GO:2000283) |
| 2.3 | 2.3 | GO:0018277 | protein deamination(GO:0018277) |
| 2.3 | 16.1 | GO:0010046 | response to mycotoxin(GO:0010046) |
| 2.3 | 6.9 | GO:0001798 | positive regulation of type IIa hypersensitivity(GO:0001798) positive regulation of type II hypersensitivity(GO:0002894) |
| 2.3 | 47.9 | GO:0016540 | protein autoprocessing(GO:0016540) |
| 2.3 | 41.1 | GO:0015816 | glycine transport(GO:0015816) |
| 2.3 | 15.8 | GO:0071279 | cellular response to cobalt ion(GO:0071279) |
| 2.2 | 8.7 | GO:0010983 | positive regulation of high-density lipoprotein particle clearance(GO:0010983) |
| 2.1 | 6.4 | GO:0071109 | superior temporal gyrus development(GO:0071109) |
| 2.1 | 2.1 | GO:0097017 | renal protein absorption(GO:0097017) |
| 2.1 | 4.1 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
| 2.0 | 8.1 | GO:0045578 | negative regulation of B cell differentiation(GO:0045578) |
| 2.0 | 19.9 | GO:1990834 | response to odorant(GO:1990834) |
| 2.0 | 17.8 | GO:0032348 | negative regulation of aldosterone metabolic process(GO:0032345) negative regulation of aldosterone biosynthetic process(GO:0032348) negative regulation of cortisol biosynthetic process(GO:2000065) |
| 1.9 | 9.7 | GO:0043553 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
| 1.9 | 13.4 | GO:0043163 | cell envelope organization(GO:0043163) external encapsulating structure organization(GO:0045229) |
| 1.9 | 5.7 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
| 1.9 | 69.0 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
| 1.9 | 5.6 | GO:1903452 | regulation of G1 to G0 transition(GO:1903450) positive regulation of G1 to G0 transition(GO:1903452) |
| 1.8 | 1.8 | GO:0060594 | mammary gland specification(GO:0060594) |
| 1.8 | 5.5 | GO:0015728 | mevalonate transport(GO:0015728) behavioral response to nutrient(GO:0051780) |
| 1.8 | 9.2 | GO:1904450 | negative regulation of gamma-aminobutyric acid secretion(GO:0014053) aspartate secretion(GO:0061528) regulation of aspartate secretion(GO:1904448) positive regulation of aspartate secretion(GO:1904450) |
| 1.8 | 7.4 | GO:1905205 | positive regulation of connective tissue replacement(GO:1905205) |
| 1.8 | 18.3 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
| 1.8 | 43.9 | GO:0090026 | positive regulation of monocyte chemotaxis(GO:0090026) |
| 1.7 | 1.7 | GO:0002784 | regulation of antimicrobial peptide production(GO:0002784) regulation of antibacterial peptide production(GO:0002786) |
| 1.7 | 12.1 | GO:1902164 | regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902162) positive regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902164) |
| 1.7 | 1.7 | GO:2001035 | tongue muscle cell differentiation(GO:0035981) positive regulation of skeletal muscle fiber differentiation(GO:1902811) regulation of tongue muscle cell differentiation(GO:2001035) positive regulation of tongue muscle cell differentiation(GO:2001037) |
| 1.7 | 8.5 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
| 1.7 | 5.1 | GO:1903572 | regulation of protein kinase D signaling(GO:1903570) positive regulation of protein kinase D signaling(GO:1903572) |
| 1.7 | 5.1 | GO:0097195 | pilomotor reflex(GO:0097195) |
| 1.7 | 5.0 | GO:0061713 | neural crest cell migration involved in heart formation(GO:0003147) anterior neural tube closure(GO:0061713) |
| 1.7 | 8.3 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
| 1.6 | 4.9 | GO:0035606 | peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
| 1.6 | 9.7 | GO:0030421 | defecation(GO:0030421) |
| 1.6 | 4.9 | GO:0034970 | histone H3-R2 methylation(GO:0034970) |
| 1.6 | 6.5 | GO:2001287 | negative regulation of caveolin-mediated endocytosis(GO:2001287) |
| 1.6 | 3.2 | GO:0060734 | regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:0060734) |
| 1.6 | 6.4 | GO:0046833 | positive regulation of RNA export from nucleus(GO:0046833) |
| 1.6 | 4.8 | GO:0046521 | sphingoid catabolic process(GO:0046521) |
| 1.6 | 12.8 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
| 1.6 | 1.6 | GO:0031077 | post-embryonic camera-type eye development(GO:0031077) |
| 1.6 | 6.4 | GO:1904199 | positive regulation of regulation of vascular smooth muscle cell membrane depolarization(GO:1904199) regulation of vascular smooth muscle cell membrane depolarization(GO:1990736) |
| 1.6 | 1.6 | GO:1901532 | regulation of hematopoietic progenitor cell differentiation(GO:1901532) |
| 1.6 | 9.5 | GO:0033591 | response to L-ascorbic acid(GO:0033591) |
| 1.6 | 1.6 | GO:0051461 | regulation of corticotropin secretion(GO:0051459) positive regulation of corticotropin secretion(GO:0051461) |
| 1.5 | 1.5 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
| 1.5 | 4.6 | GO:0070563 | negative regulation of vitamin D receptor signaling pathway(GO:0070563) |
| 1.5 | 7.7 | GO:1905167 | positive regulation of lysosomal protein catabolic process(GO:1905167) |
| 1.5 | 4.6 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
| 1.5 | 9.1 | GO:1904274 | tricellular tight junction assembly(GO:1904274) |
| 1.5 | 6.1 | GO:0060448 | dichotomous subdivision of terminal units involved in lung branching(GO:0060448) |
| 1.5 | 12.1 | GO:0060753 | regulation of mast cell chemotaxis(GO:0060753) |
| 1.5 | 4.5 | GO:0043012 | regulation of fusion of sperm to egg plasma membrane(GO:0043012) |
| 1.5 | 7.3 | GO:1903906 | plasma membrane raft distribution(GO:0044855) plasma membrane raft localization(GO:0044856) plasma membrane raft polarization(GO:0044858) regulation of plasma membrane raft polarization(GO:1903906) |
| 1.5 | 7.3 | GO:0032474 | otolith morphogenesis(GO:0032474) |
| 1.4 | 2.9 | GO:0001575 | globoside metabolic process(GO:0001575) |
| 1.4 | 25.9 | GO:0090361 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
| 1.4 | 14.4 | GO:0071639 | positive regulation of monocyte chemotactic protein-1 production(GO:0071639) |
| 1.4 | 1.4 | GO:2000774 | positive regulation of cellular senescence(GO:2000774) |
| 1.4 | 4.3 | GO:0015881 | creatine transport(GO:0015881) creatine transmembrane transport(GO:1902598) |
| 1.4 | 11.2 | GO:0046952 | ketone body catabolic process(GO:0046952) |
| 1.4 | 4.1 | GO:1902173 | negative regulation of keratinocyte apoptotic process(GO:1902173) |
| 1.4 | 2.7 | GO:1904179 | positive regulation of adipose tissue development(GO:1904179) |
| 1.4 | 4.1 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
| 1.4 | 4.1 | GO:0060697 | positive regulation of phospholipid catabolic process(GO:0060697) |
| 1.4 | 9.5 | GO:0010752 | regulation of cGMP-mediated signaling(GO:0010752) |
| 1.4 | 4.1 | GO:0048627 | myoblast development(GO:0048627) |
| 1.3 | 2.7 | GO:1903519 | apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
| 1.3 | 10.7 | GO:0048102 | autophagic cell death(GO:0048102) |
| 1.3 | 9.2 | GO:0060671 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
| 1.3 | 4.0 | GO:0019858 | cytosine metabolic process(GO:0019858) |
| 1.3 | 3.9 | GO:0003365 | establishment of cell polarity involved in ameboidal cell migration(GO:0003365) |
| 1.3 | 3.9 | GO:0045608 | negative regulation of auditory receptor cell differentiation(GO:0045608) |
| 1.3 | 3.9 | GO:0052553 | induction by symbiont of host defense response(GO:0044416) induction of host immune response by virus(GO:0046730) active induction of host immune response by virus(GO:0046732) modulation by symbiont of host defense response(GO:0052031) induction by organism of defense response of other organism involved in symbiotic interaction(GO:0052251) modulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052255) positive regulation by symbiont of host defense response(GO:0052509) positive regulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052510) modulation by organism of immune response of other organism involved in symbiotic interaction(GO:0052552) modulation by symbiont of host immune response(GO:0052553) modulation by virus of host immune response(GO:0075528) |
| 1.3 | 5.2 | GO:0009956 | radial pattern formation(GO:0009956) |
| 1.3 | 5.1 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
| 1.3 | 1.3 | GO:0010482 | epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) |
| 1.3 | 12.7 | GO:0002480 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent(GO:0002480) |
| 1.3 | 12.7 | GO:0071847 | TNFSF11-mediated signaling pathway(GO:0071847) |
| 1.3 | 15.2 | GO:0086073 | bundle of His cell-Purkinje myocyte adhesion involved in cell communication(GO:0086073) |
| 1.3 | 12.5 | GO:2001181 | positive regulation of interleukin-10 secretion(GO:2001181) |
| 1.2 | 8.7 | GO:0072674 | multinuclear osteoclast differentiation(GO:0072674) osteoclast fusion(GO:0072675) |
| 1.2 | 8.7 | GO:0048050 | post-embryonic eye morphogenesis(GO:0048050) |
| 1.2 | 8.6 | GO:2000609 | regulation of thyroid hormone generation(GO:2000609) |
| 1.2 | 1.2 | GO:0060738 | epithelial-mesenchymal signaling involved in prostate gland development(GO:0060738) |
| 1.2 | 3.6 | GO:1990108 | protein linear deubiquitination(GO:1990108) |
| 1.2 | 3.6 | GO:1990029 | atrial ventricular junction remodeling(GO:0003294) atrial cardiac muscle cell to AV node cell communication by electrical coupling(GO:0086044) bundle of His cell to Purkinje myocyte communication by electrical coupling(GO:0086054) Purkinje myocyte to ventricular cardiac muscle cell communication by electrical coupling(GO:0086055) regulation of Purkinje myocyte action potential(GO:0098906) vasomotion(GO:1990029) |
| 1.2 | 4.8 | GO:0061357 | positive regulation of Wnt protein secretion(GO:0061357) |
| 1.2 | 4.8 | GO:0035634 | response to stilbenoid(GO:0035634) |
| 1.2 | 2.4 | GO:0032912 | negative regulation of transforming growth factor beta2 production(GO:0032912) |
| 1.2 | 19.1 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
| 1.2 | 4.6 | GO:1903542 | negative regulation of exosomal secretion(GO:1903542) |
| 1.2 | 3.5 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
| 1.1 | 4.6 | GO:1990169 | detoxification of copper ion(GO:0010273) stress response to copper ion(GO:1990169) |
| 1.1 | 9.1 | GO:0030578 | PML body organization(GO:0030578) |
| 1.1 | 3.4 | GO:0046963 | 3'-phosphoadenosine 5'-phosphosulfate transport(GO:0046963) 3'-phospho-5'-adenylyl sulfate transmembrane transport(GO:1902559) |
| 1.1 | 1.1 | GO:1902256 | apoptotic process involved in outflow tract morphogenesis(GO:0003275) regulation of apoptotic process involved in outflow tract morphogenesis(GO:1902256) |
| 1.1 | 16.6 | GO:0060707 | trophoblast giant cell differentiation(GO:0060707) |
| 1.1 | 3.3 | GO:1903121 | regulation of TRAIL-activated apoptotic signaling pathway(GO:1903121) positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
| 1.1 | 1.1 | GO:0002386 | immune response in mucosal-associated lymphoid tissue(GO:0002386) |
| 1.1 | 6.5 | GO:1902045 | negative regulation of Fas signaling pathway(GO:1902045) |
| 1.1 | 4.3 | GO:2001023 | regulation of response to drug(GO:2001023) |
| 1.1 | 1.1 | GO:0070933 | histone H4 deacetylation(GO:0070933) |
| 1.1 | 7.5 | GO:0030035 | microspike assembly(GO:0030035) |
| 1.1 | 9.6 | GO:1900623 | regulation of monocyte aggregation(GO:1900623) positive regulation of monocyte aggregation(GO:1900625) |
| 1.1 | 1.1 | GO:0021773 | striatal medium spiny neuron differentiation(GO:0021773) |
| 1.1 | 2.1 | GO:0035635 | entry of bacterium into host cell(GO:0035635) |
| 1.1 | 6.3 | GO:1904222 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
| 1.1 | 1.1 | GO:0010633 | negative regulation of epithelial cell migration(GO:0010633) |
| 1.0 | 1.0 | GO:0045763 | negative regulation of cellular amino acid metabolic process(GO:0045763) |
| 1.0 | 1.0 | GO:0046688 | response to copper ion(GO:0046688) |
| 1.0 | 12.4 | GO:0021759 | globus pallidus development(GO:0021759) |
| 1.0 | 4.1 | GO:0090096 | regulation of metanephric cap mesenchymal cell proliferation(GO:0090095) positive regulation of metanephric cap mesenchymal cell proliferation(GO:0090096) |
| 1.0 | 19.4 | GO:0002138 | retinoic acid biosynthetic process(GO:0002138) diterpenoid biosynthetic process(GO:0016102) |
| 1.0 | 4.1 | GO:1903691 | positive regulation of wound healing, spreading of epidermal cells(GO:1903691) |
| 1.0 | 50.5 | GO:0043616 | keratinocyte proliferation(GO:0043616) |
| 1.0 | 15.1 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
| 1.0 | 8.0 | GO:0051122 | hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
| 1.0 | 9.9 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
| 1.0 | 10.9 | GO:0001660 | fever generation(GO:0001660) |
| 1.0 | 2.0 | GO:0090032 | negative regulation of glucocorticoid metabolic process(GO:0031944) negative regulation of glucocorticoid biosynthetic process(GO:0031947) negative regulation of steroid hormone biosynthetic process(GO:0090032) |
| 1.0 | 5.9 | GO:0018032 | protein amidation(GO:0018032) |
| 1.0 | 1.0 | GO:1901205 | regulation of adrenergic receptor signaling pathway involved in heart process(GO:1901204) negative regulation of adrenergic receptor signaling pathway involved in heart process(GO:1901205) |
| 1.0 | 5.8 | GO:0035063 | nuclear speck organization(GO:0035063) |
| 1.0 | 2.9 | GO:1904237 | regulation of substrate-dependent cell migration, cell attachment to substrate(GO:1904235) positive regulation of substrate-dependent cell migration, cell attachment to substrate(GO:1904237) |
| 1.0 | 2.9 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
| 1.0 | 1.9 | GO:0060413 | atrial septum morphogenesis(GO:0060413) |
| 1.0 | 24.8 | GO:0048730 | epidermis morphogenesis(GO:0048730) |
| 1.0 | 3.8 | GO:0035879 | plasma membrane lactate transport(GO:0035879) |
| 0.9 | 0.9 | GO:0014005 | microglia differentiation(GO:0014004) microglia development(GO:0014005) |
| 0.9 | 4.7 | GO:0030822 | positive regulation of cyclic nucleotide catabolic process(GO:0030807) positive regulation of cAMP catabolic process(GO:0030822) positive regulation of purine nucleotide catabolic process(GO:0033123) |
| 0.9 | 3.7 | GO:1902938 | regulation of intracellular calcium activated chloride channel activity(GO:1902938) |
| 0.9 | 2.8 | GO:0097676 | histone H3-K36 dimethylation(GO:0097676) |
| 0.9 | 6.5 | GO:0038172 | interleukin-33-mediated signaling pathway(GO:0038172) |
| 0.9 | 4.6 | GO:0015917 | aminophospholipid transport(GO:0015917) |
| 0.9 | 7.4 | GO:1901297 | arterial endothelial cell fate commitment(GO:0060844) positive regulation of ephrin receptor signaling pathway(GO:1901189) positive regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment(GO:1901297) positive regulation of canonical Wnt signaling pathway involved in heart development(GO:1905068) |
| 0.9 | 15.7 | GO:0033160 | positive regulation of protein import into nucleus, translocation(GO:0033160) |
| 0.9 | 6.4 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
| 0.9 | 30.8 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
| 0.9 | 1.8 | GO:1903204 | negative regulation of oxidative stress-induced neuron death(GO:1903204) |
| 0.9 | 3.6 | GO:1904799 | negative regulation of dendrite extension(GO:1903860) regulation of neuron remodeling(GO:1904799) negative regulation of neuron remodeling(GO:1904800) negative regulation of branching morphogenesis of a nerve(GO:2000173) |
| 0.9 | 2.7 | GO:0060545 | positive regulation of necroptotic process(GO:0060545) |
| 0.9 | 4.5 | GO:0045659 | regulation of neutrophil differentiation(GO:0045658) negative regulation of neutrophil differentiation(GO:0045659) |
| 0.9 | 22.3 | GO:0007021 | tubulin complex assembly(GO:0007021) |
| 0.9 | 3.6 | GO:0001971 | negative regulation of activation of membrane attack complex(GO:0001971) |
| 0.9 | 5.3 | GO:0015746 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
| 0.9 | 4.4 | GO:0090285 | negative regulation of protein glycosylation in Golgi(GO:0090285) |
| 0.9 | 9.7 | GO:0016199 | axon midline choice point recognition(GO:0016199) |
| 0.9 | 6.1 | GO:0051012 | microtubule sliding(GO:0051012) |
| 0.9 | 7.9 | GO:0035290 | trunk segmentation(GO:0035290) trunk neural crest cell migration(GO:0036484) ventral trunk neural crest cell migration(GO:0036486) neural crest cell migration involved in autonomic nervous system development(GO:1901166) |
| 0.9 | 2.6 | GO:0001544 | initiation of primordial ovarian follicle growth(GO:0001544) |
| 0.9 | 2.6 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
| 0.9 | 2.6 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
| 0.9 | 2.6 | GO:0032707 | negative regulation of interleukin-23 production(GO:0032707) |
| 0.9 | 4.3 | GO:0042412 | taurine biosynthetic process(GO:0042412) |
| 0.9 | 5.1 | GO:0035726 | common myeloid progenitor cell proliferation(GO:0035726) |
| 0.9 | 6.0 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
| 0.9 | 3.4 | GO:0035425 | autocrine signaling(GO:0035425) |
| 0.9 | 4.3 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
| 0.9 | 13.6 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
| 0.8 | 1.7 | GO:0035627 | ceramide transport(GO:0035627) |
| 0.8 | 2.5 | GO:0044878 | mitotic cytokinesis checkpoint(GO:0044878) |
| 0.8 | 13.5 | GO:0015871 | choline transport(GO:0015871) |
| 0.8 | 4.2 | GO:0030311 | poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
| 0.8 | 2.5 | GO:0007113 | endomitotic cell cycle(GO:0007113) |
| 0.8 | 5.8 | GO:0008218 | bioluminescence(GO:0008218) |
| 0.8 | 2.5 | GO:1902722 | positive regulation of prolactin secretion(GO:1902722) |
| 0.8 | 4.1 | GO:0090649 | response to oxygen-glucose deprivation(GO:0090649) cellular response to oxygen-glucose deprivation(GO:0090650) |
| 0.8 | 4.1 | GO:0061724 | lipophagy(GO:0061724) |
| 0.8 | 5.7 | GO:0006196 | AMP catabolic process(GO:0006196) |
| 0.8 | 2.4 | GO:0001172 | transcription, RNA-templated(GO:0001172) |
| 0.8 | 6.5 | GO:1902714 | negative regulation of interferon-gamma secretion(GO:1902714) |
| 0.8 | 9.7 | GO:0009134 | nucleoside diphosphate catabolic process(GO:0009134) |
| 0.8 | 7.3 | GO:0046642 | negative regulation of alpha-beta T cell proliferation(GO:0046642) |
| 0.8 | 2.4 | GO:0098886 | modification of dendritic spine(GO:0098886) |
| 0.8 | 0.8 | GO:0000491 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
| 0.8 | 3.2 | GO:0018352 | protein-pyridoxal-5-phosphate linkage(GO:0018352) |
| 0.8 | 2.4 | GO:0003366 | cell-matrix adhesion involved in ameboidal cell migration(GO:0003366) |
| 0.8 | 3.2 | GO:0006068 | ethanol catabolic process(GO:0006068) |
| 0.8 | 2.4 | GO:0071030 | nuclear mRNA surveillance of spliceosomal pre-mRNA splicing(GO:0071030) nuclear retention of unspliced pre-mRNA at the site of transcription(GO:0071048) |
| 0.8 | 2.4 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
| 0.8 | 11.9 | GO:0098887 | neurotransmitter receptor transport, endosome to postsynaptic membrane(GO:0098887) neurotransmitter receptor transport, endosome to plasma membrane(GO:0099639) |
| 0.8 | 6.3 | GO:0032485 | Ral protein signal transduction(GO:0032484) regulation of Ral protein signal transduction(GO:0032485) |
| 0.8 | 4.0 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
| 0.8 | 3.2 | GO:0002442 | serotonin production involved in inflammatory response(GO:0002351) serotonin secretion involved in inflammatory response(GO:0002442) serotonin secretion by platelet(GO:0002554) |
| 0.8 | 1.6 | GO:0035065 | regulation of histone acetylation(GO:0035065) |
| 0.8 | 1.6 | GO:0033364 | mast cell secretory granule organization(GO:0033364) |
| 0.8 | 5.5 | GO:0055059 | asymmetric neuroblast division(GO:0055059) |
| 0.8 | 0.8 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
| 0.8 | 12.4 | GO:0006600 | creatine metabolic process(GO:0006600) |
| 0.8 | 2.3 | GO:0010643 | cell communication by chemical coupling(GO:0010643) |
| 0.8 | 3.0 | GO:0001808 | negative regulation of type IV hypersensitivity(GO:0001808) |
| 0.8 | 20.6 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
| 0.8 | 2.3 | GO:0006478 | peptidyl-tyrosine sulfation(GO:0006478) |
| 0.8 | 9.9 | GO:1902961 | positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902961) positive regulation of aspartic-type peptidase activity(GO:1905247) |
| 0.8 | 1.5 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
| 0.7 | 1.5 | GO:2000412 | positive regulation of thymocyte migration(GO:2000412) |
| 0.7 | 3.7 | GO:0016240 | autophagosome docking(GO:0016240) |
| 0.7 | 6.0 | GO:1902952 | positive regulation of dendritic spine maintenance(GO:1902952) |
| 0.7 | 7.5 | GO:1904327 | protein localization to cytosolic proteasome complex(GO:1904327) protein localization to cytosolic proteasome complex involved in ERAD pathway(GO:1904379) |
| 0.7 | 3.0 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
| 0.7 | 5.2 | GO:1901164 | negative regulation of trophoblast cell migration(GO:1901164) |
| 0.7 | 9.6 | GO:2000680 | rubidium ion transport(GO:0035826) regulation of rubidium ion transport(GO:2000680) |
| 0.7 | 3.7 | GO:0061343 | cell adhesion involved in heart morphogenesis(GO:0061343) |
| 0.7 | 1.5 | GO:0006738 | nicotinamide riboside catabolic process(GO:0006738) nicotinamide riboside metabolic process(GO:0046495) pyridine nucleoside metabolic process(GO:0070637) pyridine nucleoside catabolic process(GO:0070638) |
| 0.7 | 11.6 | GO:0015074 | DNA integration(GO:0015074) |
| 0.7 | 2.9 | GO:0016094 | polyprenol biosynthetic process(GO:0016094) |
| 0.7 | 2.9 | GO:0031630 | regulation of synaptic vesicle fusion to presynaptic membrane(GO:0031630) |
| 0.7 | 2.2 | GO:0051102 | DNA ligation involved in DNA recombination(GO:0051102) |
| 0.7 | 2.2 | GO:0007257 | activation of JUN kinase activity(GO:0007257) |
| 0.7 | 0.7 | GO:1904292 | regulation of ERAD pathway(GO:1904292) |
| 0.7 | 0.7 | GO:0090283 | regulation of protein glycosylation in Golgi(GO:0090283) |
| 0.7 | 2.9 | GO:0061198 | fungiform papilla formation(GO:0061198) |
| 0.7 | 1.4 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
| 0.7 | 1.4 | GO:0023016 | signal transduction by trans-phosphorylation(GO:0023016) |
| 0.7 | 5.7 | GO:0071494 | cellular response to UV-C(GO:0071494) |
| 0.7 | 11.3 | GO:0071481 | cellular response to X-ray(GO:0071481) |
| 0.7 | 2.8 | GO:0033088 | regulation of immature T cell proliferation in thymus(GO:0033084) negative regulation of immature T cell proliferation in thymus(GO:0033088) |
| 0.7 | 6.3 | GO:0046836 | glycolipid transport(GO:0046836) |
| 0.7 | 2.8 | GO:1902766 | skeletal muscle satellite cell migration(GO:1902766) |
| 0.7 | 6.3 | GO:1902915 | negative regulation of protein K63-linked ubiquitination(GO:1900045) negative regulation of protein polyubiquitination(GO:1902915) |
| 0.7 | 2.1 | GO:0006117 | acetaldehyde metabolic process(GO:0006117) |
| 0.7 | 3.5 | GO:0014886 | transition between slow and fast fiber(GO:0014886) |
| 0.7 | 4.2 | GO:0032625 | interleukin-21 production(GO:0032625) interleukin-21 secretion(GO:0072619) |
| 0.7 | 0.7 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
| 0.7 | 11.1 | GO:0001542 | ovulation from ovarian follicle(GO:0001542) |
| 0.7 | 2.1 | GO:0030223 | neutrophil differentiation(GO:0030223) |
| 0.7 | 3.4 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
| 0.7 | 19.0 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
| 0.7 | 1.4 | GO:0060532 | bronchus cartilage development(GO:0060532) lung smooth muscle development(GO:0061145) |
| 0.7 | 1.4 | GO:1904351 | negative regulation of protein catabolic process in the vacuole(GO:1904351) negative regulation of lysosomal protein catabolic process(GO:1905166) |
| 0.7 | 2.7 | GO:1904180 | negative regulation of mitochondrial depolarization(GO:0051902) negative regulation of membrane depolarization(GO:1904180) |
| 0.7 | 4.7 | GO:0070445 | oligodendrocyte progenitor proliferation(GO:0070444) regulation of oligodendrocyte progenitor proliferation(GO:0070445) |
| 0.7 | 0.7 | GO:0061394 | regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance(GO:0061394) |
| 0.7 | 7.3 | GO:0045198 | establishment of epithelial cell apical/basal polarity(GO:0045198) |
| 0.7 | 15.9 | GO:0042744 | hydrogen peroxide catabolic process(GO:0042744) |
| 0.7 | 1.3 | GO:1901526 | positive regulation of macromitophagy(GO:1901526) positive regulation of mitophagy in response to mitochondrial depolarization(GO:1904925) |
| 0.7 | 13.9 | GO:0045056 | transcytosis(GO:0045056) |
| 0.7 | 3.3 | GO:0002296 | T-helper 1 cell lineage commitment(GO:0002296) |
| 0.7 | 2.6 | GO:0060399 | positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
| 0.7 | 2.0 | GO:1903674 | regulation of cap-dependent translational initiation(GO:1903674) positive regulation of cap-dependent translational initiation(GO:1903676) |
| 0.7 | 7.2 | GO:0002329 | pre-B cell differentiation(GO:0002329) |
| 0.7 | 12.4 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
| 0.7 | 0.7 | GO:0000349 | generation of catalytic spliceosome for first transesterification step(GO:0000349) |
| 0.6 | 3.9 | GO:0001920 | negative regulation of receptor recycling(GO:0001920) |
| 0.6 | 0.6 | GO:0042789 | mRNA transcription from RNA polymerase II promoter(GO:0042789) |
| 0.6 | 1.9 | GO:1904996 | positive regulation of leukocyte adhesion to vascular endothelial cell(GO:1904996) |
| 0.6 | 2.6 | GO:0031639 | plasminogen activation(GO:0031639) |
| 0.6 | 3.8 | GO:0006145 | purine nucleobase catabolic process(GO:0006145) |
| 0.6 | 1.3 | GO:0002428 | antigen processing and presentation of peptide antigen via MHC class Ib(GO:0002428) antigen processing and presentation of endogenous peptide antigen via MHC class Ib(GO:0002476) |
| 0.6 | 2.6 | GO:1901668 | regulation of superoxide dismutase activity(GO:1901668) |
| 0.6 | 0.6 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
| 0.6 | 3.2 | GO:0006050 | mannosamine metabolic process(GO:0006050) N-acetylmannosamine metabolic process(GO:0006051) |
| 0.6 | 5.1 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
| 0.6 | 1.3 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
| 0.6 | 1.9 | GO:0072086 | specification of loop of Henle identity(GO:0072086) |
| 0.6 | 1.3 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
| 0.6 | 1.3 | GO:0023021 | termination of signal transduction(GO:0023021) |
| 0.6 | 3.7 | GO:1901911 | diadenosine polyphosphate catabolic process(GO:0015961) diphosphoinositol polyphosphate metabolic process(GO:0071543) diadenosine pentaphosphate metabolic process(GO:1901906) diadenosine pentaphosphate catabolic process(GO:1901907) diadenosine hexaphosphate metabolic process(GO:1901908) diadenosine hexaphosphate catabolic process(GO:1901909) adenosine 5'-(hexahydrogen pentaphosphate) metabolic process(GO:1901910) adenosine 5'-(hexahydrogen pentaphosphate) catabolic process(GO:1901911) |
| 0.6 | 1.9 | GO:0007198 | adenylate cyclase-inhibiting serotonin receptor signaling pathway(GO:0007198) |
| 0.6 | 1.9 | GO:0090527 | actin filament reorganization(GO:0090527) |
| 0.6 | 1.2 | GO:0000294 | nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay(GO:0000294) |
| 0.6 | 1.9 | GO:0038060 | nitric oxide-cGMP-mediated signaling pathway(GO:0038060) |
| 0.6 | 1.2 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
| 0.6 | 7.4 | GO:0015884 | folic acid transport(GO:0015884) |
| 0.6 | 8.6 | GO:0045741 | positive regulation of epidermal growth factor-activated receptor activity(GO:0045741) |
| 0.6 | 1.8 | GO:0003206 | cardiac chamber morphogenesis(GO:0003206) |
| 0.6 | 0.6 | GO:0072268 | pattern specification involved in metanephros development(GO:0072268) |
| 0.6 | 3.0 | GO:0043335 | protein unfolding(GO:0043335) |
| 0.6 | 3.6 | GO:1903378 | positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903378) |
| 0.6 | 3.6 | GO:1900827 | maintenance of protein location in membrane(GO:0072658) maintenance of protein location in plasma membrane(GO:0072660) positive regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900827) |
| 0.6 | 3.0 | GO:0008050 | female courtship behavior(GO:0008050) |
| 0.6 | 3.6 | GO:1900245 | positive regulation of MDA-5 signaling pathway(GO:1900245) |
| 0.6 | 1.8 | GO:0006429 | leucyl-tRNA aminoacylation(GO:0006429) |
| 0.6 | 2.4 | GO:0048294 | negative regulation of isotype switching to IgE isotypes(GO:0048294) |
| 0.6 | 9.0 | GO:0001778 | plasma membrane repair(GO:0001778) |
| 0.6 | 1.8 | GO:0044805 | late nucleophagy(GO:0044805) |
| 0.6 | 1.8 | GO:0006742 | NADP catabolic process(GO:0006742) pyridine nucleotide catabolic process(GO:0019364) |
| 0.6 | 0.6 | GO:0060285 | cilium-dependent cell motility(GO:0060285) |
| 0.6 | 1.2 | GO:0043931 | ossification involved in bone maturation(GO:0043931) |
| 0.6 | 1.8 | GO:0061589 | calcium activated phosphatidylserine scrambling(GO:0061589) |
| 0.6 | 10.6 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
| 0.6 | 1.2 | GO:0050766 | positive regulation of phagocytosis(GO:0050766) |
| 0.6 | 2.9 | GO:0045631 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
| 0.6 | 1.8 | GO:2000820 | negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000820) |
| 0.6 | 14.6 | GO:0060004 | reflex(GO:0060004) |
| 0.6 | 0.6 | GO:0006679 | glucosylceramide biosynthetic process(GO:0006679) |
| 0.6 | 11.6 | GO:0031268 | pseudopodium organization(GO:0031268) |
| 0.6 | 1.7 | GO:0032667 | interleukin-23 production(GO:0032627) regulation of interleukin-23 production(GO:0032667) positive regulation of interleukin-23 production(GO:0032747) |
| 0.6 | 1.2 | GO:1904796 | regulation of core promoter binding(GO:1904796) positive regulation of core promoter binding(GO:1904798) |
| 0.6 | 2.9 | GO:1904578 | response to thapsigargin(GO:1904578) cellular response to thapsigargin(GO:1904579) |
| 0.6 | 11.6 | GO:1904259 | regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904259) positive regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904261) basement membrane assembly involved in embryonic body morphogenesis(GO:2001197) |
| 0.6 | 1.2 | GO:1900155 | regulation of bone trabecula formation(GO:1900154) negative regulation of bone trabecula formation(GO:1900155) |
| 0.6 | 2.9 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
| 0.6 | 1.7 | GO:0070944 | neutrophil mediated cytotoxicity(GO:0070942) neutrophil mediated killing of symbiont cell(GO:0070943) neutrophil mediated killing of bacterium(GO:0070944) neutrophil mediated killing of gram-negative bacterium(GO:0070945) |
| 0.6 | 2.3 | GO:1905232 | cellular response to L-glutamate(GO:1905232) |
| 0.6 | 3.4 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
| 0.6 | 1.7 | GO:1903033 | regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) |
| 0.6 | 9.0 | GO:1900112 | regulation of histone H3-K9 trimethylation(GO:1900112) |
| 0.6 | 1.1 | GO:0060166 | olfactory pit development(GO:0060166) |
| 0.6 | 2.2 | GO:1903233 | regulation of calcium ion-dependent exocytosis of neurotransmitter(GO:1903233) |
| 0.6 | 5.0 | GO:0006049 | UDP-N-acetylglucosamine catabolic process(GO:0006049) |
| 0.6 | 4.5 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
| 0.6 | 2.8 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
| 0.6 | 2.8 | GO:0036414 | protein citrullination(GO:0018101) histone citrullination(GO:0036414) |
| 0.6 | 1.1 | GO:0044828 | negative regulation by host of viral genome replication(GO:0044828) |
| 0.6 | 1.7 | GO:0002276 | basophil activation involved in immune response(GO:0002276) |
| 0.6 | 1.1 | GO:0045836 | positive regulation of meiotic nuclear division(GO:0045836) |
| 0.5 | 4.9 | GO:0040032 | post-embryonic body morphogenesis(GO:0040032) |
| 0.5 | 1.6 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
| 0.5 | 1.1 | GO:0010751 | negative regulation of nitric oxide mediated signal transduction(GO:0010751) |
| 0.5 | 2.7 | GO:0018153 | isopeptide cross-linking via N6-(L-isoglutamyl)-L-lysine(GO:0018153) isopeptide cross-linking(GO:0018262) |
| 0.5 | 5.5 | GO:1903672 | positive regulation of sprouting angiogenesis(GO:1903672) |
| 0.5 | 2.2 | GO:0051547 | regulation of keratinocyte migration(GO:0051547) |
| 0.5 | 1.1 | GO:0006382 | adenosine to inosine editing(GO:0006382) |
| 0.5 | 6.5 | GO:0006657 | CDP-choline pathway(GO:0006657) |
| 0.5 | 2.7 | GO:0031650 | regulation of heat generation(GO:0031650) |
| 0.5 | 2.2 | GO:1902744 | negative regulation of lamellipodium organization(GO:1902744) |
| 0.5 | 8.5 | GO:0008090 | retrograde axonal transport(GO:0008090) |
| 0.5 | 2.1 | GO:1903381 | neuron intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0036483) regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903381) negative regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903382) |
| 0.5 | 1.6 | GO:0072738 | response to diamide(GO:0072737) cellular response to diamide(GO:0072738) |
| 0.5 | 1.6 | GO:0061428 | negative regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061428) |
| 0.5 | 9.6 | GO:0061436 | establishment of skin barrier(GO:0061436) |
| 0.5 | 6.4 | GO:0070970 | interleukin-2 secretion(GO:0070970) |
| 0.5 | 2.1 | GO:1902661 | positive regulation of glucose mediated signaling pathway(GO:1902661) |
| 0.5 | 41.9 | GO:0050909 | sensory perception of taste(GO:0050909) |
| 0.5 | 5.3 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
| 0.5 | 0.5 | GO:1903902 | positive regulation of viral life cycle(GO:1903902) |
| 0.5 | 0.5 | GO:1902041 | regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902041) |
| 0.5 | 1.0 | GO:0032439 | endosome localization(GO:0032439) |
| 0.5 | 2.1 | GO:0010940 | positive regulation of necrotic cell death(GO:0010940) |
| 0.5 | 10.4 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
| 0.5 | 2.6 | GO:0001909 | leukocyte mediated cytotoxicity(GO:0001909) |
| 0.5 | 2.1 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
| 0.5 | 4.1 | GO:1900425 | negative regulation of defense response to bacterium(GO:1900425) |
| 0.5 | 4.6 | GO:1904352 | positive regulation of protein catabolic process in the vacuole(GO:1904352) |
| 0.5 | 2.1 | GO:1904978 | regulation of endosome organization(GO:1904978) |
| 0.5 | 3.1 | GO:0043415 | positive regulation of satellite cell activation involved in skeletal muscle regeneration(GO:0014718) positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
| 0.5 | 1.0 | GO:0003151 | outflow tract morphogenesis(GO:0003151) |
| 0.5 | 2.6 | GO:0035617 | stress granule disassembly(GO:0035617) |
| 0.5 | 1.0 | GO:0060474 | positive regulation of sperm motility involved in capacitation(GO:0060474) |
| 0.5 | 4.0 | GO:0042048 | olfactory behavior(GO:0042048) |
| 0.5 | 2.5 | GO:0038018 | Wnt receptor catabolic process(GO:0038018) |
| 0.5 | 0.5 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
| 0.5 | 1.5 | GO:0048203 | vesicle targeting, trans-Golgi to endosome(GO:0048203) |
| 0.5 | 4.5 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
| 0.5 | 2.5 | GO:0009804 | coumarin metabolic process(GO:0009804) |
| 0.5 | 1.0 | GO:1903298 | regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903297) negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903298) intrinsic apoptotic signaling pathway in response to hypoxia(GO:1990144) |
| 0.5 | 1.5 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
| 0.5 | 7.4 | GO:0097264 | self proteolysis(GO:0097264) |
| 0.5 | 2.5 | GO:0002282 | microglial cell activation involved in immune response(GO:0002282) |
| 0.5 | 5.4 | GO:0002084 | protein depalmitoylation(GO:0002084) |
| 0.5 | 4.4 | GO:0055118 | negative regulation of cardiac muscle contraction(GO:0055118) |
| 0.5 | 0.5 | GO:0090118 | receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport(GO:0090118) |
| 0.5 | 1.0 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
| 0.5 | 2.9 | GO:0070458 | cellular detoxification of nitrogen compound(GO:0070458) |
| 0.5 | 3.4 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
| 0.5 | 1.5 | GO:0042938 | dipeptide transport(GO:0042938) |
| 0.5 | 4.8 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
| 0.5 | 1.5 | GO:0038033 | positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway(GO:0038033) |
| 0.5 | 0.5 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) platelet activating factor metabolic process(GO:0046469) |
| 0.5 | 1.0 | GO:0071611 | macrophage colony-stimulating factor production(GO:0036301) granulocyte colony-stimulating factor production(GO:0071611) regulation of granulocyte colony-stimulating factor production(GO:0071655) positive regulation of granulocyte colony-stimulating factor production(GO:0071657) regulation of macrophage colony-stimulating factor production(GO:1901256) positive regulation of macrophage colony-stimulating factor production(GO:1901258) |
| 0.5 | 0.5 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
| 0.5 | 1.0 | GO:0071474 | cellular hyperosmotic response(GO:0071474) |
| 0.5 | 1.0 | GO:2000729 | positive regulation of mesenchymal cell proliferation involved in ureter development(GO:2000729) |
| 0.5 | 1.4 | GO:0048007 | antigen processing and presentation via MHC class Ib(GO:0002475) antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
| 0.5 | 3.8 | GO:0071205 | protein localization to juxtaparanode region of axon(GO:0071205) |
| 0.5 | 1.4 | GO:0045898 | regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045898) |
| 0.5 | 1.9 | GO:0019072 | viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
| 0.5 | 0.9 | GO:1904181 | positive regulation of membrane depolarization(GO:1904181) |
| 0.5 | 0.9 | GO:0046066 | dGDP metabolic process(GO:0046066) |
| 0.5 | 5.2 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
| 0.5 | 1.9 | GO:0006726 | eye pigment biosynthetic process(GO:0006726) eye pigment metabolic process(GO:0042441) pigment metabolic process involved in developmental pigmentation(GO:0043324) pigment metabolic process involved in pigmentation(GO:0043474) |
| 0.5 | 3.3 | GO:0046604 | positive regulation of mitotic centrosome separation(GO:0046604) |
| 0.5 | 0.5 | GO:0007060 | male meiosis chromosome segregation(GO:0007060) |
| 0.5 | 1.9 | GO:1904046 | negative regulation of vascular endothelial growth factor production(GO:1904046) |
| 0.5 | 3.7 | GO:0007296 | vitellogenesis(GO:0007296) |
| 0.5 | 3.2 | GO:0001661 | conditioned taste aversion(GO:0001661) |
| 0.5 | 2.3 | GO:0072656 | maintenance of protein location in mitochondrion(GO:0072656) |
| 0.5 | 2.3 | GO:0033629 | negative regulation of cell adhesion mediated by integrin(GO:0033629) |
| 0.5 | 2.3 | GO:0003383 | apical constriction(GO:0003383) |
| 0.5 | 4.6 | GO:1990441 | negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990441) |
| 0.5 | 1.4 | GO:0008057 | eye pigment granule organization(GO:0008057) |
| 0.5 | 2.3 | GO:0038031 | non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
| 0.5 | 5.4 | GO:1902951 | negative regulation of dendritic spine maintenance(GO:1902951) |
| 0.5 | 0.5 | GO:0035897 | proteolysis in other organism(GO:0035897) |
| 0.5 | 4.5 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
| 0.5 | 4.5 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
| 0.5 | 2.3 | GO:0019511 | peptidyl-proline hydroxylation(GO:0019511) |
| 0.5 | 3.2 | GO:0015824 | proline transport(GO:0015824) |
| 0.4 | 2.2 | GO:0044778 | meiotic DNA integrity checkpoint(GO:0044778) |
| 0.4 | 1.3 | GO:0071542 | dopaminergic neuron differentiation(GO:0071542) |
| 0.4 | 0.9 | GO:0022037 | metencephalon development(GO:0022037) |
| 0.4 | 1.3 | GO:0050775 | positive regulation of dendrite morphogenesis(GO:0050775) |
| 0.4 | 4.0 | GO:2000467 | positive regulation of glycogen (starch) synthase activity(GO:2000467) |
| 0.4 | 1.3 | GO:1903966 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
| 0.4 | 0.4 | GO:0045730 | respiratory burst(GO:0045730) |
| 0.4 | 4.0 | GO:0010818 | T cell chemotaxis(GO:0010818) |
| 0.4 | 4.9 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
| 0.4 | 2.6 | GO:0001692 | histamine metabolic process(GO:0001692) |
| 0.4 | 1.3 | GO:0045081 | negative regulation of interleukin-10 biosynthetic process(GO:0045081) |
| 0.4 | 1.3 | GO:0035508 | positive regulation of myosin-light-chain-phosphatase activity(GO:0035508) |
| 0.4 | 0.9 | GO:0010763 | positive regulation of fibroblast migration(GO:0010763) |
| 0.4 | 2.2 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
| 0.4 | 1.7 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
| 0.4 | 0.4 | GO:0030194 | positive regulation of blood coagulation(GO:0030194) positive regulation of coagulation(GO:0050820) positive regulation of hemostasis(GO:1900048) |
| 0.4 | 0.4 | GO:1990542 | mitochondrial transmembrane transport(GO:1990542) |
| 0.4 | 2.2 | GO:0001827 | inner cell mass cell fate commitment(GO:0001827) |
| 0.4 | 3.0 | GO:0010133 | proline catabolic process to glutamate(GO:0010133) |
| 0.4 | 2.6 | GO:0045656 | negative regulation of monocyte differentiation(GO:0045656) |
| 0.4 | 1.3 | GO:1904247 | positive regulation of polynucleotide adenylyltransferase activity(GO:1904247) |
| 0.4 | 11.1 | GO:0046596 | regulation of viral entry into host cell(GO:0046596) |
| 0.4 | 4.7 | GO:0048298 | positive regulation of isotype switching to IgA isotypes(GO:0048298) |
| 0.4 | 2.1 | GO:1903644 | regulation of chaperone-mediated protein folding(GO:1903644) |
| 0.4 | 1.3 | GO:0044827 | modulation by host of viral genome replication(GO:0044827) |
| 0.4 | 20.8 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
| 0.4 | 3.4 | GO:0043622 | cortical microtubule organization(GO:0043622) |
| 0.4 | 0.8 | GO:0006788 | heme oxidation(GO:0006788) |
| 0.4 | 1.3 | GO:0098734 | macromolecule depalmitoylation(GO:0098734) |
| 0.4 | 0.4 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
| 0.4 | 0.8 | GO:0048843 | negative regulation of axon extension involved in axon guidance(GO:0048843) |
| 0.4 | 0.4 | GO:0060268 | negative regulation of respiratory burst(GO:0060268) |
| 0.4 | 1.7 | GO:2000435 | regulation of protein neddylation(GO:2000434) negative regulation of protein neddylation(GO:2000435) |
| 0.4 | 0.8 | GO:0014050 | negative regulation of glutamate secretion(GO:0014050) |
| 0.4 | 3.7 | GO:0035583 | sequestering of TGFbeta in extracellular matrix(GO:0035583) |
| 0.4 | 0.4 | GO:0009405 | pathogenesis(GO:0009405) |
| 0.4 | 1.7 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
| 0.4 | 1.2 | GO:0070384 | Harderian gland development(GO:0070384) |
| 0.4 | 2.9 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
| 0.4 | 4.1 | GO:2001016 | positive regulation of skeletal muscle cell differentiation(GO:2001016) |
| 0.4 | 0.4 | GO:0002763 | positive regulation of myeloid leukocyte differentiation(GO:0002763) |
| 0.4 | 2.5 | GO:0001712 | ectodermal cell fate commitment(GO:0001712) |
| 0.4 | 4.5 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
| 0.4 | 1.2 | GO:0051037 | regulation of transcription involved in meiotic cell cycle(GO:0051037) |
| 0.4 | 0.4 | GO:0042823 | pyridoxal phosphate biosynthetic process(GO:0042823) |
| 0.4 | 1.2 | GO:0046379 | extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
| 0.4 | 0.8 | GO:0015808 | L-alanine transport(GO:0015808) |
| 0.4 | 2.4 | GO:0044791 | modulation by host of viral release from host cell(GO:0044789) positive regulation by host of viral release from host cell(GO:0044791) |
| 0.4 | 1.2 | GO:0003050 | regulation of systemic arterial blood pressure by atrial natriuretic peptide(GO:0003050) |
| 0.4 | 2.0 | GO:0010760 | negative regulation of macrophage chemotaxis(GO:0010760) |
| 0.4 | 2.0 | GO:0052027 | modulation of signal transduction in other organism(GO:0044501) modulation by symbiont of host signal transduction pathway(GO:0052027) modulation of signal transduction in other organism involved in symbiotic interaction(GO:0052250) modulation by symbiont of host I-kappaB kinase/NF-kappaB cascade(GO:0085032) |
| 0.4 | 8.1 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) |
| 0.4 | 0.8 | GO:1902617 | response to fluoride(GO:1902617) |
| 0.4 | 0.8 | GO:0051446 | positive regulation of meiotic cell cycle(GO:0051446) |
| 0.4 | 9.6 | GO:0032515 | negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
| 0.4 | 1.2 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
| 0.4 | 2.8 | GO:0051443 | positive regulation of ubiquitin-protein transferase activity(GO:0051443) |
| 0.4 | 0.8 | GO:1902965 | regulation of protein localization to early endosome(GO:1902965) positive regulation of protein localization to early endosome(GO:1902966) |
| 0.4 | 2.4 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
| 0.4 | 0.4 | GO:1902309 | negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
| 0.4 | 9.9 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
| 0.4 | 1.2 | GO:0070535 | histone H2A K63-linked ubiquitination(GO:0070535) |
| 0.4 | 3.9 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
| 0.4 | 5.1 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
| 0.4 | 3.9 | GO:0046940 | nucleoside monophosphate phosphorylation(GO:0046940) |
| 0.4 | 0.8 | GO:0055099 | response to high density lipoprotein particle(GO:0055099) |
| 0.4 | 1.2 | GO:0048210 | Golgi vesicle fusion to target membrane(GO:0048210) |
| 0.4 | 1.5 | GO:0070459 | prolactin secretion(GO:0070459) |
| 0.4 | 0.8 | GO:0010716 | negative regulation of extracellular matrix disassembly(GO:0010716) |
| 0.4 | 3.4 | GO:0002191 | cap-dependent translational initiation(GO:0002191) |
| 0.4 | 0.8 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
| 0.4 | 0.8 | GO:0048268 | clathrin coat assembly(GO:0048268) |
| 0.4 | 3.4 | GO:0039530 | MDA-5 signaling pathway(GO:0039530) |
| 0.4 | 0.4 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
| 0.4 | 0.4 | GO:0045950 | negative regulation of mitotic recombination(GO:0045950) |
| 0.4 | 3.0 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
| 0.4 | 2.3 | GO:0055011 | atrial cardiac muscle cell differentiation(GO:0055011) atrial cardiac muscle cell development(GO:0055014) |
| 0.4 | 6.4 | GO:0033623 | regulation of integrin activation(GO:0033623) |
| 0.4 | 0.4 | GO:0097198 | histone H3-K36 trimethylation(GO:0097198) |
| 0.4 | 3.7 | GO:0098914 | membrane repolarization during atrial cardiac muscle cell action potential(GO:0098914) |
| 0.4 | 0.4 | GO:1902527 | positive regulation of protein monoubiquitination(GO:1902527) |
| 0.4 | 0.4 | GO:1904861 | excitatory synapse assembly(GO:1904861) |
| 0.4 | 2.2 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
| 0.4 | 2.2 | GO:2000404 | regulation of T cell migration(GO:2000404) |
| 0.4 | 2.6 | GO:2000490 | negative regulation of hepatic stellate cell activation(GO:2000490) |
| 0.4 | 7.7 | GO:0050716 | positive regulation of interleukin-1 secretion(GO:0050716) |
| 0.4 | 0.7 | GO:1902683 | regulation of receptor localization to synapse(GO:1902683) |
| 0.4 | 0.7 | GO:0036369 | transcription factor catabolic process(GO:0036369) |
| 0.4 | 0.7 | GO:0007338 | single fertilization(GO:0007338) |
| 0.4 | 0.7 | GO:0032808 | lacrimal gland development(GO:0032808) |
| 0.4 | 0.7 | GO:2000402 | negative regulation of lymphocyte migration(GO:2000402) |
| 0.4 | 1.1 | GO:2000301 | negative regulation of synaptic vesicle exocytosis(GO:2000301) |
| 0.4 | 2.2 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
| 0.4 | 0.7 | GO:0035878 | nail development(GO:0035878) |
| 0.4 | 8.6 | GO:0035855 | megakaryocyte development(GO:0035855) |
| 0.4 | 1.8 | GO:0045359 | positive regulation of interferon-beta biosynthetic process(GO:0045359) |
| 0.4 | 2.9 | GO:0018879 | biphenyl metabolic process(GO:0018879) |
| 0.4 | 1.1 | GO:0046901 | tetrahydrofolylpolyglutamate biosynthetic process(GO:0046901) |
| 0.4 | 1.4 | GO:1903445 | intermembrane transport(GO:0046909) protein transport from ciliary membrane to plasma membrane(GO:1903445) |
| 0.4 | 0.7 | GO:0032730 | positive regulation of interleukin-1 alpha production(GO:0032730) |
| 0.4 | 4.3 | GO:0038092 | nodal signaling pathway(GO:0038092) |
| 0.4 | 0.7 | GO:0001951 | intestinal D-glucose absorption(GO:0001951) |
| 0.4 | 0.4 | GO:1900226 | negative regulation of NLRP3 inflammasome complex assembly(GO:1900226) |
| 0.4 | 2.1 | GO:0033489 | cholesterol biosynthetic process via desmosterol(GO:0033489) cholesterol biosynthetic process via lathosterol(GO:0033490) |
| 0.4 | 2.1 | GO:0016098 | monoterpenoid metabolic process(GO:0016098) |
| 0.4 | 3.5 | GO:0035728 | response to hepatocyte growth factor(GO:0035728) |
| 0.4 | 1.8 | GO:0050859 | negative regulation of B cell receptor signaling pathway(GO:0050859) |
| 0.4 | 0.7 | GO:0035397 | helper T cell enhancement of adaptive immune response(GO:0035397) |
| 0.4 | 3.9 | GO:0070141 | response to UV-A(GO:0070141) |
| 0.4 | 1.8 | GO:0016128 | ergosterol biosynthetic process(GO:0006696) ergosterol metabolic process(GO:0008204) phytosteroid metabolic process(GO:0016128) phytosteroid biosynthetic process(GO:0016129) |
| 0.4 | 1.1 | GO:0030718 | germ-line stem cell population maintenance(GO:0030718) |
| 0.3 | 2.4 | GO:0052696 | flavonoid glucuronidation(GO:0052696) xenobiotic glucuronidation(GO:0052697) |
| 0.3 | 3.1 | GO:0006477 | protein sulfation(GO:0006477) |
| 0.3 | 2.8 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
| 0.3 | 1.0 | GO:1903677 | regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
| 0.3 | 1.4 | GO:2000825 | positive regulation of androgen receptor activity(GO:2000825) |
| 0.3 | 0.3 | GO:0050720 | interleukin-1 beta biosynthetic process(GO:0050720) |
| 0.3 | 2.1 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
| 0.3 | 0.7 | GO:1902774 | late endosome to lysosome transport(GO:1902774) |
| 0.3 | 4.5 | GO:0046520 | sphingoid biosynthetic process(GO:0046520) |
| 0.3 | 1.0 | GO:2000744 | anterior head development(GO:0097065) regulation of anterior head development(GO:2000742) positive regulation of anterior head development(GO:2000744) |
| 0.3 | 1.4 | GO:0036269 | swimming behavior(GO:0036269) |
| 0.3 | 0.3 | GO:1903625 | negative regulation of DNA catabolic process(GO:1903625) |
| 0.3 | 2.4 | GO:0014846 | esophagus smooth muscle contraction(GO:0014846) |
| 0.3 | 2.1 | GO:0006857 | oligopeptide transport(GO:0006857) |
| 0.3 | 2.4 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
| 0.3 | 2.4 | GO:1901838 | positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901838) |
| 0.3 | 1.7 | GO:0097201 | negative regulation of transcription from RNA polymerase II promoter in response to stress(GO:0097201) |
| 0.3 | 19.4 | GO:0018149 | peptide cross-linking(GO:0018149) |
| 0.3 | 1.7 | GO:0002317 | plasma cell differentiation(GO:0002317) |
| 0.3 | 2.4 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
| 0.3 | 4.1 | GO:0007258 | JUN phosphorylation(GO:0007258) |
| 0.3 | 5.4 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
| 0.3 | 1.0 | GO:0046041 | ITP metabolic process(GO:0046041) |
| 0.3 | 1.3 | GO:0006218 | uridine catabolic process(GO:0006218) |
| 0.3 | 3.0 | GO:0010603 | regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
| 0.3 | 5.0 | GO:0048535 | lymph node development(GO:0048535) |
| 0.3 | 1.0 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
| 0.3 | 1.3 | GO:0043456 | regulation of pentose-phosphate shunt(GO:0043456) |
| 0.3 | 0.3 | GO:0014054 | positive regulation of gamma-aminobutyric acid secretion(GO:0014054) |
| 0.3 | 2.0 | GO:0042738 | exogenous drug catabolic process(GO:0042738) |
| 0.3 | 4.3 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
| 0.3 | 1.0 | GO:1900108 | negative regulation of nodal signaling pathway(GO:1900108) |
| 0.3 | 2.0 | GO:0009407 | toxin catabolic process(GO:0009407) secondary metabolite catabolic process(GO:0090487) |
| 0.3 | 0.3 | GO:0031120 | snRNA pseudouridine synthesis(GO:0031120) |
| 0.3 | 3.6 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
| 0.3 | 1.6 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
| 0.3 | 0.6 | GO:0035469 | determination of pancreatic left/right asymmetry(GO:0035469) |
| 0.3 | 1.9 | GO:0060633 | negative regulation of transcription initiation from RNA polymerase II promoter(GO:0060633) |
| 0.3 | 4.2 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
| 0.3 | 1.6 | GO:0060252 | positive regulation of glial cell proliferation(GO:0060252) |
| 0.3 | 0.3 | GO:0051873 | disruption by host of symbiont cells(GO:0051852) killing by host of symbiont cells(GO:0051873) |
| 0.3 | 1.3 | GO:0071894 | histone H2B conserved C-terminal lysine ubiquitination(GO:0071894) |
| 0.3 | 1.0 | GO:0006210 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
| 0.3 | 1.9 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
| 0.3 | 0.6 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
| 0.3 | 1.6 | GO:0051892 | negative regulation of cardioblast differentiation(GO:0051892) regulation of cardiac muscle cell myoblast differentiation(GO:2000690) negative regulation of cardiac muscle cell myoblast differentiation(GO:2000691) |
| 0.3 | 0.3 | GO:0097484 | dendrite extension(GO:0097484) |
| 0.3 | 1.9 | GO:0006489 | dolichyl diphosphate biosynthetic process(GO:0006489) dolichyl diphosphate metabolic process(GO:0046465) |
| 0.3 | 3.5 | GO:0001953 | negative regulation of cell-matrix adhesion(GO:0001953) |
| 0.3 | 0.3 | GO:0045653 | negative regulation of megakaryocyte differentiation(GO:0045653) |
| 0.3 | 1.6 | GO:2000312 | regulation of kainate selective glutamate receptor activity(GO:2000312) |
| 0.3 | 2.9 | GO:0071285 | cellular response to lithium ion(GO:0071285) |
| 0.3 | 2.2 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
| 0.3 | 0.3 | GO:0006680 | glucosylceramide catabolic process(GO:0006680) |
| 0.3 | 0.3 | GO:0019249 | lactate biosynthetic process(GO:0019249) |
| 0.3 | 6.3 | GO:0002347 | response to tumor cell(GO:0002347) |
| 0.3 | 5.3 | GO:0007172 | signal complex assembly(GO:0007172) |
| 0.3 | 0.3 | GO:0070341 | fat cell proliferation(GO:0070341) regulation of fat cell proliferation(GO:0070344) negative regulation of fat cell proliferation(GO:0070345) |
| 0.3 | 0.3 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
| 0.3 | 0.9 | GO:0021526 | medial motor column neuron differentiation(GO:0021526) |
| 0.3 | 1.2 | GO:0009236 | cobalamin biosynthetic process(GO:0009236) |
| 0.3 | 13.8 | GO:0097503 | sialylation(GO:0097503) |
| 0.3 | 2.5 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
| 0.3 | 3.4 | GO:0042355 | fucose catabolic process(GO:0019317) L-fucose metabolic process(GO:0042354) L-fucose catabolic process(GO:0042355) |
| 0.3 | 1.2 | GO:0033603 | positive regulation of dopamine secretion(GO:0033603) |
| 0.3 | 3.4 | GO:0018377 | protein myristoylation(GO:0018377) |
| 0.3 | 1.5 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
| 0.3 | 4.0 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
| 0.3 | 2.4 | GO:0098989 | NMDA selective glutamate receptor signaling pathway(GO:0098989) |
| 0.3 | 0.6 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
| 0.3 | 1.2 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
| 0.3 | 0.6 | GO:0071072 | negative regulation of phospholipid biosynthetic process(GO:0071072) |
| 0.3 | 3.6 | GO:0090232 | positive regulation of spindle checkpoint(GO:0090232) |
| 0.3 | 1.5 | GO:0003069 | age-dependent response to oxidative stress(GO:0001306) age-dependent response to reactive oxygen species(GO:0001315) regulation of systemic arterial blood pressure by acetylcholine(GO:0003068) vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure(GO:0003069) regulation of systemic arterial blood pressure by neurotransmitter(GO:0003070) age-dependent general metabolic decline(GO:0007571) |
| 0.3 | 2.4 | GO:2000795 | negative regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000795) |
| 0.3 | 0.9 | GO:0061386 | closure of optic fissure(GO:0061386) |
| 0.3 | 0.3 | GO:1903094 | negative regulation of protein deubiquitination(GO:0090086) regulation of protein K48-linked deubiquitination(GO:1903093) negative regulation of protein K48-linked deubiquitination(GO:1903094) negative regulation of ubiquitin-specific protease activity(GO:2000157) |
| 0.3 | 2.7 | GO:0016191 | synaptic vesicle uncoating(GO:0016191) |
| 0.3 | 0.9 | GO:0043095 | regulation of GTP cyclohydrolase I activity(GO:0043095) negative regulation of GTP cyclohydrolase I activity(GO:0043105) |
| 0.3 | 0.9 | GO:0003245 | cardiac muscle tissue growth involved in heart morphogenesis(GO:0003245) |
| 0.3 | 1.8 | GO:0045040 | protein import into mitochondrial outer membrane(GO:0045040) |
| 0.3 | 1.5 | GO:0090156 | cellular sphingolipid homeostasis(GO:0090156) |
| 0.3 | 3.0 | GO:0016584 | nucleosome positioning(GO:0016584) |
| 0.3 | 0.9 | GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
| 0.3 | 1.2 | GO:0035616 | histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
| 0.3 | 1.2 | GO:0061209 | cell proliferation involved in mesonephros development(GO:0061209) mesenchymal cell proliferation involved in ureteric bud development(GO:0072138) |
| 0.3 | 2.3 | GO:0046959 | habituation(GO:0046959) |
| 0.3 | 0.6 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
| 0.3 | 0.6 | GO:0032796 | uropod organization(GO:0032796) |
| 0.3 | 0.9 | GO:0021503 | neural fold bending(GO:0021503) |
| 0.3 | 2.3 | GO:0051013 | microtubule severing(GO:0051013) |
| 0.3 | 2.0 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
| 0.3 | 0.6 | GO:0070253 | somatostatin secretion(GO:0070253) |
| 0.3 | 1.4 | GO:0035811 | negative regulation of urine volume(GO:0035811) |
| 0.3 | 0.9 | GO:0035038 | female pronucleus assembly(GO:0035038) |
| 0.3 | 1.1 | GO:0035822 | meiotic gene conversion(GO:0006311) gene conversion(GO:0035822) |
| 0.3 | 0.6 | GO:0007439 | ectodermal digestive tract development(GO:0007439) embryonic ectodermal digestive tract development(GO:0048611) |
| 0.3 | 4.9 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
| 0.3 | 0.3 | GO:0006990 | positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) |
| 0.3 | 0.3 | GO:0071603 | endothelial cell-cell adhesion(GO:0071603) |
| 0.3 | 3.1 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
| 0.3 | 4.0 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
| 0.3 | 2.8 | GO:1902037 | negative regulation of hematopoietic stem cell differentiation(GO:1902037) |
| 0.3 | 6.5 | GO:0051639 | actin filament network formation(GO:0051639) |
| 0.3 | 2.6 | GO:1902414 | protein localization to cell junction(GO:1902414) |
| 0.3 | 1.1 | GO:0001835 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
| 0.3 | 2.5 | GO:0007256 | activation of JNKK activity(GO:0007256) |
| 0.3 | 1.1 | GO:0072553 | terminal button organization(GO:0072553) |
| 0.3 | 3.1 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
| 0.3 | 4.2 | GO:0097151 | positive regulation of inhibitory postsynaptic potential(GO:0097151) modulation of inhibitory postsynaptic potential(GO:0098828) |
| 0.3 | 2.2 | GO:0060051 | negative regulation of protein glycosylation(GO:0060051) |
| 0.3 | 0.6 | GO:2000643 | positive regulation of early endosome to late endosome transport(GO:2000643) |
| 0.3 | 0.8 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
| 0.3 | 0.8 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
| 0.3 | 3.9 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
| 0.3 | 0.6 | GO:0010980 | regulation of vitamin D 24-hydroxylase activity(GO:0010979) positive regulation of vitamin D 24-hydroxylase activity(GO:0010980) |
| 0.3 | 1.1 | GO:0006566 | threonine metabolic process(GO:0006566) |
| 0.3 | 0.8 | GO:0038178 | complement component C5a signaling pathway(GO:0038178) |
| 0.3 | 0.6 | GO:0060856 | establishment of blood-brain barrier(GO:0060856) |
| 0.3 | 0.3 | GO:1903527 | positive regulation of membrane tubulation(GO:1903527) |
| 0.3 | 0.8 | GO:0033602 | negative regulation of dopamine secretion(GO:0033602) |
| 0.3 | 1.4 | GO:2001245 | regulation of phosphatidylcholine biosynthetic process(GO:2001245) |
| 0.3 | 2.2 | GO:0097396 | response to interleukin-17(GO:0097396) cellular response to interleukin-17(GO:0097398) |
| 0.3 | 2.7 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
| 0.3 | 0.5 | GO:0060605 | tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
| 0.3 | 0.5 | GO:0033590 | response to cobalamin(GO:0033590) |
| 0.3 | 1.1 | GO:0071420 | cellular response to histamine(GO:0071420) |
| 0.3 | 0.5 | GO:0097501 | stress response to metal ion(GO:0097501) |
| 0.3 | 1.6 | GO:1905216 | positive regulation of mRNA binding(GO:1902416) positive regulation of RNA binding(GO:1905216) |
| 0.3 | 1.1 | GO:1904715 | negative regulation of chaperone-mediated autophagy(GO:1904715) |
| 0.3 | 3.8 | GO:0007614 | short-term memory(GO:0007614) |
| 0.3 | 1.4 | GO:1902534 | single-organism membrane invagination(GO:1902534) |
| 0.3 | 1.9 | GO:1904381 | Golgi apparatus mannose trimming(GO:1904381) |
| 0.3 | 3.2 | GO:0097119 | postsynaptic density protein 95 clustering(GO:0097119) |
| 0.3 | 1.1 | GO:0036289 | peptidyl-serine autophosphorylation(GO:0036289) |
| 0.3 | 1.6 | GO:0090625 | mRNA cleavage involved in gene silencing by siRNA(GO:0090625) |
| 0.3 | 6.2 | GO:0060219 | camera-type eye photoreceptor cell differentiation(GO:0060219) |
| 0.3 | 6.1 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
| 0.3 | 1.3 | GO:0000050 | urea cycle(GO:0000050) |
| 0.3 | 6.4 | GO:0006491 | N-glycan processing(GO:0006491) |
| 0.3 | 1.1 | GO:0035522 | monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
| 0.3 | 4.0 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
| 0.3 | 0.8 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
| 0.3 | 1.6 | GO:0030860 | regulation of polarized epithelial cell differentiation(GO:0030860) |
| 0.3 | 2.7 | GO:0034214 | protein hexamerization(GO:0034214) |
| 0.3 | 0.8 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
| 0.3 | 1.3 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
| 0.3 | 27.3 | GO:0009301 | snRNA transcription(GO:0009301) snRNA transcription from RNA polymerase II promoter(GO:0042795) |
| 0.3 | 0.3 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
| 0.3 | 1.1 | GO:0032088 | negative regulation of NF-kappaB transcription factor activity(GO:0032088) |
| 0.3 | 1.6 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
| 0.3 | 1.1 | GO:0030856 | regulation of epithelial cell differentiation(GO:0030856) |
| 0.3 | 1.1 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
| 0.3 | 0.3 | GO:0001516 | prostaglandin biosynthetic process(GO:0001516) prostanoid biosynthetic process(GO:0046457) |
| 0.3 | 1.6 | GO:0048845 | venous blood vessel morphogenesis(GO:0048845) |
| 0.3 | 0.3 | GO:0061097 | regulation of protein tyrosine kinase activity(GO:0061097) |
| 0.3 | 0.5 | GO:0048146 | positive regulation of fibroblast proliferation(GO:0048146) |
| 0.3 | 2.1 | GO:0043524 | negative regulation of neuron apoptotic process(GO:0043524) |
| 0.3 | 1.6 | GO:0051673 | membrane disruption in other organism(GO:0051673) |
| 0.3 | 1.3 | GO:0070997 | neuron death(GO:0070997) |
| 0.3 | 0.8 | GO:0002441 | histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
| 0.3 | 4.7 | GO:1904424 | regulation of GTP binding(GO:1904424) |
| 0.3 | 2.3 | GO:0098712 | L-glutamate import across plasma membrane(GO:0098712) |
| 0.3 | 1.0 | GO:0042539 | hypotonic salinity response(GO:0042539) cellular hypotonic salinity response(GO:0071477) |
| 0.3 | 0.8 | GO:0031053 | primary miRNA processing(GO:0031053) |
| 0.3 | 0.5 | GO:1900025 | negative regulation of substrate adhesion-dependent cell spreading(GO:1900025) |
| 0.3 | 0.3 | GO:0010918 | positive regulation of mitochondrial membrane potential(GO:0010918) |
| 0.3 | 3.9 | GO:0045063 | T-helper 1 cell differentiation(GO:0045063) |
| 0.3 | 2.8 | GO:0032237 | activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
| 0.3 | 0.5 | GO:0035357 | peroxisome proliferator activated receptor signaling pathway(GO:0035357) |
| 0.3 | 1.8 | GO:0032510 | endosome to lysosome transport via multivesicular body sorting pathway(GO:0032510) |
| 0.3 | 2.0 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
| 0.3 | 2.0 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
| 0.3 | 0.3 | GO:0006562 | proline catabolic process(GO:0006562) |
| 0.3 | 0.3 | GO:0000466 | maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000466) |
| 0.3 | 0.3 | GO:0033085 | negative regulation of T cell differentiation in thymus(GO:0033085) negative regulation of thymocyte aggregation(GO:2000399) |
| 0.3 | 3.5 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
| 0.3 | 1.0 | GO:0045586 | regulation of gamma-delta T cell differentiation(GO:0045586) |
| 0.3 | 1.0 | GO:0033159 | negative regulation of protein import into nucleus, translocation(GO:0033159) |
| 0.2 | 0.5 | GO:0002888 | positive regulation of myeloid leukocyte mediated immunity(GO:0002888) |
| 0.2 | 1.0 | GO:0035279 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
| 0.2 | 0.7 | GO:0090187 | positive regulation of pancreatic juice secretion(GO:0090187) |
| 0.2 | 0.2 | GO:1902186 | regulation of viral release from host cell(GO:1902186) |
| 0.2 | 0.7 | GO:0003214 | cardiac left ventricle morphogenesis(GO:0003214) |
| 0.2 | 0.7 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
| 0.2 | 0.2 | GO:1900086 | positive regulation of peptidyl-tyrosine autophosphorylation(GO:1900086) |
| 0.2 | 1.0 | GO:0014042 | positive regulation of neuron maturation(GO:0014042) |
| 0.2 | 1.2 | GO:0044268 | multicellular organismal protein metabolic process(GO:0044268) |
| 0.2 | 3.0 | GO:0033622 | integrin activation(GO:0033622) |
| 0.2 | 27.0 | GO:0006501 | C-terminal protein lipidation(GO:0006501) |
| 0.2 | 4.0 | GO:0050872 | white fat cell differentiation(GO:0050872) |
| 0.2 | 2.7 | GO:0097167 | circadian regulation of translation(GO:0097167) |
| 0.2 | 3.2 | GO:1901407 | regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) |
| 0.2 | 4.7 | GO:0032732 | positive regulation of interleukin-1 production(GO:0032732) |
| 0.2 | 1.0 | GO:0019417 | sulfur oxidation(GO:0019417) |
| 0.2 | 1.7 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
| 0.2 | 2.2 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
| 0.2 | 5.1 | GO:0034380 | high-density lipoprotein particle assembly(GO:0034380) |
| 0.2 | 1.0 | GO:0002003 | angiotensin maturation(GO:0002003) |
| 0.2 | 0.5 | GO:0009216 | purine deoxyribonucleoside triphosphate biosynthetic process(GO:0009216) |
| 0.2 | 0.2 | GO:0002663 | B cell tolerance induction(GO:0002514) regulation of B cell tolerance induction(GO:0002661) positive regulation of B cell tolerance induction(GO:0002663) |
| 0.2 | 1.5 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
| 0.2 | 0.5 | GO:0070315 | G1 to G0 transition involved in cell differentiation(GO:0070315) |
| 0.2 | 4.3 | GO:0009311 | oligosaccharide metabolic process(GO:0009311) |
| 0.2 | 0.5 | GO:0046967 | cytosol to ER transport(GO:0046967) |
| 0.2 | 6.5 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
| 0.2 | 0.2 | GO:1904562 | phosphatidylinositol 5-phosphate metabolic process(GO:1904562) |
| 0.2 | 0.5 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
| 0.2 | 1.2 | GO:0061055 | myotome development(GO:0061055) |
| 0.2 | 0.5 | GO:0050713 | negative regulation of interleukin-1 beta secretion(GO:0050713) |
| 0.2 | 0.2 | GO:0032079 | positive regulation of endodeoxyribonuclease activity(GO:0032079) |
| 0.2 | 1.7 | GO:0010025 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
| 0.2 | 1.2 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
| 0.2 | 0.2 | GO:1900227 | positive regulation of NLRP3 inflammasome complex assembly(GO:1900227) |
| 0.2 | 0.9 | GO:0090083 | regulation of inclusion body assembly(GO:0090083) |
| 0.2 | 5.0 | GO:0048012 | hepatocyte growth factor receptor signaling pathway(GO:0048012) |
| 0.2 | 0.2 | GO:0045974 | miRNA mediated inhibition of translation(GO:0035278) negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
| 0.2 | 0.7 | GO:0070831 | basement membrane assembly(GO:0070831) |
| 0.2 | 0.9 | GO:1904806 | regulation of protein oxidation(GO:1904806) positive regulation of protein oxidation(GO:1904808) |
| 0.2 | 0.2 | GO:0090288 | negative regulation of cellular response to growth factor stimulus(GO:0090288) |
| 0.2 | 1.4 | GO:2001286 | regulation of caveolin-mediated endocytosis(GO:2001286) |
| 0.2 | 0.2 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
| 0.2 | 0.2 | GO:2000812 | regulation of barbed-end actin filament capping(GO:2000812) |
| 0.2 | 0.2 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
| 0.2 | 4.9 | GO:0035360 | positive regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035360) |
| 0.2 | 2.8 | GO:0003096 | renal sodium ion transport(GO:0003096) |
| 0.2 | 0.2 | GO:0016569 | covalent chromatin modification(GO:0016569) |
| 0.2 | 1.6 | GO:0019885 | antigen processing and presentation of endogenous peptide antigen(GO:0002483) antigen processing and presentation of endogenous peptide antigen via MHC class I(GO:0019885) |
| 0.2 | 0.7 | GO:1900744 | regulation of p38MAPK cascade(GO:1900744) |
| 0.2 | 0.7 | GO:0000189 | MAPK import into nucleus(GO:0000189) |
| 0.2 | 0.2 | GO:0097091 | synaptic vesicle clustering(GO:0097091) |
| 0.2 | 3.7 | GO:0051923 | sulfation(GO:0051923) |
| 0.2 | 0.7 | GO:0040009 | regulation of growth rate(GO:0040009) |
| 0.2 | 0.9 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
| 0.2 | 0.2 | GO:0019240 | citrulline biosynthetic process(GO:0019240) |
| 0.2 | 13.5 | GO:0046473 | phosphatidic acid metabolic process(GO:0046473) |
| 0.2 | 0.7 | GO:0061042 | vascular wound healing(GO:0061042) |
| 0.2 | 0.5 | GO:0072104 | glomerulus vasculature morphogenesis(GO:0072103) glomerular capillary formation(GO:0072104) |
| 0.2 | 0.5 | GO:0036216 | response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) |
| 0.2 | 1.6 | GO:2000587 | negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
| 0.2 | 0.9 | GO:0097498 | endothelial tube lumen extension(GO:0097498) |
| 0.2 | 4.3 | GO:0032331 | negative regulation of chondrocyte differentiation(GO:0032331) |
| 0.2 | 0.7 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
| 0.2 | 1.3 | GO:0093001 | glycolysis from storage polysaccharide through glucose-1-phosphate(GO:0093001) |
| 0.2 | 1.8 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
| 0.2 | 0.7 | GO:1900153 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900151) positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900153) |
| 0.2 | 0.2 | GO:0002437 | inflammatory response to antigenic stimulus(GO:0002437) |
| 0.2 | 0.7 | GO:0035022 | positive regulation of Rac protein signal transduction(GO:0035022) |
| 0.2 | 0.7 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
| 0.2 | 9.6 | GO:0043551 | regulation of phosphatidylinositol 3-kinase activity(GO:0043551) |
| 0.2 | 1.1 | GO:1902953 | positive regulation of ER to Golgi vesicle-mediated transport(GO:1902953) |
| 0.2 | 0.9 | GO:0045591 | positive regulation of regulatory T cell differentiation(GO:0045591) |
| 0.2 | 0.2 | GO:0007220 | Notch receptor processing(GO:0007220) |
| 0.2 | 0.4 | GO:0050902 | leukocyte adhesive activation(GO:0050902) |
| 0.2 | 0.9 | GO:1902474 | positive regulation of protein localization to synapse(GO:1902474) |
| 0.2 | 0.2 | GO:0072387 | flavin adenine dinucleotide metabolic process(GO:0072387) |
| 0.2 | 0.2 | GO:0033023 | mast cell homeostasis(GO:0033023) mast cell apoptotic process(GO:0033024) regulation of mast cell apoptotic process(GO:0033025) |
| 0.2 | 1.7 | GO:0070212 | protein poly-ADP-ribosylation(GO:0070212) |
| 0.2 | 5.4 | GO:0097435 | fibril organization(GO:0097435) |
| 0.2 | 0.9 | GO:0097411 | hypoxia-inducible factor-1alpha signaling pathway(GO:0097411) |
| 0.2 | 0.6 | GO:1903551 | regulation of extracellular exosome assembly(GO:1903551) |
| 0.2 | 0.6 | GO:2000275 | regulation of oxidative phosphorylation uncoupler activity(GO:2000275) |
| 0.2 | 0.9 | GO:0031112 | positive regulation of microtubule polymerization or depolymerization(GO:0031112) positive regulation of microtubule polymerization(GO:0031116) |
| 0.2 | 1.1 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
| 0.2 | 3.0 | GO:0021692 | cerebellar Purkinje cell layer morphogenesis(GO:0021692) |
| 0.2 | 0.6 | GO:1902490 | regulation of sperm capacitation(GO:1902490) |
| 0.2 | 4.4 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
| 0.2 | 0.6 | GO:0061092 | regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
| 0.2 | 0.4 | GO:0006864 | pyrimidine nucleotide transport(GO:0006864) mitochondrial pyrimidine nucleotide import(GO:1990519) |
| 0.2 | 0.6 | GO:0090141 | positive regulation of mitochondrial fission(GO:0090141) |
| 0.2 | 1.9 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
| 0.2 | 0.4 | GO:0032713 | negative regulation of interleukin-4 production(GO:0032713) |
| 0.2 | 1.3 | GO:0033512 | L-lysine catabolic process to acetyl-CoA via saccharopine(GO:0033512) |
| 0.2 | 1.5 | GO:1990539 | fructose import(GO:0032445) carbohydrate import into cell(GO:0097319) carbohydrate import across plasma membrane(GO:0098704) fructose import across plasma membrane(GO:1990539) |
| 0.2 | 4.4 | GO:0006376 | mRNA splice site selection(GO:0006376) |
| 0.2 | 1.5 | GO:0045995 | regulation of embryonic development(GO:0045995) |
| 0.2 | 2.7 | GO:0010968 | regulation of microtubule nucleation(GO:0010968) |
| 0.2 | 0.6 | GO:1902544 | regulation of DNA N-glycosylase activity(GO:1902544) |
| 0.2 | 0.4 | GO:1905007 | positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation(GO:1905007) |
| 0.2 | 0.8 | GO:0046338 | phosphatidylethanolamine catabolic process(GO:0046338) |
| 0.2 | 1.4 | GO:0032185 | septin cytoskeleton organization(GO:0032185) |
| 0.2 | 0.2 | GO:0009441 | glycolate metabolic process(GO:0009441) |
| 0.2 | 0.4 | GO:0021942 | radial glia guided migration of Purkinje cell(GO:0021942) |
| 0.2 | 5.2 | GO:0034389 | lipid particle organization(GO:0034389) |
| 0.2 | 0.2 | GO:0046958 | nonassociative learning(GO:0046958) |
| 0.2 | 0.2 | GO:1902514 | regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1902514) |
| 0.2 | 0.4 | GO:1900368 | regulation of RNA interference(GO:1900368) |
| 0.2 | 0.4 | GO:0046626 | regulation of insulin receptor signaling pathway(GO:0046626) |
| 0.2 | 0.6 | GO:0035411 | catenin import into nucleus(GO:0035411) |
| 0.2 | 11.9 | GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
| 0.2 | 3.8 | GO:0070828 | heterochromatin organization(GO:0070828) |
| 0.2 | 1.6 | GO:0000380 | alternative mRNA splicing, via spliceosome(GO:0000380) |
| 0.2 | 0.2 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
| 0.2 | 6.2 | GO:0071425 | hematopoietic stem cell proliferation(GO:0071425) |
| 0.2 | 2.8 | GO:0003360 | brainstem development(GO:0003360) |
| 0.2 | 2.2 | GO:0051791 | medium-chain fatty acid metabolic process(GO:0051791) |
| 0.2 | 1.4 | GO:0032468 | Golgi calcium ion homeostasis(GO:0032468) |
| 0.2 | 2.2 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
| 0.2 | 0.6 | GO:1904211 | membrane protein proteolysis involved in retrograde protein transport, ER to cytosol(GO:1904211) |
| 0.2 | 1.6 | GO:0046629 | gamma-delta T cell activation(GO:0046629) |
| 0.2 | 0.2 | GO:0035902 | response to immobilization stress(GO:0035902) |
| 0.2 | 0.8 | GO:1903237 | negative regulation of leukocyte tethering or rolling(GO:1903237) |
| 0.2 | 0.4 | GO:2000767 | positive regulation of cytoplasmic translation(GO:2000767) |
| 0.2 | 0.6 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
| 0.2 | 33.5 | GO:0043484 | regulation of RNA splicing(GO:0043484) |
| 0.2 | 1.9 | GO:0032926 | negative regulation of activin receptor signaling pathway(GO:0032926) |
| 0.2 | 0.4 | GO:0007598 | blood coagulation, extrinsic pathway(GO:0007598) |
| 0.2 | 1.0 | GO:1904158 | axonemal central apparatus assembly(GO:1904158) |
| 0.2 | 0.6 | GO:0006043 | glucosamine catabolic process(GO:0006043) |
| 0.2 | 1.5 | GO:0045176 | apical protein localization(GO:0045176) |
| 0.2 | 0.6 | GO:1990922 | regulation of hepatic stellate cell proliferation(GO:1904897) positive regulation of hepatic stellate cell proliferation(GO:1904899) hepatic stellate cell proliferation(GO:1990922) |
| 0.2 | 2.3 | GO:0070932 | histone H3 deacetylation(GO:0070932) |
| 0.2 | 1.1 | GO:0038112 | interleukin-8-mediated signaling pathway(GO:0038112) |
| 0.2 | 1.1 | GO:0019264 | glycine biosynthetic process from serine(GO:0019264) |
| 0.2 | 0.4 | GO:1990535 | neuron projection maintenance(GO:1990535) |
| 0.2 | 1.1 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
| 0.2 | 2.3 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
| 0.2 | 0.2 | GO:0060462 | lung lobe development(GO:0060462) lung lobe morphogenesis(GO:0060463) |
| 0.2 | 0.2 | GO:0033198 | response to ATP(GO:0033198) |
| 0.2 | 0.9 | GO:2000059 | negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000059) |
| 0.2 | 0.2 | GO:1990791 | dorsal root ganglion development(GO:1990791) |
| 0.2 | 0.4 | GO:0060940 | epithelial to mesenchymal transition involved in cardiac fibroblast development(GO:0060940) |
| 0.2 | 0.8 | GO:0042351 | 'de novo' GDP-L-fucose biosynthetic process(GO:0042351) |
| 0.2 | 2.8 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
| 0.2 | 0.4 | GO:0010936 | negative regulation of macrophage cytokine production(GO:0010936) |
| 0.2 | 1.1 | GO:0060674 | placenta blood vessel development(GO:0060674) |
| 0.2 | 0.2 | GO:0021559 | trigeminal nerve development(GO:0021559) |
| 0.2 | 0.4 | GO:0051386 | regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
| 0.2 | 0.2 | GO:0045475 | locomotor rhythm(GO:0045475) |
| 0.2 | 3.7 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
| 0.2 | 0.4 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
| 0.2 | 5.6 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
| 0.2 | 0.4 | GO:0030575 | nuclear body organization(GO:0030575) |
| 0.2 | 0.4 | GO:1990036 | regulation of calcium ion import into sarcoplasmic reticulum(GO:1902080) negative regulation of calcium ion import into sarcoplasmic reticulum(GO:1902081) calcium ion import into sarcoplasmic reticulum(GO:1990036) |
| 0.2 | 0.9 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
| 0.2 | 0.7 | GO:0051490 | negative regulation of filopodium assembly(GO:0051490) |
| 0.2 | 0.7 | GO:0035574 | histone H4-K20 demethylation(GO:0035574) |
| 0.2 | 0.7 | GO:0035964 | COPI-coated vesicle budding(GO:0035964) Golgi transport vesicle coating(GO:0048200) COPI coating of Golgi vesicle(GO:0048205) |
| 0.2 | 0.2 | GO:0015670 | carbon dioxide transport(GO:0015670) |
| 0.2 | 0.2 | GO:0035494 | SNARE complex disassembly(GO:0035494) |
| 0.2 | 0.6 | GO:2000489 | regulation of hepatic stellate cell activation(GO:2000489) positive regulation of hepatic stellate cell activation(GO:2000491) |
| 0.2 | 0.6 | GO:0060574 | intestinal epithelial cell maturation(GO:0060574) |
| 0.2 | 1.3 | GO:0015727 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) |
| 0.2 | 0.6 | GO:0002384 | hepatic immune response(GO:0002384) |
| 0.2 | 0.4 | GO:1903393 | positive regulation of adherens junction organization(GO:1903393) |
| 0.2 | 1.3 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
| 0.2 | 1.3 | GO:1990481 | mRNA pseudouridine synthesis(GO:1990481) |
| 0.2 | 1.5 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
| 0.2 | 1.4 | GO:0072189 | ureter development(GO:0072189) |
| 0.2 | 0.5 | GO:0036010 | protein localization to endosome(GO:0036010) |
| 0.2 | 0.5 | GO:0048631 | regulation of skeletal muscle tissue growth(GO:0048631) |
| 0.2 | 2.9 | GO:0008228 | opsonization(GO:0008228) |
| 0.2 | 3.6 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
| 0.2 | 2.3 | GO:0014059 | dopamine secretion(GO:0014046) regulation of dopamine secretion(GO:0014059) |
| 0.2 | 2.8 | GO:0036065 | fucosylation(GO:0036065) |
| 0.2 | 2.3 | GO:0003215 | cardiac right ventricle morphogenesis(GO:0003215) |
| 0.2 | 3.2 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
| 0.2 | 1.4 | GO:0098779 | mitophagy in response to mitochondrial depolarization(GO:0098779) |
| 0.2 | 0.2 | GO:2001184 | positive regulation of interleukin-12 secretion(GO:2001184) |
| 0.2 | 1.2 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
| 0.2 | 0.5 | GO:1904587 | response to glycoprotein(GO:1904587) |
| 0.2 | 0.2 | GO:0060412 | ventricular septum morphogenesis(GO:0060412) |
| 0.2 | 0.5 | GO:0002372 | myeloid dendritic cell cytokine production(GO:0002372) |
| 0.2 | 0.3 | GO:0090166 | Golgi disassembly(GO:0090166) |
| 0.2 | 0.5 | GO:1900075 | regulation of neuromuscular synaptic transmission(GO:1900073) positive regulation of neuromuscular synaptic transmission(GO:1900075) |
| 0.2 | 0.5 | GO:0098884 | postsynaptic neurotransmitter receptor internalization(GO:0098884) |
| 0.2 | 3.8 | GO:0045022 | early endosome to late endosome transport(GO:0045022) vesicle-mediated transport between endosomal compartments(GO:0098927) |
| 0.2 | 0.7 | GO:1902229 | regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902229) |
| 0.2 | 0.3 | GO:1901656 | glycoside transport(GO:1901656) |
| 0.2 | 1.0 | GO:0007406 | negative regulation of neuroblast proliferation(GO:0007406) |
| 0.2 | 3.1 | GO:0042832 | defense response to protozoan(GO:0042832) |
| 0.2 | 1.5 | GO:0010571 | positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
| 0.2 | 2.7 | GO:2000052 | positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
| 0.2 | 1.4 | GO:0045329 | carnitine biosynthetic process(GO:0045329) |
| 0.2 | 1.0 | GO:1902916 | positive regulation of protein polyubiquitination(GO:1902916) |
| 0.2 | 1.3 | GO:0051583 | dopamine uptake involved in synaptic transmission(GO:0051583) catecholamine uptake involved in synaptic transmission(GO:0051934) catecholamine uptake(GO:0090493) dopamine uptake(GO:0090494) |
| 0.2 | 3.2 | GO:0033235 | positive regulation of protein sumoylation(GO:0033235) |
| 0.2 | 0.2 | GO:0032881 | regulation of polysaccharide metabolic process(GO:0032881) regulation of glycogen metabolic process(GO:0070873) |
| 0.2 | 0.5 | GO:0051898 | negative regulation of protein kinase B signaling(GO:0051898) |
| 0.2 | 0.5 | GO:0033007 | negative regulation of mast cell activation involved in immune response(GO:0033007) negative regulation of mast cell degranulation(GO:0043305) |
| 0.2 | 1.0 | GO:0035404 | histone-serine phosphorylation(GO:0035404) |
| 0.2 | 1.2 | GO:0030643 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
| 0.2 | 0.3 | GO:0001836 | release of cytochrome c from mitochondria(GO:0001836) |
| 0.2 | 1.2 | GO:0014809 | regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion(GO:0014809) |
| 0.2 | 1.0 | GO:0097475 | motor neuron migration(GO:0097475) |
| 0.2 | 4.3 | GO:1903846 | positive regulation of transforming growth factor beta receptor signaling pathway(GO:0030511) positive regulation of cellular response to transforming growth factor beta stimulus(GO:1903846) |
| 0.2 | 0.5 | GO:0051642 | centrosome localization(GO:0051642) |
| 0.2 | 1.0 | GO:0018343 | protein farnesylation(GO:0018343) |
| 0.2 | 1.0 | GO:1990416 | cellular response to brain-derived neurotrophic factor stimulus(GO:1990416) |
| 0.2 | 0.3 | GO:0010700 | negative regulation of norepinephrine secretion(GO:0010700) |
| 0.2 | 2.0 | GO:0034063 | stress granule assembly(GO:0034063) |
| 0.2 | 0.7 | GO:0051413 | response to cortisone(GO:0051413) |
| 0.2 | 0.3 | GO:0043968 | histone H2A acetylation(GO:0043968) |
| 0.2 | 1.5 | GO:0051918 | regulation of fibrinolysis(GO:0051917) negative regulation of fibrinolysis(GO:0051918) |
| 0.2 | 0.7 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
| 0.2 | 1.5 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
| 0.2 | 0.5 | GO:0014744 | positive regulation of muscle adaptation(GO:0014744) |
| 0.2 | 0.2 | GO:0008343 | adult feeding behavior(GO:0008343) |
| 0.2 | 1.1 | GO:2001268 | urokinase plasminogen activator signaling pathway(GO:0038195) negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001268) |
| 0.2 | 0.6 | GO:0048875 | chemical homeostasis within a tissue(GO:0048875) |
| 0.2 | 0.2 | GO:0060684 | epithelial-mesenchymal cell signaling(GO:0060684) |
| 0.2 | 0.8 | GO:1904751 | positive regulation of protein localization to nucleolus(GO:1904751) |
| 0.2 | 6.4 | GO:0048488 | synaptic vesicle endocytosis(GO:0048488) |
| 0.2 | 10.6 | GO:0038083 | peptidyl-tyrosine autophosphorylation(GO:0038083) |
| 0.2 | 0.5 | GO:0045210 | FasL biosynthetic process(GO:0045210) |
| 0.2 | 0.5 | GO:0045739 | positive regulation of DNA repair(GO:0045739) |
| 0.2 | 3.5 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
| 0.2 | 0.3 | GO:0071625 | vocalization behavior(GO:0071625) |
| 0.2 | 0.2 | GO:0002032 | desensitization of G-protein coupled receptor protein signaling pathway by arrestin(GO:0002032) |
| 0.2 | 3.5 | GO:0051865 | protein autoubiquitination(GO:0051865) |
| 0.2 | 1.7 | GO:0031284 | positive regulation of guanylate cyclase activity(GO:0031284) |
| 0.2 | 0.5 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
| 0.2 | 2.5 | GO:0060287 | epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
| 0.2 | 0.6 | GO:0099566 | regulation of postsynaptic cytosolic calcium ion concentration(GO:0099566) |
| 0.2 | 0.2 | GO:0046337 | phosphatidylethanolamine metabolic process(GO:0046337) |
| 0.2 | 0.2 | GO:0010939 | regulation of necrotic cell death(GO:0010939) |
| 0.2 | 0.5 | GO:0010826 | negative regulation of centrosome duplication(GO:0010826) negative regulation of centrosome cycle(GO:0046606) |
| 0.2 | 3.1 | GO:0050779 | RNA destabilization(GO:0050779) |
| 0.2 | 0.6 | GO:0021785 | branchiomotor neuron axon guidance(GO:0021785) |
| 0.2 | 0.9 | GO:0008063 | Toll signaling pathway(GO:0008063) |
| 0.2 | 0.6 | GO:0042749 | regulation of circadian sleep/wake cycle(GO:0042749) |
| 0.2 | 5.8 | GO:0006783 | heme biosynthetic process(GO:0006783) |
| 0.2 | 0.8 | GO:0097368 | establishment of Sertoli cell barrier(GO:0097368) |
| 0.2 | 1.2 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
| 0.2 | 0.3 | GO:0010621 | negative regulation of transcription by transcription factor localization(GO:0010621) |
| 0.2 | 0.2 | GO:0032494 | response to peptidoglycan(GO:0032494) |
| 0.2 | 0.3 | GO:0030505 | inorganic diphosphate transport(GO:0030505) |
| 0.2 | 0.3 | GO:0046462 | monoacylglycerol metabolic process(GO:0046462) monoacylglycerol catabolic process(GO:0052651) |
| 0.2 | 0.5 | GO:0015680 | intracellular copper ion transport(GO:0015680) |
| 0.2 | 0.9 | GO:1901096 | regulation of autophagosome maturation(GO:1901096) |
| 0.1 | 0.9 | GO:0051968 | positive regulation of synaptic transmission, glutamatergic(GO:0051968) |
| 0.1 | 0.6 | GO:0030573 | bile acid catabolic process(GO:0030573) |
| 0.1 | 2.2 | GO:0080182 | histone H3-K4 trimethylation(GO:0080182) |
| 0.1 | 1.3 | GO:0036500 | ATF6-mediated unfolded protein response(GO:0036500) |
| 0.1 | 0.7 | GO:0048749 | compound eye development(GO:0048749) |
| 0.1 | 1.9 | GO:0001913 | T cell mediated cytotoxicity(GO:0001913) |
| 0.1 | 1.6 | GO:0048702 | embryonic neurocranium morphogenesis(GO:0048702) |
| 0.1 | 0.4 | GO:0051043 | regulation of membrane protein ectodomain proteolysis(GO:0051043) negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
| 0.1 | 0.3 | GO:0001927 | exocyst assembly(GO:0001927) |
| 0.1 | 0.1 | GO:0002589 | regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002589) negative regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002590) |
| 0.1 | 1.0 | GO:0070537 | histone H2A K63-linked deubiquitination(GO:0070537) |
| 0.1 | 0.1 | GO:0034141 | positive regulation of toll-like receptor 3 signaling pathway(GO:0034141) |
| 0.1 | 1.0 | GO:0060235 | lens induction in camera-type eye(GO:0060235) |
| 0.1 | 0.6 | GO:0003197 | endocardial cushion development(GO:0003197) |
| 0.1 | 0.4 | GO:0002209 | behavioral fear response(GO:0001662) behavioral defense response(GO:0002209) |
| 0.1 | 1.8 | GO:0014874 | response to stimulus involved in regulation of muscle adaptation(GO:0014874) |
| 0.1 | 0.3 | GO:2001015 | negative regulation of skeletal muscle cell differentiation(GO:2001015) |
| 0.1 | 0.6 | GO:0018002 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
| 0.1 | 0.4 | GO:0048213 | Golgi vesicle prefusion complex stabilization(GO:0048213) |
| 0.1 | 0.4 | GO:0051138 | positive regulation of NK T cell differentiation(GO:0051138) |
| 0.1 | 0.6 | GO:0014063 | negative regulation of serotonin secretion(GO:0014063) |
| 0.1 | 0.9 | GO:0034628 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
| 0.1 | 0.1 | GO:1904933 | regulation of cell proliferation in midbrain(GO:1904933) |
| 0.1 | 0.4 | GO:0048368 | lateral mesoderm development(GO:0048368) |
| 0.1 | 1.0 | GO:0060174 | limb bud formation(GO:0060174) |
| 0.1 | 1.6 | GO:0021680 | cerebellar Purkinje cell layer development(GO:0021680) |
| 0.1 | 1.0 | GO:0021853 | cerebral cortex GABAergic interneuron migration(GO:0021853) interneuron migration(GO:1904936) |
| 0.1 | 0.4 | GO:0021683 | cerebellar granular layer morphogenesis(GO:0021683) |
| 0.1 | 3.1 | GO:0007176 | regulation of epidermal growth factor-activated receptor activity(GO:0007176) |
| 0.1 | 0.3 | GO:0098911 | regulation of ventricular cardiac muscle cell action potential(GO:0098911) |
| 0.1 | 0.4 | GO:0006013 | mannose metabolic process(GO:0006013) |
| 0.1 | 0.1 | GO:0043652 | engulfment of apoptotic cell(GO:0043652) |
| 0.1 | 0.7 | GO:0030037 | actin filament reorganization involved in cell cycle(GO:0030037) |
| 0.1 | 1.4 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
| 0.1 | 1.1 | GO:1990504 | dense core granule exocytosis(GO:1990504) |
| 0.1 | 0.5 | GO:0002143 | tRNA wobble position uridine thiolation(GO:0002143) |
| 0.1 | 0.3 | GO:0002175 | protein localization to paranode region of axon(GO:0002175) |
| 0.1 | 0.4 | GO:0098976 | excitatory chemical synaptic transmission(GO:0098976) regulation of AMPA glutamate receptor clustering(GO:1904717) positive regulation of AMPA glutamate receptor clustering(GO:1904719) |
| 0.1 | 1.4 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
| 0.1 | 0.5 | GO:0051176 | positive regulation of sulfur metabolic process(GO:0051176) |
| 0.1 | 1.8 | GO:0006704 | glucocorticoid biosynthetic process(GO:0006704) |
| 0.1 | 0.1 | GO:0090611 | ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway(GO:0090611) |
| 0.1 | 1.1 | GO:0072733 | response to staurosporine(GO:0072733) cellular response to staurosporine(GO:0072734) |
| 0.1 | 0.4 | GO:0046898 | response to cycloheximide(GO:0046898) |
| 0.1 | 0.3 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
| 0.1 | 2.3 | GO:1902236 | negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902236) |
| 0.1 | 0.9 | GO:0090204 | protein localization to nuclear pore(GO:0090204) |
| 0.1 | 0.5 | GO:1902528 | regulation of protein linear polyubiquitination(GO:1902528) positive regulation of protein linear polyubiquitination(GO:1902530) |
| 0.1 | 0.1 | GO:1904252 | negative regulation of bile acid biosynthetic process(GO:0070858) negative regulation of bile acid metabolic process(GO:1904252) |
| 0.1 | 2.9 | GO:1901687 | glutathione derivative metabolic process(GO:1901685) glutathione derivative biosynthetic process(GO:1901687) |
| 0.1 | 0.1 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
| 0.1 | 1.1 | GO:0051096 | positive regulation of helicase activity(GO:0051096) |
| 0.1 | 1.1 | GO:0071802 | negative regulation of podosome assembly(GO:0071802) |
| 0.1 | 1.7 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
| 0.1 | 0.8 | GO:1901355 | cellular response to rapamycin(GO:0072752) response to rapamycin(GO:1901355) |
| 0.1 | 0.5 | GO:1903333 | regulation of protein refolding(GO:0061083) negative regulation of protein refolding(GO:0061084) negative regulation of protein folding(GO:1903333) |
| 0.1 | 0.3 | GO:1904220 | regulation of serine C-palmitoyltransferase activity(GO:1904220) |
| 0.1 | 0.5 | GO:0001866 | NK T cell proliferation(GO:0001866) |
| 0.1 | 0.1 | GO:0048260 | positive regulation of receptor-mediated endocytosis(GO:0048260) |
| 0.1 | 0.1 | GO:0040019 | positive regulation of embryonic development(GO:0040019) |
| 0.1 | 0.3 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
| 0.1 | 4.9 | GO:0046676 | negative regulation of insulin secretion(GO:0046676) |
| 0.1 | 1.1 | GO:0042780 | tRNA 3'-end processing(GO:0042780) |
| 0.1 | 0.6 | GO:0070669 | response to interleukin-2(GO:0070669) cellular response to interleukin-2(GO:0071352) |
| 0.1 | 3.7 | GO:0097120 | receptor localization to synapse(GO:0097120) |
| 0.1 | 0.8 | GO:1990592 | protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
| 0.1 | 0.6 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
| 0.1 | 2.4 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
| 0.1 | 0.3 | GO:0010793 | regulation of mRNA export from nucleus(GO:0010793) |
| 0.1 | 0.5 | GO:0001945 | lymph vessel development(GO:0001945) |
| 0.1 | 0.5 | GO:2001106 | regulation of Rho guanyl-nucleotide exchange factor activity(GO:2001106) |
| 0.1 | 0.1 | GO:0036342 | post-anal tail morphogenesis(GO:0036342) |
| 0.1 | 1.2 | GO:0006552 | leucine catabolic process(GO:0006552) |
| 0.1 | 0.4 | GO:2000854 | positive regulation of corticosterone secretion(GO:2000854) |
| 0.1 | 1.2 | GO:0070131 | positive regulation of mitochondrial translation(GO:0070131) |
| 0.1 | 0.6 | GO:1903385 | regulation of homophilic cell adhesion(GO:1903385) |
| 0.1 | 1.1 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
| 0.1 | 1.7 | GO:0035435 | phosphate ion transmembrane transport(GO:0035435) |
| 0.1 | 0.5 | GO:0055005 | ventricular cardiac myofibril assembly(GO:0055005) |
| 0.1 | 0.6 | GO:0021564 | vagus nerve development(GO:0021564) |
| 0.1 | 0.4 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
| 0.1 | 0.1 | GO:0003250 | cell proliferation involved in heart valve morphogenesis(GO:0003249) regulation of cell proliferation involved in heart valve morphogenesis(GO:0003250) cell proliferation involved in heart valve development(GO:2000793) |
| 0.1 | 1.3 | GO:0046325 | negative regulation of glucose import(GO:0046325) |
| 0.1 | 0.6 | GO:0051451 | myoblast migration(GO:0051451) |
| 0.1 | 0.4 | GO:0042214 | terpene metabolic process(GO:0042214) |
| 0.1 | 0.1 | GO:0034086 | maintenance of sister chromatid cohesion(GO:0034086) maintenance of mitotic sister chromatid cohesion(GO:0034088) |
| 0.1 | 0.4 | GO:0003095 | pressure natriuresis(GO:0003095) |
| 0.1 | 1.2 | GO:0015747 | urate transport(GO:0015747) |
| 0.1 | 0.8 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
| 0.1 | 0.2 | GO:0006711 | estrogen catabolic process(GO:0006711) |
| 0.1 | 0.4 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
| 0.1 | 0.4 | GO:0006433 | prolyl-tRNA aminoacylation(GO:0006433) |
| 0.1 | 0.5 | GO:1904647 | response to rotenone(GO:1904647) |
| 0.1 | 0.9 | GO:0046073 | dTMP biosynthetic process(GO:0006231) dTMP metabolic process(GO:0046073) |
| 0.1 | 0.1 | GO:0045964 | positive regulation of catecholamine metabolic process(GO:0045915) positive regulation of dopamine metabolic process(GO:0045964) |
| 0.1 | 0.8 | GO:0090266 | regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090266) regulation of mitotic spindle checkpoint(GO:1903504) |
| 0.1 | 0.5 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
| 0.1 | 1.5 | GO:0015705 | iodide transport(GO:0015705) |
| 0.1 | 0.3 | GO:0032233 | positive regulation of actin filament bundle assembly(GO:0032233) |
| 0.1 | 0.1 | GO:0045416 | positive regulation of interleukin-8 biosynthetic process(GO:0045416) |
| 0.1 | 0.5 | GO:0051126 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) negative regulation of actin nucleation(GO:0051126) |
| 0.1 | 0.1 | GO:0051462 | cortisol secretion(GO:0043400) regulation of cortisol secretion(GO:0051462) |
| 0.1 | 1.6 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
| 0.1 | 1.8 | GO:0003323 | type B pancreatic cell development(GO:0003323) |
| 0.1 | 0.5 | GO:0008105 | asymmetric protein localization(GO:0008105) |
| 0.1 | 0.1 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
| 0.1 | 0.3 | GO:0006423 | cysteinyl-tRNA aminoacylation(GO:0006423) |
| 0.1 | 1.4 | GO:0031953 | negative regulation of protein autophosphorylation(GO:0031953) |
| 0.1 | 0.2 | GO:0014067 | negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
| 0.1 | 1.4 | GO:0015760 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
| 0.1 | 5.7 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
| 0.1 | 0.8 | GO:0044381 | glucose import in response to insulin stimulus(GO:0044381) |
| 0.1 | 0.3 | GO:0014028 | notochord formation(GO:0014028) |
| 0.1 | 0.1 | GO:0002664 | regulation of T cell tolerance induction(GO:0002664) |
| 0.1 | 0.3 | GO:0006020 | inositol metabolic process(GO:0006020) |
| 0.1 | 0.1 | GO:0006880 | intracellular sequestering of iron ion(GO:0006880) sequestering of iron ion(GO:0097577) |
| 0.1 | 0.6 | GO:0030949 | positive regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030949) |
| 0.1 | 0.1 | GO:0070425 | negative regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070425) negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070433) cellular response to muramyl dipeptide(GO:0071225) |
| 0.1 | 0.2 | GO:0090045 | positive regulation of deacetylase activity(GO:0090045) |
| 0.1 | 0.9 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
| 0.1 | 0.3 | GO:0033037 | polysaccharide localization(GO:0033037) |
| 0.1 | 0.8 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
| 0.1 | 1.3 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
| 0.1 | 0.4 | GO:1902572 | negative regulation of serine-type endopeptidase activity(GO:1900004) negative regulation of serine-type peptidase activity(GO:1902572) |
| 0.1 | 0.8 | GO:1905150 | regulation of voltage-gated sodium channel activity(GO:1905150) |
| 0.1 | 0.2 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
| 0.1 | 0.2 | GO:1904398 | positive regulation of neuromuscular junction development(GO:1904398) |
| 0.1 | 0.2 | GO:0042636 | negative regulation of hair cycle(GO:0042636) |
| 0.1 | 0.1 | GO:0042255 | ribosome assembly(GO:0042255) |
| 0.1 | 2.0 | GO:0007130 | synaptonemal complex assembly(GO:0007130) |
| 0.1 | 0.1 | GO:0007039 | protein catabolic process in the vacuole(GO:0007039) |
| 0.1 | 0.4 | GO:0015874 | norepinephrine transport(GO:0015874) |
| 0.1 | 9.9 | GO:1900181 | negative regulation of protein localization to nucleus(GO:1900181) |
| 0.1 | 0.1 | GO:1903895 | negative regulation of IRE1-mediated unfolded protein response(GO:1903895) |
| 0.1 | 0.3 | GO:0035349 | coenzyme A transport(GO:0015880) coenzyme A transmembrane transport(GO:0035349) adenosine 3',5'-bisphosphate transmembrane transport(GO:0071106) AMP transport(GO:0080121) |
| 0.1 | 1.0 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
| 0.1 | 0.2 | GO:0035720 | intraciliary anterograde transport(GO:0035720) |
| 0.1 | 0.3 | GO:1904886 | beta-catenin destruction complex disassembly(GO:1904886) |
| 0.1 | 0.5 | GO:0046950 | cellular ketone body metabolic process(GO:0046950) |
| 0.1 | 0.1 | GO:0061356 | Wnt protein secretion(GO:0061355) regulation of Wnt protein secretion(GO:0061356) |
| 0.1 | 0.3 | GO:0006754 | ATP biosynthetic process(GO:0006754) |
| 0.1 | 1.1 | GO:0060087 | relaxation of vascular smooth muscle(GO:0060087) |
| 0.1 | 0.6 | GO:0031122 | cytoplasmic microtubule organization(GO:0031122) |
| 0.1 | 0.7 | GO:0042303 | molting cycle(GO:0042303) hair cycle(GO:0042633) |
| 0.1 | 0.3 | GO:0019046 | release from viral latency(GO:0019046) |
| 0.1 | 1.8 | GO:0019835 | cytolysis(GO:0019835) |
| 0.1 | 0.1 | GO:0046108 | uridine metabolic process(GO:0046108) |
| 0.1 | 0.3 | GO:0033344 | cholesterol efflux(GO:0033344) |
| 0.1 | 2.6 | GO:0050962 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
| 0.1 | 1.3 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
| 0.1 | 1.2 | GO:1903432 | regulation of TORC1 signaling(GO:1903432) |
| 0.1 | 1.0 | GO:0038166 | angiotensin-activated signaling pathway(GO:0038166) |
| 0.1 | 0.1 | GO:0002761 | regulation of myeloid leukocyte differentiation(GO:0002761) |
| 0.1 | 0.3 | GO:0036496 | regulation of translational initiation by eIF2 alpha dephosphorylation(GO:0036496) |
| 0.1 | 0.5 | GO:0010592 | positive regulation of lamellipodium assembly(GO:0010592) |
| 0.1 | 0.8 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
| 0.1 | 0.2 | GO:0050885 | neuromuscular process controlling balance(GO:0050885) |
| 0.1 | 1.3 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
| 0.1 | 0.8 | GO:0018230 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
| 0.1 | 0.4 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
| 0.1 | 0.2 | GO:0042495 | detection of triacyl bacterial lipopeptide(GO:0042495) detection of bacterial lipopeptide(GO:0070340) |
| 0.1 | 10.7 | GO:0001578 | microtubule bundle formation(GO:0001578) |
| 0.1 | 0.3 | GO:2000291 | regulation of myoblast proliferation(GO:2000291) |
| 0.1 | 1.3 | GO:0003016 | respiratory system process(GO:0003016) |
| 0.1 | 0.4 | GO:0051279 | regulation of release of sequestered calcium ion into cytosol(GO:0051279) regulation of ryanodine-sensitive calcium-release channel activity(GO:0060314) |
| 0.1 | 0.5 | GO:0015783 | GDP-fucose transport(GO:0015783) purine nucleotide-sugar transport(GO:0036079) |
| 0.1 | 0.3 | GO:2000819 | regulation of nucleotide-excision repair(GO:2000819) |
| 0.1 | 0.1 | GO:2000794 | regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000794) |
| 0.1 | 0.2 | GO:0033341 | regulation of collagen binding(GO:0033341) |
| 0.1 | 0.5 | GO:0039526 | suppression by virus of host apoptotic process(GO:0019050) negative regulation by symbiont of host apoptotic process(GO:0033668) modulation by virus of host apoptotic process(GO:0039526) negative regulation by symbiont of host programmed cell death(GO:0052041) negative regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052490) |
| 0.1 | 0.3 | GO:0071629 | cytoplasm-associated proteasomal ubiquitin-dependent protein catabolic process(GO:0071629) |
| 0.1 | 2.5 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
| 0.1 | 0.6 | GO:0060334 | regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
| 0.1 | 1.2 | GO:0097296 | activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:0097296) |
| 0.1 | 0.3 | GO:0040040 | thermosensory behavior(GO:0040040) |
| 0.1 | 0.2 | GO:0046834 | lipid phosphorylation(GO:0046834) |
| 0.1 | 1.5 | GO:0007340 | acrosome reaction(GO:0007340) |
| 0.1 | 0.4 | GO:0016334 | morphogenesis of follicular epithelium(GO:0016333) establishment or maintenance of polarity of follicular epithelium(GO:0016334) establishment of planar polarity of follicular epithelium(GO:0042247) |
| 0.1 | 0.6 | GO:0042168 | heme metabolic process(GO:0042168) |
| 0.1 | 0.5 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
| 0.1 | 0.2 | GO:0034378 | chylomicron assembly(GO:0034378) |
| 0.1 | 1.3 | GO:0042953 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
| 0.1 | 0.5 | GO:0000271 | polysaccharide biosynthetic process(GO:0000271) |
| 0.1 | 0.6 | GO:0000291 | nuclear-transcribed mRNA catabolic process, exonucleolytic(GO:0000291) |
| 0.1 | 0.4 | GO:2001238 | positive regulation of extrinsic apoptotic signaling pathway(GO:2001238) |
| 0.1 | 0.3 | GO:0050688 | regulation of defense response to virus(GO:0050688) |
| 0.1 | 0.4 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
| 0.1 | 0.8 | GO:0034384 | high-density lipoprotein particle clearance(GO:0034384) |
| 0.1 | 0.9 | GO:0031086 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) |
| 0.1 | 1.0 | GO:0014072 | response to isoquinoline alkaloid(GO:0014072) response to morphine(GO:0043278) |
| 0.1 | 4.2 | GO:0018279 | protein N-linked glycosylation via asparagine(GO:0018279) |
| 0.1 | 0.3 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
| 0.1 | 0.1 | GO:0036090 | cleavage furrow ingression(GO:0036090) |
| 0.1 | 2.0 | GO:0046006 | regulation of activated T cell proliferation(GO:0046006) |
| 0.1 | 0.9 | GO:0045671 | negative regulation of osteoclast differentiation(GO:0045671) |
| 0.1 | 0.1 | GO:1903401 | L-lysine transmembrane transport(GO:1903401) |
| 0.1 | 0.4 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
| 0.1 | 0.3 | GO:0035518 | histone H2A monoubiquitination(GO:0035518) |
| 0.1 | 0.1 | GO:0021847 | ventricular zone neuroblast division(GO:0021847) |
| 0.1 | 1.2 | GO:0007097 | nuclear migration(GO:0007097) |
| 0.1 | 0.2 | GO:0045590 | negative regulation of regulatory T cell differentiation(GO:0045590) |
| 0.1 | 0.9 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
| 0.1 | 0.3 | GO:0050918 | positive chemotaxis(GO:0050918) |
| 0.1 | 2.1 | GO:1903146 | regulation of mitophagy(GO:1903146) |
| 0.1 | 0.2 | GO:2000553 | positive regulation of T-helper 2 cell cytokine production(GO:2000553) |
| 0.1 | 0.4 | GO:0017185 | peptidyl-lysine hydroxylation(GO:0017185) |
| 0.1 | 4.9 | GO:1901998 | toxin transport(GO:1901998) |
| 0.1 | 0.3 | GO:0043536 | positive regulation of blood vessel endothelial cell migration(GO:0043536) |
| 0.1 | 1.5 | GO:0046348 | amino sugar catabolic process(GO:0046348) |
| 0.1 | 0.7 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
| 0.1 | 0.2 | GO:0090091 | positive regulation of extracellular matrix disassembly(GO:0090091) |
| 0.1 | 0.2 | GO:1903722 | regulation of centriole elongation(GO:1903722) |
| 0.1 | 1.2 | GO:1901017 | negative regulation of potassium ion transmembrane transporter activity(GO:1901017) |
| 0.1 | 0.3 | GO:2001200 | positive regulation of dendritic cell differentiation(GO:2001200) |
| 0.1 | 0.8 | GO:0019255 | glucose 1-phosphate metabolic process(GO:0019255) |
| 0.1 | 0.3 | GO:0014041 | regulation of neuron maturation(GO:0014041) |
| 0.1 | 4.4 | GO:0010507 | negative regulation of autophagy(GO:0010507) |
| 0.1 | 0.7 | GO:0071711 | basement membrane organization(GO:0071711) |
| 0.1 | 1.3 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
| 0.1 | 0.8 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
| 0.1 | 0.3 | GO:0071692 | protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
| 0.1 | 1.5 | GO:0048706 | embryonic skeletal system development(GO:0048706) |
| 0.1 | 0.6 | GO:1900046 | regulation of blood coagulation(GO:0030193) regulation of hemostasis(GO:1900046) |
| 0.1 | 6.3 | GO:0010508 | positive regulation of autophagy(GO:0010508) |
| 0.1 | 1.1 | GO:0034397 | telomere localization(GO:0034397) |
| 0.1 | 0.2 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
| 0.1 | 0.1 | GO:0048841 | regulation of axon extension involved in axon guidance(GO:0048841) |
| 0.1 | 0.1 | GO:0033078 | extrathymic T cell differentiation(GO:0033078) regulation of extrathymic T cell differentiation(GO:0033082) |
| 0.1 | 0.7 | GO:0098535 | de novo centriole assembly(GO:0098535) |
| 0.1 | 0.5 | GO:0016127 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
| 0.1 | 0.7 | GO:0046133 | pyrimidine ribonucleoside catabolic process(GO:0046133) |
| 0.1 | 0.3 | GO:0040023 | establishment of nucleus localization(GO:0040023) |
| 0.1 | 0.3 | GO:0014065 | phosphatidylinositol 3-kinase signaling(GO:0014065) |
| 0.1 | 0.9 | GO:0006749 | glutathione metabolic process(GO:0006749) |
| 0.1 | 0.8 | GO:0048820 | hair follicle maturation(GO:0048820) |
| 0.1 | 0.2 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
| 0.1 | 0.1 | GO:0010831 | positive regulation of myotube differentiation(GO:0010831) |
| 0.1 | 0.1 | GO:0009128 | purine nucleoside monophosphate catabolic process(GO:0009128) |
| 0.1 | 0.1 | GO:0060689 | cell differentiation involved in salivary gland development(GO:0060689) |
| 0.1 | 5.1 | GO:0070936 | protein K48-linked ubiquitination(GO:0070936) |
| 0.1 | 14.5 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
| 0.1 | 0.1 | GO:0097084 | vascular smooth muscle cell development(GO:0097084) |
| 0.1 | 2.9 | GO:0072488 | ammonium transmembrane transport(GO:0072488) |
| 0.1 | 0.3 | GO:0018874 | benzoate metabolic process(GO:0018874) |
| 0.1 | 0.2 | GO:0044727 | DNA demethylation of male pronucleus(GO:0044727) |
| 0.1 | 0.2 | GO:0080184 | response to phenylpropanoid(GO:0080184) |
| 0.1 | 0.1 | GO:0032239 | regulation of nucleobase-containing compound transport(GO:0032239) |
| 0.1 | 1.5 | GO:0036151 | phosphatidylcholine acyl-chain remodeling(GO:0036151) |
| 0.1 | 0.3 | GO:0034334 | adherens junction maintenance(GO:0034334) |
| 0.1 | 2.7 | GO:0000272 | polysaccharide catabolic process(GO:0000272) |
| 0.1 | 0.1 | GO:0043416 | regulation of skeletal muscle tissue regeneration(GO:0043416) |
| 0.1 | 0.2 | GO:0014010 | regulation of Schwann cell proliferation(GO:0010624) negative regulation of Schwann cell proliferation(GO:0010626) Schwann cell proliferation(GO:0014010) |
| 0.1 | 0.4 | GO:0017187 | peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
| 0.1 | 0.8 | GO:0043966 | histone H3 acetylation(GO:0043966) |
| 0.1 | 0.1 | GO:0002396 | MHC protein complex assembly(GO:0002396) MHC class II protein complex assembly(GO:0002399) peptide antigen assembly with MHC protein complex(GO:0002501) peptide antigen assembly with MHC class II protein complex(GO:0002503) |
| 0.1 | 0.2 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
| 0.1 | 0.6 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
| 0.1 | 0.6 | GO:0034332 | adherens junction organization(GO:0034332) |
| 0.1 | 0.2 | GO:0043589 | skin morphogenesis(GO:0043589) |
| 0.1 | 0.6 | GO:0071763 | nuclear membrane organization(GO:0071763) |
| 0.1 | 0.5 | GO:0042554 | superoxide anion generation(GO:0042554) |
| 0.1 | 0.6 | GO:0060750 | epithelial cell proliferation involved in mammary gland duct elongation(GO:0060750) branch elongation involved in mammary gland duct branching(GO:0060751) |
| 0.1 | 0.7 | GO:1900115 | extracellular regulation of signal transduction(GO:1900115) extracellular negative regulation of signal transduction(GO:1900116) |
| 0.1 | 0.2 | GO:0048539 | bone marrow development(GO:0048539) |
| 0.1 | 0.3 | GO:0035459 | cargo loading into vesicle(GO:0035459) |
| 0.1 | 0.5 | GO:0070221 | sulfide oxidation(GO:0019418) sulfide oxidation, using sulfide:quinone oxidoreductase(GO:0070221) |
| 0.1 | 0.2 | GO:0010390 | histone monoubiquitination(GO:0010390) |
| 0.1 | 0.1 | GO:0038163 | thrombopoietin-mediated signaling pathway(GO:0038163) |
| 0.1 | 0.2 | GO:2001267 | regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001267) |
| 0.1 | 0.2 | GO:1902308 | regulation of peptidyl-serine dephosphorylation(GO:1902308) |
| 0.1 | 0.1 | GO:0072021 | ascending thin limb development(GO:0072021) metanephric ascending thin limb development(GO:0072218) |
| 0.1 | 0.8 | GO:0015693 | magnesium ion transport(GO:0015693) |
| 0.1 | 0.2 | GO:0021919 | BMP signaling pathway involved in spinal cord dorsal/ventral patterning(GO:0021919) |
| 0.1 | 0.5 | GO:0019563 | glycerol catabolic process(GO:0019563) |
| 0.1 | 0.2 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
| 0.1 | 1.0 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
| 0.1 | 0.7 | GO:0046415 | urate metabolic process(GO:0046415) |
| 0.1 | 0.3 | GO:0080009 | mRNA methylation(GO:0080009) |
| 0.1 | 0.2 | GO:0043932 | ossification involved in bone remodeling(GO:0043932) |
| 0.1 | 1.0 | GO:1902259 | regulation of delayed rectifier potassium channel activity(GO:1902259) |
| 0.1 | 0.1 | GO:0097010 | eukaryotic translation initiation factor 4F complex assembly(GO:0097010) |
| 0.1 | 0.1 | GO:0008611 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) ether biosynthetic process(GO:1901503) |
| 0.1 | 0.3 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
| 0.1 | 0.4 | GO:1903003 | positive regulation of protein deubiquitination(GO:1903003) |
| 0.1 | 0.2 | GO:0061056 | sclerotome development(GO:0061056) |
| 0.1 | 0.7 | GO:0002230 | positive regulation of defense response to virus by host(GO:0002230) |
| 0.1 | 0.1 | GO:0003416 | endochondral bone growth(GO:0003416) |
| 0.1 | 0.3 | GO:0046092 | deoxycytidine metabolic process(GO:0046092) |
| 0.1 | 0.6 | GO:0016558 | protein import into peroxisome matrix(GO:0016558) |
| 0.1 | 0.6 | GO:0018095 | protein polyglutamylation(GO:0018095) |
| 0.1 | 0.8 | GO:2000675 | negative regulation of type B pancreatic cell apoptotic process(GO:2000675) |
| 0.1 | 0.1 | GO:0061107 | seminal vesicle development(GO:0061107) |
| 0.1 | 0.5 | GO:0032057 | negative regulation of translational initiation in response to stress(GO:0032057) |
| 0.1 | 0.1 | GO:0070723 | response to cholesterol(GO:0070723) |
| 0.1 | 1.8 | GO:0030199 | collagen fibril organization(GO:0030199) |
| 0.1 | 0.4 | GO:0072695 | negative regulation of DNA recombination at telomere(GO:0048239) regulation of DNA recombination at telomere(GO:0072695) |
| 0.1 | 2.2 | GO:0035036 | sperm-egg recognition(GO:0035036) |
| 0.1 | 0.2 | GO:0038193 | thromboxane A2 signaling pathway(GO:0038193) |
| 0.1 | 0.3 | GO:0008211 | glucocorticoid metabolic process(GO:0008211) |
| 0.1 | 1.2 | GO:0061418 | regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061418) |
| 0.1 | 0.7 | GO:0007616 | long-term memory(GO:0007616) |
| 0.1 | 0.1 | GO:0070346 | positive regulation of fat cell proliferation(GO:0070346) |
| 0.1 | 0.9 | GO:0060044 | negative regulation of cardiac muscle cell proliferation(GO:0060044) |
| 0.1 | 1.1 | GO:1903078 | positive regulation of protein localization to plasma membrane(GO:1903078) |
| 0.1 | 0.4 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
| 0.1 | 0.4 | GO:0048705 | skeletal system morphogenesis(GO:0048705) |
| 0.1 | 2.7 | GO:0006968 | cellular defense response(GO:0006968) |
| 0.1 | 0.5 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
| 0.1 | 0.1 | GO:0002327 | immature B cell differentiation(GO:0002327) |
| 0.1 | 0.7 | GO:0000447 | endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000447) |
| 0.1 | 0.1 | GO:0045668 | negative regulation of osteoblast differentiation(GO:0045668) |
| 0.1 | 0.2 | GO:0032972 | regulation of muscle filament sliding speed(GO:0032972) |
| 0.1 | 0.4 | GO:0007141 | male meiosis I(GO:0007141) |
| 0.1 | 0.1 | GO:1903348 | positive regulation of bicellular tight junction assembly(GO:1903348) |
| 0.1 | 0.1 | GO:0021542 | dentate gyrus development(GO:0021542) |
| 0.1 | 0.2 | GO:0006624 | vacuolar protein processing(GO:0006624) |
| 0.1 | 0.5 | GO:0072033 | renal vesicle formation(GO:0072033) |
| 0.1 | 0.7 | GO:0007501 | mesodermal cell fate specification(GO:0007501) |
| 0.1 | 5.2 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
| 0.1 | 5.7 | GO:0070268 | cornification(GO:0070268) |
| 0.1 | 0.1 | GO:0021650 | vestibulocochlear nerve formation(GO:0021650) |
| 0.1 | 0.1 | GO:2000035 | regulation of stem cell division(GO:2000035) |
| 0.1 | 0.3 | GO:0002710 | negative regulation of T cell mediated immunity(GO:0002710) |
| 0.1 | 0.2 | GO:0032959 | inositol trisphosphate biosynthetic process(GO:0032959) |
| 0.1 | 0.1 | GO:0010713 | negative regulation of collagen metabolic process(GO:0010713) negative regulation of multicellular organismal metabolic process(GO:0044252) |
| 0.1 | 1.6 | GO:0014037 | Schwann cell differentiation(GO:0014037) |
| 0.1 | 0.3 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
| 0.1 | 0.7 | GO:0007213 | G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) |
| 0.1 | 0.5 | GO:0042753 | positive regulation of circadian rhythm(GO:0042753) |
| 0.1 | 0.5 | GO:0046685 | response to arsenic-containing substance(GO:0046685) |
| 0.1 | 0.2 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
| 0.1 | 0.2 | GO:0035900 | response to isolation stress(GO:0035900) |
| 0.1 | 0.3 | GO:0006404 | RNA import into nucleus(GO:0006404) |
| 0.1 | 0.2 | GO:0016062 | adaptation of rhodopsin mediated signaling(GO:0016062) light adaption(GO:0036367) |
| 0.1 | 0.4 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
| 0.1 | 0.2 | GO:0070898 | RNA polymerase III transcriptional preinitiation complex assembly(GO:0070898) |
| 0.1 | 0.6 | GO:0034656 | nucleobase-containing small molecule catabolic process(GO:0034656) |
| 0.1 | 0.1 | GO:0002923 | regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002923) |
| 0.1 | 0.1 | GO:0048486 | parasympathetic nervous system development(GO:0048486) |
| 0.1 | 1.0 | GO:0035767 | endothelial cell chemotaxis(GO:0035767) |
| 0.1 | 1.5 | GO:0003341 | cilium movement(GO:0003341) |
| 0.1 | 0.7 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
| 0.1 | 0.2 | GO:1990697 | protein depalmitoleylation(GO:1990697) |
| 0.1 | 0.1 | GO:0019405 | alditol catabolic process(GO:0019405) |
| 0.1 | 0.1 | GO:0010801 | negative regulation of peptidyl-threonine phosphorylation(GO:0010801) |
| 0.1 | 0.2 | GO:0001763 | morphogenesis of a branching structure(GO:0001763) |
| 0.1 | 0.2 | GO:0007512 | adult heart development(GO:0007512) |
| 0.1 | 0.3 | GO:0040016 | embryonic cleavage(GO:0040016) |
| 0.1 | 0.4 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
| 0.1 | 0.2 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
| 0.1 | 0.2 | GO:0071569 | protein ufmylation(GO:0071569) |
| 0.1 | 0.8 | GO:0043562 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
| 0.1 | 0.1 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
| 0.1 | 0.1 | GO:0048266 | behavioral response to pain(GO:0048266) |
| 0.1 | 1.9 | GO:0090383 | phagosome acidification(GO:0090383) |
| 0.1 | 2.0 | GO:0007044 | cell-substrate junction assembly(GO:0007044) |
| 0.1 | 0.1 | GO:0007189 | adenylate cyclase-activating G-protein coupled receptor signaling pathway(GO:0007189) |
| 0.0 | 0.0 | GO:0071287 | cellular response to manganese ion(GO:0071287) |
| 0.0 | 0.1 | GO:0042226 | interleukin-6 biosynthetic process(GO:0042226) |
| 0.0 | 0.4 | GO:0071918 | urea transmembrane transport(GO:0071918) |
| 0.0 | 0.1 | GO:0048512 | rhythmic behavior(GO:0007622) circadian behavior(GO:0048512) |
| 0.0 | 0.2 | GO:1903070 | negative regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903070) |
| 0.0 | 0.0 | GO:0046716 | muscle cell cellular homeostasis(GO:0046716) |
| 0.0 | 0.8 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
| 0.0 | 0.0 | GO:0002215 | defense response to nematode(GO:0002215) |
| 0.0 | 0.1 | GO:0048250 | mitochondrial iron ion transport(GO:0048250) |
| 0.0 | 0.2 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
| 0.0 | 0.6 | GO:0003417 | growth plate cartilage development(GO:0003417) |
| 0.0 | 0.5 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
| 0.0 | 0.3 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
| 0.0 | 0.2 | GO:0010225 | response to UV-C(GO:0010225) |
| 0.0 | 0.1 | GO:0002323 | natural killer cell activation involved in immune response(GO:0002323) |
| 0.0 | 0.2 | GO:0071468 | cellular response to acidic pH(GO:0071468) |
| 0.0 | 0.8 | GO:0018146 | keratan sulfate biosynthetic process(GO:0018146) |
| 0.0 | 0.1 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
| 0.0 | 0.3 | GO:0060612 | adipose tissue development(GO:0060612) |
| 0.0 | 0.6 | GO:0033540 | fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
| 0.0 | 0.3 | GO:0009256 | 10-formyltetrahydrofolate metabolic process(GO:0009256) |
| 0.0 | 0.0 | GO:0060372 | regulation of atrial cardiac muscle cell membrane repolarization(GO:0060372) |
| 0.0 | 1.0 | GO:0015800 | acidic amino acid transport(GO:0015800) |
| 0.0 | 0.1 | GO:0033152 | immunoglobulin V(D)J recombination(GO:0033152) |
| 0.0 | 0.1 | GO:2000303 | regulation of sphingolipid biosynthetic process(GO:0090153) regulation of membrane lipid metabolic process(GO:1905038) regulation of ceramide biosynthetic process(GO:2000303) |
| 0.0 | 0.0 | GO:2000169 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) regulation of peptidyl-cysteine S-nitrosylation(GO:2000169) |
| 0.0 | 0.1 | GO:0035162 | embryonic hemopoiesis(GO:0035162) |
| 0.0 | 0.0 | GO:0035995 | detection of muscle stretch(GO:0035995) |
| 0.0 | 0.1 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
| 0.0 | 0.6 | GO:0001707 | mesoderm formation(GO:0001707) |
| 0.0 | 0.5 | GO:0021984 | adenohypophysis development(GO:0021984) |
| 0.0 | 0.5 | GO:0042220 | response to cocaine(GO:0042220) |
| 0.0 | 0.1 | GO:1905051 | regulation of base-excision repair(GO:1905051) positive regulation of base-excision repair(GO:1905053) |
| 0.0 | 0.1 | GO:0030520 | intracellular estrogen receptor signaling pathway(GO:0030520) |
| 0.0 | 0.1 | GO:2000659 | regulation of interleukin-1-mediated signaling pathway(GO:2000659) |
| 0.0 | 0.5 | GO:0016486 | peptide hormone processing(GO:0016486) |
| 0.0 | 1.4 | GO:0009584 | detection of visible light(GO:0009584) |
| 0.0 | 0.1 | GO:0001923 | B-1 B cell differentiation(GO:0001923) |
| 0.0 | 0.2 | GO:0097210 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
| 0.0 | 0.3 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
| 0.0 | 0.1 | GO:0044028 | DNA hypomethylation(GO:0044028) hypomethylation of CpG island(GO:0044029) |
| 0.0 | 0.0 | GO:0071317 | cellular response to morphine(GO:0071315) cellular response to isoquinoline alkaloid(GO:0071317) |
| 0.0 | 0.1 | GO:0043634 | polyadenylation-dependent ncRNA catabolic process(GO:0043634) |
| 0.0 | 0.1 | GO:0036324 | vascular endothelial growth factor receptor-2 signaling pathway(GO:0036324) |
| 0.0 | 0.2 | GO:0045766 | positive regulation of angiogenesis(GO:0045766) |
| 0.0 | 0.1 | GO:0032918 | polyamine acetylation(GO:0032917) spermidine acetylation(GO:0032918) |
| 0.0 | 1.1 | GO:0032755 | positive regulation of interleukin-6 production(GO:0032755) |
| 0.0 | 0.3 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
| 0.0 | 0.1 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
| 0.0 | 0.6 | GO:0051645 | Golgi localization(GO:0051645) |
| 0.0 | 0.2 | GO:2000637 | positive regulation of gene silencing by miRNA(GO:2000637) |
| 0.0 | 0.4 | GO:0019720 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) |
| 0.0 | 0.1 | GO:0002726 | positive regulation of T cell cytokine production(GO:0002726) |
| 0.0 | 0.1 | GO:0007056 | spindle assembly involved in female meiosis(GO:0007056) |
| 0.0 | 0.6 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
| 0.0 | 1.0 | GO:0045600 | positive regulation of fat cell differentiation(GO:0045600) |
| 0.0 | 0.9 | GO:0048168 | regulation of neuronal synaptic plasticity(GO:0048168) |
| 0.0 | 0.5 | GO:0060976 | coronary vasculature development(GO:0060976) |
| 0.0 | 0.3 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
| 0.0 | 0.1 | GO:0035329 | hippo signaling(GO:0035329) |
| 0.0 | 0.2 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
| 0.0 | 0.3 | GO:0001514 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
| 0.0 | 0.1 | GO:0001757 | somite specification(GO:0001757) |
| 0.0 | 0.0 | GO:0051125 | regulation of actin nucleation(GO:0051125) |
| 0.0 | 0.4 | GO:0002097 | tRNA wobble base modification(GO:0002097) |
| 0.0 | 0.2 | GO:1903546 | protein localization to photoreceptor outer segment(GO:1903546) |
| 0.0 | 0.1 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
| 0.0 | 0.2 | GO:0032786 | positive regulation of DNA-templated transcription, elongation(GO:0032786) |
| 0.0 | 0.4 | GO:0008088 | axo-dendritic transport(GO:0008088) |
| 0.0 | 0.3 | GO:0014887 | muscle hypertrophy in response to stress(GO:0003299) cardiac muscle adaptation(GO:0014887) cardiac muscle hypertrophy in response to stress(GO:0014898) |
| 0.0 | 0.0 | GO:1903413 | cellular response to bile acid(GO:1903413) |
| 0.0 | 5.8 | GO:0010951 | negative regulation of endopeptidase activity(GO:0010951) |
| 0.0 | 0.1 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
| 0.0 | 0.1 | GO:0048318 | axial mesoderm development(GO:0048318) |
| 0.0 | 5.3 | GO:0000377 | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile(GO:0000377) mRNA splicing, via spliceosome(GO:0000398) |
| 0.0 | 0.0 | GO:1904884 | telomerase catalytic core complex assembly(GO:1904868) regulation of telomerase catalytic core complex assembly(GO:1904882) positive regulation of telomerase catalytic core complex assembly(GO:1904884) |
| 0.0 | 0.4 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
| 0.0 | 0.4 | GO:0097320 | membrane tubulation(GO:0097320) |
| 0.0 | 0.1 | GO:0044458 | motile cilium assembly(GO:0044458) |
| 0.0 | 0.2 | GO:0045541 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
| 0.0 | 0.0 | GO:0060579 | ventral spinal cord interneuron fate commitment(GO:0060579) cell fate commitment involved in pattern specification(GO:0060581) |
| 0.0 | 0.1 | GO:0010755 | regulation of plasminogen activation(GO:0010755) |
| 0.0 | 0.1 | GO:0002643 | regulation of tolerance induction(GO:0002643) |
| 0.0 | 0.1 | GO:1900044 | regulation of protein K63-linked ubiquitination(GO:1900044) |
| 0.0 | 0.1 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
| 0.0 | 0.1 | GO:0071344 | diphosphate metabolic process(GO:0071344) |
| 0.0 | 0.1 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
| 0.0 | 0.1 | GO:0070173 | regulation of enamel mineralization(GO:0070173) |
| 0.0 | 0.2 | GO:0072673 | lamellipodium morphogenesis(GO:0072673) |
| 0.0 | 0.2 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
| 0.0 | 0.4 | GO:0001829 | trophectodermal cell differentiation(GO:0001829) |
| 0.0 | 0.2 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
| 0.0 | 1.3 | GO:0031529 | ruffle organization(GO:0031529) |
| 0.0 | 0.4 | GO:0007020 | microtubule nucleation(GO:0007020) |
| 0.0 | 0.1 | GO:0030730 | sequestering of triglyceride(GO:0030730) |
| 0.0 | 0.0 | GO:0046294 | formaldehyde catabolic process(GO:0046294) |
| 0.0 | 0.5 | GO:0043046 | DNA methylation involved in gamete generation(GO:0043046) |
| 0.0 | 0.1 | GO:0010835 | regulation of protein ADP-ribosylation(GO:0010835) |
| 0.0 | 0.0 | GO:0021855 | hypothalamus cell migration(GO:0021855) |
| 0.0 | 0.0 | GO:0060484 | lung-associated mesenchyme development(GO:0060484) |
| 0.0 | 0.0 | GO:0020027 | hemoglobin metabolic process(GO:0020027) |
| 0.0 | 0.1 | GO:0060283 | negative regulation of oocyte development(GO:0060283) negative regulation of oocyte maturation(GO:1900194) |
| 0.0 | 0.0 | GO:0070781 | response to biotin(GO:0070781) |
| 0.0 | 0.1 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
| 0.0 | 0.0 | GO:0009582 | detection of abiotic stimulus(GO:0009582) |
| 0.0 | 0.2 | GO:0006772 | thiamine metabolic process(GO:0006772) |
| 0.0 | 0.1 | GO:0006004 | fucose metabolic process(GO:0006004) |
| 0.0 | 0.1 | GO:0048485 | sympathetic nervous system development(GO:0048485) |
| 0.0 | 0.1 | GO:0071361 | cellular response to ethanol(GO:0071361) |
| 0.0 | 0.1 | GO:0043438 | acetoacetic acid metabolic process(GO:0043438) |
| 0.0 | 0.0 | GO:0071850 | mitotic cell cycle arrest(GO:0071850) |
| 0.0 | 0.4 | GO:0034260 | negative regulation of GTPase activity(GO:0034260) |
| 0.0 | 0.0 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
| 0.0 | 1.1 | GO:0007032 | endosome organization(GO:0007032) |
| 0.0 | 0.0 | GO:0032438 | melanosome organization(GO:0032438) |
| 0.0 | 0.2 | GO:0042481 | regulation of odontogenesis(GO:0042481) |
| 0.0 | 0.1 | GO:0021780 | oligodendrocyte cell fate specification(GO:0021778) oligodendrocyte cell fate commitment(GO:0021779) glial cell fate specification(GO:0021780) |
| 0.0 | 0.1 | GO:0050976 | detection of mechanical stimulus involved in sensory perception of touch(GO:0050976) |
| 0.0 | 0.1 | GO:0017121 | phospholipid scrambling(GO:0017121) |
| 0.0 | 0.0 | GO:0071288 | cellular response to mercury ion(GO:0071288) |
| 0.0 | 0.9 | GO:0010811 | positive regulation of cell-substrate adhesion(GO:0010811) |
| 0.0 | 0.5 | GO:0060333 | interferon-gamma-mediated signaling pathway(GO:0060333) |
| 0.0 | 0.0 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
| 0.0 | 0.1 | GO:0000012 | single strand break repair(GO:0000012) |
| 0.0 | 0.1 | GO:0051969 | regulation of transmission of nerve impulse(GO:0051969) |
| 0.0 | 0.1 | GO:0008612 | peptidyl-lysine modification to peptidyl-hypusine(GO:0008612) |
| 0.0 | 0.3 | GO:0051290 | protein heterotetramerization(GO:0051290) |
| 0.0 | 0.0 | GO:1904238 | mesangial cell differentiation(GO:0072007) kidney interstitial fibroblast differentiation(GO:0072071) pericyte cell differentiation(GO:1904238) |
| 0.0 | 0.0 | GO:0015755 | fructose transport(GO:0015755) |
| 0.0 | 0.4 | GO:0007274 | neuromuscular synaptic transmission(GO:0007274) |
| 0.0 | 0.0 | GO:0035249 | synaptic transmission, glutamatergic(GO:0035249) |
| 0.0 | 0.0 | GO:1904117 | response to vasopressin(GO:1904116) cellular response to vasopressin(GO:1904117) |
| 0.0 | 0.1 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
| 0.0 | 0.3 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
| 0.0 | 0.1 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
| 0.0 | 0.1 | GO:0000722 | telomere maintenance via recombination(GO:0000722) |
| 0.0 | 0.0 | GO:0042533 | tumor necrosis factor biosynthetic process(GO:0042533) regulation of tumor necrosis factor biosynthetic process(GO:0042534) |
| 0.0 | 0.2 | GO:0042044 | fluid transport(GO:0042044) |
| 0.0 | 0.0 | GO:0034393 | positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
| 0.0 | 0.1 | GO:0034454 | microtubule anchoring at centrosome(GO:0034454) |
| 0.0 | 0.1 | GO:0072584 | caveolin-mediated endocytosis(GO:0072584) |
| 0.0 | 0.1 | GO:0070233 | negative regulation of T cell apoptotic process(GO:0070233) |
| 0.0 | 0.1 | GO:0051708 | intracellular transport of viral protein in host cell(GO:0019060) symbiont intracellular protein transport in host(GO:0030581) intracellular protein transport in other organism involved in symbiotic interaction(GO:0051708) |
| 0.0 | 0.0 | GO:0002577 | regulation of antigen processing and presentation(GO:0002577) |
| 0.0 | 0.1 | GO:0090646 | mitochondrial tRNA processing(GO:0090646) |
| 0.0 | 0.0 | GO:2000765 | regulation of cytoplasmic translation(GO:2000765) |
| 0.0 | 0.0 | GO:1904100 | regulation of protein O-linked glycosylation(GO:1904098) positive regulation of protein O-linked glycosylation(GO:1904100) |
| 0.0 | 0.2 | GO:0015918 | sterol transport(GO:0015918) |
| 0.0 | 0.1 | GO:0070986 | left/right axis specification(GO:0070986) |
| 0.0 | 0.0 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
| 0.0 | 0.1 | GO:0010044 | response to aluminum ion(GO:0010044) |
Gene overrepresentation in cellular_component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 6.6 | 46.0 | GO:0097209 | epidermal lamellar body(GO:0097209) |
| 3.3 | 39.3 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
| 3.1 | 21.7 | GO:0072558 | NLRP1 inflammasome complex(GO:0072558) |
| 3.0 | 3.0 | GO:0071062 | alphav-beta3 integrin-vitronectin complex(GO:0071062) |
| 2.9 | 8.8 | GO:0043511 | inhibin complex(GO:0043511) inhibin A complex(GO:0043512) |
| 2.9 | 31.8 | GO:0005610 | laminin-5 complex(GO:0005610) |
| 2.3 | 6.9 | GO:0072563 | endothelial microparticle(GO:0072563) |
| 2.2 | 9.0 | GO:0043194 | axon initial segment(GO:0043194) |
| 2.1 | 8.5 | GO:0038039 | G-protein coupled receptor heterodimeric complex(GO:0038039) |
| 1.8 | 9.2 | GO:0032144 | 4-aminobutyrate transaminase complex(GO:0032144) |
| 1.8 | 14.3 | GO:0097129 | cyclin D2-CDK4 complex(GO:0097129) |
| 1.7 | 15.3 | GO:0098845 | postsynaptic endosome(GO:0098845) |
| 1.6 | 12.4 | GO:0035692 | macrophage migration inhibitory factor receptor complex(GO:0035692) |
| 1.5 | 6.2 | GO:0071665 | gamma-catenin-TCF7L2 complex(GO:0071665) |
| 1.5 | 12.3 | GO:0097442 | CA3 pyramidal cell dendrite(GO:0097442) |
| 1.5 | 16.8 | GO:0044354 | pinosome(GO:0044352) macropinosome(GO:0044354) |
| 1.4 | 4.2 | GO:0005595 | collagen type XII trimer(GO:0005595) |
| 1.4 | 1.4 | GO:0070557 | PCNA-p21 complex(GO:0070557) |
| 1.4 | 24.5 | GO:0097512 | cardiac myofibril(GO:0097512) |
| 1.3 | 6.5 | GO:0044393 | microspike(GO:0044393) |
| 1.3 | 10.3 | GO:0070876 | SOSS complex(GO:0070876) |
| 1.2 | 4.9 | GO:0072534 | perineuronal net(GO:0072534) |
| 1.2 | 27.8 | GO:0043203 | axon hillock(GO:0043203) |
| 1.2 | 4.8 | GO:0005846 | nuclear cap binding complex(GO:0005846) |
| 1.2 | 38.0 | GO:0034706 | sodium channel complex(GO:0034706) |
| 1.2 | 3.5 | GO:0034365 | discoidal high-density lipoprotein particle(GO:0034365) |
| 1.1 | 1.1 | GO:0030665 | clathrin-coated vesicle membrane(GO:0030665) |
| 1.1 | 3.3 | GO:0034686 | integrin alphav-beta8 complex(GO:0034686) |
| 1.0 | 1.0 | GO:0005682 | U5 snRNP(GO:0005682) |
| 1.0 | 27.9 | GO:0030056 | hemidesmosome(GO:0030056) |
| 1.0 | 14.2 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
| 1.0 | 6.0 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
| 1.0 | 8.0 | GO:0070435 | Shc-EGFR complex(GO:0070435) |
| 1.0 | 2.9 | GO:1990032 | parallel fiber(GO:1990032) |
| 1.0 | 10.5 | GO:0042612 | MHC class I protein complex(GO:0042612) |
| 0.9 | 8.8 | GO:0032010 | phagolysosome(GO:0032010) |
| 0.8 | 25.9 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
| 0.8 | 3.3 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
| 0.8 | 0.8 | GO:0043614 | multi-eIF complex(GO:0043614) |
| 0.8 | 34.4 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
| 0.8 | 2.4 | GO:0097444 | spine apparatus(GO:0097444) |
| 0.8 | 8.0 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
| 0.8 | 7.1 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
| 0.8 | 10.2 | GO:0017059 | serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
| 0.8 | 4.7 | GO:0010370 | perinucleolar chromocenter(GO:0010370) |
| 0.8 | 1.5 | GO:0031528 | microvillus membrane(GO:0031528) |
| 0.7 | 3.0 | GO:1990796 | photoreceptor cell terminal bouton(GO:1990796) |
| 0.7 | 5.1 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
| 0.7 | 50.8 | GO:0001533 | cornified envelope(GO:0001533) |
| 0.7 | 2.1 | GO:0035525 | NF-kappaB p50/p65 complex(GO:0035525) |
| 0.7 | 2.8 | GO:0031592 | centrosomal corona(GO:0031592) |
| 0.7 | 3.4 | GO:0071149 | TEAD-2-YAP complex(GO:0071149) |
| 0.7 | 2.0 | GO:0036117 | hyaluranon cable(GO:0036117) |
| 0.7 | 18.0 | GO:0097386 | glial cell projection(GO:0097386) |
| 0.7 | 2.7 | GO:0071020 | post-spliceosomal complex(GO:0071020) |
| 0.7 | 3.3 | GO:0035370 | UBC13-UEV1A complex(GO:0035370) |
| 0.7 | 0.7 | GO:0005668 | RNA polymerase transcription factor SL1 complex(GO:0005668) |
| 0.7 | 5.3 | GO:0033268 | node of Ranvier(GO:0033268) |
| 0.7 | 17.0 | GO:0005922 | connexon complex(GO:0005922) |
| 0.7 | 71.6 | GO:0016328 | lateral plasma membrane(GO:0016328) |
| 0.6 | 7.8 | GO:0072379 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
| 0.6 | 2.6 | GO:0031213 | RSF complex(GO:0031213) |
| 0.6 | 21.6 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
| 0.6 | 0.6 | GO:0030934 | anchoring collagen complex(GO:0030934) |
| 0.6 | 5.7 | GO:0042824 | MHC class I peptide loading complex(GO:0042824) |
| 0.6 | 1.3 | GO:1990682 | CSF1-CSF1R complex(GO:1990682) |
| 0.6 | 3.7 | GO:0000308 | cytoplasmic cyclin-dependent protein kinase holoenzyme complex(GO:0000308) |
| 0.6 | 5.4 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
| 0.6 | 7.0 | GO:0061689 | tricellular tight junction(GO:0061689) |
| 0.6 | 2.9 | GO:0097179 | protease inhibitor complex(GO:0097179) |
| 0.6 | 1.7 | GO:0001534 | radial spoke(GO:0001534) |
| 0.6 | 5.7 | GO:0005955 | calcineurin complex(GO:0005955) |
| 0.6 | 12.4 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
| 0.6 | 2.2 | GO:0055087 | Ski complex(GO:0055087) |
| 0.5 | 14.3 | GO:0043205 | microfibril(GO:0001527) fibril(GO:0043205) |
| 0.5 | 2.7 | GO:0034669 | integrin alpha4-beta7 complex(GO:0034669) |
| 0.5 | 1.1 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
| 0.5 | 7.9 | GO:0030478 | actin cap(GO:0030478) |
| 0.5 | 1.0 | GO:0030684 | preribosome(GO:0030684) preribosome, small subunit precursor(GO:0030688) |
| 0.5 | 2.0 | GO:0005889 | hydrogen:potassium-exchanging ATPase complex(GO:0005889) |
| 0.5 | 6.9 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
| 0.5 | 3.4 | GO:0044194 | cytolytic granule(GO:0044194) |
| 0.5 | 1.0 | GO:0098592 | cytoplasmic side of apical plasma membrane(GO:0098592) |
| 0.5 | 3.9 | GO:0070695 | FHF complex(GO:0070695) |
| 0.5 | 7.3 | GO:0045180 | basal cortex(GO:0045180) |
| 0.5 | 6.2 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
| 0.5 | 1.4 | GO:0005584 | collagen type I trimer(GO:0005584) |
| 0.5 | 8.0 | GO:0031089 | platelet dense granule lumen(GO:0031089) |
| 0.5 | 2.8 | GO:0031258 | lamellipodium membrane(GO:0031258) |
| 0.5 | 1.4 | GO:0036194 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
| 0.5 | 3.6 | GO:0034361 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
| 0.5 | 4.1 | GO:0051286 | cell tip(GO:0051286) |
| 0.5 | 3.2 | GO:0089701 | U2AF(GO:0089701) |
| 0.4 | 1.3 | GO:0002945 | cyclin K-CDK13 complex(GO:0002945) |
| 0.4 | 1.3 | GO:0061574 | ASAP complex(GO:0061574) |
| 0.4 | 7.0 | GO:0032426 | stereocilium tip(GO:0032426) |
| 0.4 | 3.8 | GO:0097208 | alveolar lamellar body(GO:0097208) |
| 0.4 | 1.2 | GO:0070195 | growth hormone receptor complex(GO:0070195) |
| 0.4 | 1.6 | GO:0031905 | early endosome lumen(GO:0031905) |
| 0.4 | 29.0 | GO:0002102 | podosome(GO:0002102) |
| 0.4 | 2.4 | GO:1990357 | terminal web(GO:1990357) |
| 0.4 | 1.2 | GO:1990393 | 3M complex(GO:1990393) |
| 0.4 | 3.1 | GO:0002177 | manchette(GO:0002177) |
| 0.4 | 9.6 | GO:0071682 | endocytic vesicle lumen(GO:0071682) |
| 0.4 | 1.2 | GO:0019008 | molybdopterin synthase complex(GO:0019008) |
| 0.4 | 2.3 | GO:0070436 | Grb2-EGFR complex(GO:0070436) |
| 0.4 | 2.3 | GO:0070381 | endosome to plasma membrane transport vesicle(GO:0070381) |
| 0.4 | 3.0 | GO:0097165 | nuclear stress granule(GO:0097165) |
| 0.4 | 2.6 | GO:0036021 | endolysosome lumen(GO:0036021) |
| 0.4 | 11.6 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
| 0.4 | 0.4 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
| 0.4 | 3.3 | GO:0005833 | hemoglobin complex(GO:0005833) |
| 0.4 | 2.2 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
| 0.4 | 1.1 | GO:1990666 | PCSK9-LDLR complex(GO:1990666) |
| 0.4 | 1.8 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
| 0.4 | 1.4 | GO:0070931 | Golgi-associated vesicle lumen(GO:0070931) |
| 0.4 | 4.7 | GO:0030061 | mitochondrial crista(GO:0030061) |
| 0.4 | 6.1 | GO:0061700 | GATOR2 complex(GO:0061700) |
| 0.4 | 0.4 | GO:0043260 | laminin-11 complex(GO:0043260) |
| 0.4 | 2.8 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
| 0.4 | 3.9 | GO:0097470 | ribbon synapse(GO:0097470) |
| 0.3 | 10.8 | GO:0005614 | interstitial matrix(GO:0005614) |
| 0.3 | 2.8 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
| 0.3 | 4.2 | GO:0046581 | intercellular canaliculus(GO:0046581) |
| 0.3 | 9.3 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
| 0.3 | 4.8 | GO:0000322 | storage vacuole(GO:0000322) |
| 0.3 | 15.4 | GO:0097228 | sperm principal piece(GO:0097228) |
| 0.3 | 1.4 | GO:0031166 | integral component of vacuolar membrane(GO:0031166) |
| 0.3 | 1.7 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
| 0.3 | 1.7 | GO:0000333 | telomerase catalytic core complex(GO:0000333) |
| 0.3 | 1.4 | GO:0035354 | Toll-like receptor 1-Toll-like receptor 2 protein complex(GO:0035354) |
| 0.3 | 0.3 | GO:0097441 | basilar dendrite(GO:0097441) |
| 0.3 | 1.3 | GO:0030904 | retromer complex(GO:0030904) |
| 0.3 | 0.7 | GO:0005900 | oncostatin-M receptor complex(GO:0005900) |
| 0.3 | 2.9 | GO:0035976 | AP1 complex(GO:0035976) |
| 0.3 | 0.3 | GO:0072588 | box H/ACA snoRNP complex(GO:0031429) box H/ACA RNP complex(GO:0072588) box H/ACA scaRNP complex(GO:0072589) box H/ACA telomerase RNP complex(GO:0090661) |
| 0.3 | 2.0 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
| 0.3 | 2.3 | GO:0033010 | paranodal junction(GO:0033010) |
| 0.3 | 3.2 | GO:0005677 | chromatin silencing complex(GO:0005677) |
| 0.3 | 4.8 | GO:0001520 | outer dense fiber(GO:0001520) |
| 0.3 | 0.9 | GO:0000502 | proteasome complex(GO:0000502) |
| 0.3 | 8.5 | GO:0098553 | integral component of lumenal side of endoplasmic reticulum membrane(GO:0071556) lumenal side of endoplasmic reticulum membrane(GO:0098553) |
| 0.3 | 0.3 | GO:0071012 | catalytic step 1 spliceosome(GO:0071012) |
| 0.3 | 2.8 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
| 0.3 | 43.5 | GO:0005796 | Golgi lumen(GO:0005796) |
| 0.3 | 0.6 | GO:0032002 | interleukin-28 receptor complex(GO:0032002) |
| 0.3 | 3.0 | GO:0042599 | lamellar body(GO:0042599) |
| 0.3 | 0.3 | GO:0000153 | cytoplasmic ubiquitin ligase complex(GO:0000153) |
| 0.3 | 4.3 | GO:0030057 | desmosome(GO:0030057) |
| 0.3 | 0.6 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
| 0.3 | 6.7 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
| 0.3 | 0.6 | GO:0016010 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
| 0.3 | 0.9 | GO:0005608 | laminin-3 complex(GO:0005608) |
| 0.3 | 2.6 | GO:0030893 | meiotic cohesin complex(GO:0030893) |
| 0.3 | 2.9 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
| 0.3 | 23.9 | GO:0035577 | azurophil granule membrane(GO:0035577) |
| 0.3 | 5.9 | GO:0001891 | phagocytic cup(GO:0001891) |
| 0.3 | 7.9 | GO:0035145 | exon-exon junction complex(GO:0035145) |
| 0.3 | 5.3 | GO:0060077 | inhibitory synapse(GO:0060077) |
| 0.3 | 34.1 | GO:0070821 | tertiary granule membrane(GO:0070821) |
| 0.3 | 3.0 | GO:0098560 | cytoplasmic side of late endosome membrane(GO:0098560) |
| 0.3 | 1.9 | GO:1902560 | GMP reductase complex(GO:1902560) |
| 0.3 | 4.6 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
| 0.3 | 6.7 | GO:0005605 | basal lamina(GO:0005605) |
| 0.3 | 1.1 | GO:1990745 | EARP complex(GO:1990745) |
| 0.3 | 16.2 | GO:0045178 | basal part of cell(GO:0045178) |
| 0.3 | 2.6 | GO:0098645 | network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) |
| 0.3 | 21.4 | GO:0030315 | T-tubule(GO:0030315) |
| 0.3 | 2.6 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
| 0.3 | 1.8 | GO:0005854 | nascent polypeptide-associated complex(GO:0005854) |
| 0.3 | 0.8 | GO:0070877 | microprocessor complex(GO:0070877) ribonuclease III complex(GO:1903095) |
| 0.3 | 0.5 | GO:0035061 | interchromatin granule(GO:0035061) |
| 0.3 | 0.5 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
| 0.3 | 3.8 | GO:0000974 | Prp19 complex(GO:0000974) |
| 0.3 | 1.3 | GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
| 0.3 | 2.0 | GO:0097452 | GAIT complex(GO:0097452) |
| 0.3 | 1.8 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
| 0.2 | 1.5 | GO:0098839 | postsynaptic density membrane(GO:0098839) |
| 0.2 | 0.7 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
| 0.2 | 21.8 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
| 0.2 | 0.2 | GO:0035189 | Rb-E2F complex(GO:0035189) |
| 0.2 | 2.4 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
| 0.2 | 1.9 | GO:0034715 | pICln-Sm protein complex(GO:0034715) |
| 0.2 | 4.6 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
| 0.2 | 0.5 | GO:1990622 | CHOP-ATF3 complex(GO:1990622) |
| 0.2 | 0.2 | GO:0071159 | NF-kappaB complex(GO:0071159) |
| 0.2 | 5.9 | GO:0071437 | invadopodium(GO:0071437) |
| 0.2 | 0.5 | GO:1990923 | PET complex(GO:1990923) |
| 0.2 | 0.5 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
| 0.2 | 1.6 | GO:1990452 | Parkin-FBXW7-Cul1 ubiquitin ligase complex(GO:1990452) |
| 0.2 | 0.9 | GO:0016939 | kinesin II complex(GO:0016939) |
| 0.2 | 20.2 | GO:1904724 | tertiary granule lumen(GO:1904724) |
| 0.2 | 2.0 | GO:1990578 | perinuclear endoplasmic reticulum membrane(GO:1990578) |
| 0.2 | 0.7 | GO:0005674 | transcription factor TFIIF complex(GO:0005674) |
| 0.2 | 2.2 | GO:0016589 | NURF complex(GO:0016589) |
| 0.2 | 6.1 | GO:0042101 | T cell receptor complex(GO:0042101) |
| 0.2 | 0.2 | GO:0031674 | I band(GO:0031674) |
| 0.2 | 0.4 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
| 0.2 | 0.4 | GO:0031616 | spindle pole centrosome(GO:0031616) |
| 0.2 | 5.3 | GO:0071004 | U2-type prespliceosome(GO:0071004) |
| 0.2 | 1.9 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
| 0.2 | 5.2 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
| 0.2 | 0.2 | GO:0000346 | transcription export complex(GO:0000346) |
| 0.2 | 29.9 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
| 0.2 | 0.4 | GO:0042565 | RNA nuclear export complex(GO:0042565) |
| 0.2 | 3.7 | GO:0031045 | dense core granule(GO:0031045) |
| 0.2 | 2.4 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
| 0.2 | 1.0 | GO:0000839 | Hrd1p ubiquitin ligase ERAD-L complex(GO:0000839) |
| 0.2 | 2.0 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
| 0.2 | 1.8 | GO:0098576 | lumenal side of membrane(GO:0098576) |
| 0.2 | 5.2 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
| 0.2 | 0.2 | GO:0016013 | syntrophin complex(GO:0016013) |
| 0.2 | 0.6 | GO:0033011 | perinuclear theca(GO:0033011) |
| 0.2 | 4.5 | GO:0031143 | pseudopodium(GO:0031143) |
| 0.2 | 3.9 | GO:0090543 | Flemming body(GO:0090543) |
| 0.2 | 0.6 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
| 0.2 | 0.4 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
| 0.2 | 1.5 | GO:0070847 | core mediator complex(GO:0070847) |
| 0.2 | 1.9 | GO:0070552 | BRISC complex(GO:0070552) |
| 0.2 | 20.1 | GO:0001725 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
| 0.2 | 32.3 | GO:0016605 | PML body(GO:0016605) |
| 0.2 | 0.6 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
| 0.2 | 1.3 | GO:0071203 | WASH complex(GO:0071203) |
| 0.2 | 6.4 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
| 0.2 | 2.5 | GO:0030897 | HOPS complex(GO:0030897) |
| 0.2 | 0.7 | GO:0045293 | MIS complex(GO:0036396) mRNA editing complex(GO:0045293) |
| 0.2 | 1.8 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
| 0.2 | 2.3 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
| 0.2 | 1.1 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
| 0.2 | 2.5 | GO:0005845 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
| 0.2 | 1.1 | GO:0030118 | clathrin coat(GO:0030118) |
| 0.2 | 5.3 | GO:0001772 | immunological synapse(GO:0001772) |
| 0.2 | 0.2 | GO:0042025 | host cell nucleus(GO:0042025) |
| 0.2 | 25.7 | GO:0031225 | anchored component of membrane(GO:0031225) |
| 0.2 | 1.6 | GO:0097413 | Lewy body(GO:0097413) |
| 0.2 | 0.5 | GO:0099634 | postsynaptic specialization membrane(GO:0099634) |
| 0.2 | 1.0 | GO:1990131 | Gtr1-Gtr2 GTPase complex(GO:1990131) |
| 0.2 | 7.9 | GO:0035580 | specific granule lumen(GO:0035580) |
| 0.2 | 0.5 | GO:0098844 | postsynaptic endocytic zone membrane(GO:0098844) |
| 0.2 | 2.9 | GO:0044295 | axonal growth cone(GO:0044295) |
| 0.2 | 1.9 | GO:0033018 | sarcoplasmic reticulum lumen(GO:0033018) |
| 0.2 | 2.7 | GO:0033270 | paranode region of axon(GO:0033270) |
| 0.2 | 0.5 | GO:0097123 | cyclin A1-CDK2 complex(GO:0097123) |
| 0.2 | 10.2 | GO:0005801 | cis-Golgi network(GO:0005801) |
| 0.2 | 2.2 | GO:0031305 | intrinsic component of mitochondrial inner membrane(GO:0031304) integral component of mitochondrial inner membrane(GO:0031305) |
| 0.2 | 0.2 | GO:0044279 | other organism cell membrane(GO:0044218) other organism membrane(GO:0044279) |
| 0.2 | 0.7 | GO:0061617 | MICOS complex(GO:0061617) |
| 0.2 | 0.5 | GO:0071011 | precatalytic spliceosome(GO:0071011) |
| 0.2 | 3.1 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
| 0.2 | 4.0 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
| 0.2 | 1.7 | GO:0097225 | sperm midpiece(GO:0097225) |
| 0.2 | 0.8 | GO:0017102 | methionyl glutamyl tRNA synthetase complex(GO:0017102) |
| 0.2 | 0.5 | GO:0043083 | synaptic cleft(GO:0043083) |
| 0.2 | 0.8 | GO:0002178 | palmitoyltransferase complex(GO:0002178) |
| 0.2 | 1.1 | GO:0031467 | Cul7-RING ubiquitin ligase complex(GO:0031467) |
| 0.2 | 0.5 | GO:0030895 | apolipoprotein B mRNA editing enzyme complex(GO:0030895) |
| 0.2 | 11.5 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
| 0.2 | 1.2 | GO:0035253 | ciliary rootlet(GO:0035253) |
| 0.2 | 0.5 | GO:0000229 | cytoplasmic chromosome(GO:0000229) |
| 0.2 | 0.5 | GO:0071564 | npBAF complex(GO:0071564) |
| 0.2 | 0.5 | GO:0034515 | proteasome storage granule(GO:0034515) |
| 0.2 | 2.3 | GO:0032039 | integrator complex(GO:0032039) |
| 0.2 | 0.8 | GO:0031417 | NatC complex(GO:0031417) |
| 0.1 | 40.0 | GO:0019897 | extrinsic component of plasma membrane(GO:0019897) |
| 0.1 | 3.6 | GO:0008180 | COP9 signalosome(GO:0008180) |
| 0.1 | 0.3 | GO:0045323 | interleukin-1 receptor complex(GO:0045323) |
| 0.1 | 12.9 | GO:0001669 | acrosomal vesicle(GO:0001669) |
| 0.1 | 11.0 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
| 0.1 | 9.9 | GO:0005604 | basement membrane(GO:0005604) |
| 0.1 | 1.9 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
| 0.1 | 1.9 | GO:0033162 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
| 0.1 | 0.6 | GO:0033565 | ESCRT-0 complex(GO:0033565) |
| 0.1 | 0.4 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
| 0.1 | 1.1 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
| 0.1 | 0.6 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
| 0.1 | 1.5 | GO:0097550 | transcriptional preinitiation complex(GO:0097550) |
| 0.1 | 3.5 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
| 0.1 | 5.0 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
| 0.1 | 1.7 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
| 0.1 | 0.8 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
| 0.1 | 0.8 | GO:0036020 | endolysosome membrane(GO:0036020) |
| 0.1 | 0.3 | GO:0043198 | dendritic shaft(GO:0043198) |
| 0.1 | 0.4 | GO:0000438 | core TFIIH complex portion of holo TFIIH complex(GO:0000438) |
| 0.1 | 19.5 | GO:0000118 | histone deacetylase complex(GO:0000118) |
| 0.1 | 0.8 | GO:0005753 | mitochondrial proton-transporting ATP synthase complex(GO:0005753) |
| 0.1 | 1.1 | GO:0070545 | PeBoW complex(GO:0070545) |
| 0.1 | 0.7 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
| 0.1 | 1.1 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
| 0.1 | 9.5 | GO:0030286 | dynein complex(GO:0030286) |
| 0.1 | 0.4 | GO:1990716 | axonemal central apparatus(GO:1990716) |
| 0.1 | 0.6 | GO:0030906 | retromer, cargo-selective complex(GO:0030906) |
| 0.1 | 1.4 | GO:0033391 | chromatoid body(GO:0033391) |
| 0.1 | 0.7 | GO:0045272 | plasma membrane respiratory chain complex I(GO:0045272) |
| 0.1 | 0.6 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
| 0.1 | 8.2 | GO:0042581 | specific granule(GO:0042581) |
| 0.1 | 0.6 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
| 0.1 | 0.1 | GO:0036019 | endolysosome(GO:0036019) |
| 0.1 | 3.4 | GO:1904813 | ficolin-1-rich granule(GO:0101002) ficolin-1-rich granule lumen(GO:1904813) |
| 0.1 | 0.5 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
| 0.1 | 1.5 | GO:0070776 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
| 0.1 | 0.5 | GO:0001741 | XY body(GO:0001741) |
| 0.1 | 0.5 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
| 0.1 | 0.1 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
| 0.1 | 13.1 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
| 0.1 | 0.6 | GO:0098799 | outer mitochondrial membrane protein complex(GO:0098799) |
| 0.1 | 0.8 | GO:0005579 | membrane attack complex(GO:0005579) |
| 0.1 | 2.7 | GO:0097342 | ripoptosome(GO:0097342) |
| 0.1 | 2.1 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
| 0.1 | 1.8 | GO:0042641 | actomyosin(GO:0042641) |
| 0.1 | 0.3 | GO:0042585 | germinal vesicle(GO:0042585) |
| 0.1 | 0.7 | GO:0032585 | multivesicular body membrane(GO:0032585) |
| 0.1 | 0.3 | GO:0035749 | myelin sheath adaxonal region(GO:0035749) lateral loop(GO:0043219) |
| 0.1 | 0.4 | GO:0098843 | postsynaptic endocytic zone(GO:0098843) |
| 0.1 | 0.5 | GO:0031902 | late endosome membrane(GO:0031902) |
| 0.1 | 0.1 | GO:0032437 | cuticular plate(GO:0032437) |
| 0.1 | 0.1 | GO:0097526 | spliceosomal tri-snRNP complex(GO:0097526) |
| 0.1 | 0.2 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
| 0.1 | 1.9 | GO:0070069 | cytochrome complex(GO:0070069) |
| 0.1 | 1.4 | GO:0017119 | Golgi transport complex(GO:0017119) |
| 0.1 | 2.4 | GO:0070820 | tertiary granule(GO:0070820) |
| 0.1 | 1.0 | GO:0032584 | growth cone membrane(GO:0032584) |
| 0.1 | 2.6 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
| 0.1 | 1.0 | GO:0000445 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
| 0.1 | 11.5 | GO:0030667 | secretory granule membrane(GO:0030667) |
| 0.1 | 10.3 | GO:0005905 | clathrin-coated pit(GO:0005905) |
| 0.1 | 0.1 | GO:0044214 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
| 0.1 | 17.0 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
| 0.1 | 1.0 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
| 0.1 | 6.4 | GO:0005681 | spliceosomal complex(GO:0005681) |
| 0.1 | 0.9 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
| 0.1 | 0.8 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
| 0.1 | 0.5 | GO:0005827 | polar microtubule(GO:0005827) |
| 0.1 | 0.1 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
| 0.1 | 9.4 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
| 0.1 | 1.3 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
| 0.1 | 4.2 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
| 0.1 | 12.3 | GO:0031227 | intrinsic component of endoplasmic reticulum membrane(GO:0031227) |
| 0.1 | 0.5 | GO:0032444 | activin responsive factor complex(GO:0032444) |
| 0.1 | 0.3 | GO:0045179 | apical cortex(GO:0045179) |
| 0.1 | 7.8 | GO:0016363 | nuclear matrix(GO:0016363) |
| 0.1 | 0.6 | GO:0032433 | filopodium tip(GO:0032433) |
| 0.1 | 8.1 | GO:0030018 | Z disc(GO:0030018) |
| 0.1 | 0.2 | GO:0016600 | flotillin complex(GO:0016600) |
| 0.1 | 1.3 | GO:0000813 | ESCRT I complex(GO:0000813) |
| 0.1 | 7.4 | GO:0070160 | occluding junction(GO:0070160) |
| 0.1 | 0.4 | GO:1990730 | VCP-NSFL1C complex(GO:1990730) |
| 0.1 | 8.4 | GO:0005911 | cell-cell junction(GO:0005911) |
| 0.1 | 0.1 | GO:0034678 | integrin alpha8-beta1 complex(GO:0034678) |
| 0.1 | 0.1 | GO:0032449 | CBM complex(GO:0032449) |
| 0.1 | 0.2 | GO:0005899 | insulin receptor complex(GO:0005899) |
| 0.1 | 1.5 | GO:0097381 | photoreceptor disc membrane(GO:0097381) |
| 0.1 | 0.3 | GO:0009368 | endopeptidase Clp complex(GO:0009368) |
| 0.1 | 0.8 | GO:0030126 | COPI vesicle coat(GO:0030126) |
| 0.1 | 1.9 | GO:0031231 | integral component of peroxisomal membrane(GO:0005779) intrinsic component of peroxisomal membrane(GO:0031231) |
| 0.1 | 0.2 | GO:0042022 | interleukin-12 receptor complex(GO:0042022) |
| 0.1 | 10.8 | GO:0001726 | ruffle(GO:0001726) |
| 0.1 | 216.0 | GO:0070062 | extracellular exosome(GO:0070062) |
| 0.1 | 2.5 | GO:0015030 | Cajal body(GO:0015030) |
| 0.1 | 0.1 | GO:0005642 | annulate lamellae(GO:0005642) |
| 0.1 | 0.7 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
| 0.1 | 1.6 | GO:0016514 | SWI/SNF complex(GO:0016514) |
| 0.1 | 0.1 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
| 0.1 | 8.7 | GO:0001650 | fibrillar center(GO:0001650) |
| 0.1 | 6.7 | GO:0030141 | secretory granule(GO:0030141) |
| 0.1 | 0.2 | GO:0016272 | prefoldin complex(GO:0016272) |
| 0.1 | 1.2 | GO:0035861 | site of double-strand break(GO:0035861) |
| 0.1 | 0.2 | GO:0019031 | viral envelope(GO:0019031) viral membrane(GO:0036338) |
| 0.1 | 0.5 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
| 0.1 | 0.6 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
| 0.1 | 0.9 | GO:0005770 | late endosome(GO:0005770) |
| 0.1 | 0.7 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
| 0.0 | 0.4 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
| 0.0 | 0.6 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
| 0.0 | 0.2 | GO:0035859 | Seh1-associated complex(GO:0035859) |
| 0.0 | 0.2 | GO:0031672 | A band(GO:0031672) |
| 0.0 | 0.1 | GO:0005745 | m-AAA complex(GO:0005745) |
| 0.0 | 0.7 | GO:0071141 | SMAD protein complex(GO:0071141) |
| 0.0 | 0.3 | GO:0031430 | M band(GO:0031430) |
| 0.0 | 0.3 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
| 0.0 | 0.2 | GO:0055038 | recycling endosome membrane(GO:0055038) |
| 0.0 | 0.2 | GO:0016938 | kinesin I complex(GO:0016938) |
| 0.0 | 0.6 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
| 0.0 | 0.2 | GO:0005767 | secondary lysosome(GO:0005767) |
| 0.0 | 0.2 | GO:0031415 | NatA complex(GO:0031415) |
| 0.0 | 0.1 | GO:0097224 | sperm connecting piece(GO:0097224) |
| 0.0 | 0.1 | GO:0042587 | glycogen granule(GO:0042587) |
| 0.0 | 0.1 | GO:0005953 | CAAX-protein geranylgeranyltransferase complex(GO:0005953) |
| 0.0 | 0.1 | GO:0031251 | PAN complex(GO:0031251) |
| 0.0 | 0.0 | GO:0031414 | N-terminal protein acetyltransferase complex(GO:0031414) |
| 0.0 | 0.1 | GO:0005818 | astral microtubule(GO:0000235) aster(GO:0005818) |
| 0.0 | 0.6 | GO:1904115 | axon cytoplasm(GO:1904115) |
| 0.0 | 0.0 | GO:0031085 | BLOC-3 complex(GO:0031085) |
| 0.0 | 0.2 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
| 0.0 | 0.2 | GO:0099738 | cell cortex region(GO:0099738) |
| 0.0 | 0.8 | GO:0016234 | inclusion body(GO:0016234) |
| 0.0 | 1.0 | GO:0005811 | lipid particle(GO:0005811) |
| 0.0 | 0.1 | GO:0042405 | nuclear inclusion body(GO:0042405) |
| 0.0 | 0.4 | GO:0000786 | nucleosome(GO:0000786) |
| 0.0 | 0.1 | GO:0001739 | sex chromatin(GO:0001739) |
| 0.0 | 0.2 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
| 0.0 | 0.1 | GO:0030870 | Mre11 complex(GO:0030870) |
| 0.0 | 0.1 | GO:0030678 | mitochondrial ribonuclease P complex(GO:0030678) |
Gene overrepresentation in molecular_function category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 4.3 | 21.5 | GO:0030197 | extracellular matrix constituent, lubricant activity(GO:0030197) |
| 4.1 | 12.2 | GO:0086040 | sodium:proton antiporter activity involved in regulation of cardiac muscle cell membrane potential(GO:0086040) |
| 4.1 | 20.3 | GO:0060961 | phospholipase D inhibitor activity(GO:0060961) |
| 3.7 | 18.7 | GO:0005152 | interleukin-1 receptor antagonist activity(GO:0005152) |
| 3.7 | 14.6 | GO:0016880 | glutamate-ammonia ligase activity(GO:0004356) ammonia ligase activity(GO:0016211) acid-ammonia (or amide) ligase activity(GO:0016880) |
| 3.5 | 52.8 | GO:0038062 | protein tyrosine kinase collagen receptor activity(GO:0038062) |
| 2.9 | 8.8 | GO:0036313 | phosphatidylinositol 3-kinase catalytic subunit binding(GO:0036313) |
| 2.9 | 42.8 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
| 2.6 | 18.2 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
| 2.5 | 9.9 | GO:0008260 | 3-oxoacid CoA-transferase activity(GO:0008260) |
| 2.3 | 7.0 | GO:0036487 | nitric-oxide synthase inhibitor activity(GO:0036487) |
| 2.3 | 23.4 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
| 2.3 | 20.6 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
| 2.2 | 17.4 | GO:0042289 | MHC class II protein binding(GO:0042289) |
| 2.2 | 6.5 | GO:0016964 | alpha-2 macroglobulin receptor activity(GO:0016964) |
| 2.1 | 40.1 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
| 1.9 | 43.8 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
| 1.9 | 5.7 | GO:0031731 | CCR6 chemokine receptor binding(GO:0031731) |
| 1.9 | 5.6 | GO:1990698 | palmitoleoyltransferase activity(GO:1990698) |
| 1.8 | 5.5 | GO:0015130 | mevalonate transmembrane transporter activity(GO:0015130) |
| 1.8 | 9.2 | GO:0032145 | 4-aminobutyrate transaminase activity(GO:0003867) succinate-semialdehyde dehydrogenase binding(GO:0032145) (S)-3-amino-2-methylpropionate transaminase activity(GO:0047298) |
| 1.8 | 8.9 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
| 1.8 | 16.0 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
| 1.7 | 8.5 | GO:0050473 | arachidonate 15-lipoxygenase activity(GO:0050473) |
| 1.6 | 11.0 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
| 1.5 | 6.2 | GO:0005199 | structural constituent of cell wall(GO:0005199) |
| 1.4 | 14.4 | GO:0004111 | creatine kinase activity(GO:0004111) |
| 1.4 | 1.4 | GO:0038049 | transcription factor activity, ligand-activated RNA polymerase II transcription factor binding(GO:0038049) |
| 1.4 | 4.3 | GO:0005308 | creatine transmembrane transporter activity(GO:0005308) |
| 1.4 | 5.5 | GO:0004142 | diacylglycerol cholinephosphotransferase activity(GO:0004142) |
| 1.4 | 16.2 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
| 1.3 | 5.4 | GO:0031685 | adenosine receptor binding(GO:0031685) |
| 1.3 | 8.0 | GO:0070699 | type II activin receptor binding(GO:0070699) |
| 1.3 | 1.3 | GO:0004909 | interleukin-1, Type I, activating receptor activity(GO:0004909) |
| 1.3 | 20.8 | GO:0008517 | folic acid transporter activity(GO:0008517) |
| 1.3 | 6.4 | GO:0047757 | chondroitin-glucuronate 5-epimerase activity(GO:0047757) |
| 1.3 | 3.8 | GO:0019150 | D-ribulokinase activity(GO:0019150) |
| 1.3 | 8.8 | GO:0035014 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) |
| 1.2 | 7.5 | GO:0019828 | aspartic-type endopeptidase inhibitor activity(GO:0019828) |
| 1.2 | 3.6 | GO:0086079 | gap junction channel activity involved in atrial cardiac muscle cell-AV node cell electrical coupling(GO:0086076) gap junction channel activity involved in bundle of His cell-Purkinje myocyte electrical coupling(GO:0086078) gap junction channel activity involved in Purkinje myocyte-ventricular cardiac muscle cell electrical coupling(GO:0086079) |
| 1.2 | 7.2 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
| 1.2 | 1.2 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
| 1.2 | 5.8 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
| 1.2 | 4.7 | GO:0035501 | MH1 domain binding(GO:0035501) |
| 1.2 | 3.5 | GO:0005298 | proline:sodium symporter activity(GO:0005298) |
| 1.2 | 3.5 | GO:0003845 | 11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity(GO:0003845) |
| 1.1 | 4.6 | GO:0047273 | galactosylgalactosylglucosylceramide beta-D-acetylgalactosaminyltransferase activity(GO:0047273) |
| 1.1 | 3.4 | GO:0070984 | SET domain binding(GO:0070984) |
| 1.1 | 4.5 | GO:1990254 | keratin filament binding(GO:1990254) |
| 1.1 | 3.4 | GO:0046964 | 3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity(GO:0046964) |
| 1.1 | 9.0 | GO:0086083 | cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication(GO:0086083) |
| 1.1 | 11.2 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
| 1.1 | 3.3 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
| 1.1 | 8.7 | GO:0016454 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
| 1.1 | 13.7 | GO:0038132 | neuregulin binding(GO:0038132) |
| 1.0 | 14.7 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
| 1.0 | 1.0 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
| 1.0 | 5.2 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
| 1.0 | 4.1 | GO:1990175 | EH domain binding(GO:1990175) |
| 1.0 | 6.1 | GO:0051033 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
| 1.0 | 3.0 | GO:0003842 | 1-pyrroline-5-carboxylate dehydrogenase activity(GO:0003842) |
| 1.0 | 4.0 | GO:0008431 | vitamin E binding(GO:0008431) |
| 1.0 | 3.0 | GO:1902271 | D3 vitamins binding(GO:1902271) |
| 1.0 | 3.0 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
| 1.0 | 5.9 | GO:0004598 | peptidylglycine monooxygenase activity(GO:0004504) peptidylamidoglycolate lyase activity(GO:0004598) |
| 1.0 | 5.8 | GO:0022897 | peptide:proton symporter activity(GO:0015333) proton-dependent peptide secondary active transmembrane transporter activity(GO:0022897) |
| 1.0 | 12.5 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
| 1.0 | 4.8 | GO:0055100 | adiponectin binding(GO:0055100) |
| 1.0 | 4.8 | GO:0086089 | voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization(GO:0086089) |
| 1.0 | 8.6 | GO:0016679 | oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) |
| 0.9 | 3.8 | GO:0050698 | proteoglycan sulfotransferase activity(GO:0050698) |
| 0.9 | 3.8 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
| 0.9 | 287.4 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
| 0.9 | 2.8 | GO:0002113 | interleukin-33 binding(GO:0002113) |
| 0.9 | 4.7 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) |
| 0.9 | 5.6 | GO:0017153 | sodium:dicarboxylate symporter activity(GO:0017153) |
| 0.9 | 4.6 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
| 0.9 | 3.7 | GO:0002114 | interleukin-33 receptor activity(GO:0002114) |
| 0.9 | 5.5 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
| 0.9 | 9.9 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
| 0.9 | 3.6 | GO:0034188 | apolipoprotein A-I receptor activity(GO:0034188) phosphatidylserine-translocating ATPase activity(GO:0090556) |
| 0.9 | 0.9 | GO:0070506 | high-density lipoprotein particle receptor activity(GO:0070506) |
| 0.9 | 1.8 | GO:0016638 | oxidoreductase activity, acting on the CH-NH2 group of donors(GO:0016638) |
| 0.9 | 2.7 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
| 0.9 | 3.5 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
| 0.9 | 13.0 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
| 0.9 | 19.0 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
| 0.9 | 1.7 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
| 0.9 | 4.3 | GO:0015254 | glycerol channel activity(GO:0015254) |
| 0.9 | 3.4 | GO:0047888 | fatty acid peroxidase activity(GO:0047888) |
| 0.8 | 12.7 | GO:0042834 | peptidoglycan binding(GO:0042834) |
| 0.8 | 3.4 | GO:0004461 | lactose synthase activity(GO:0004461) |
| 0.8 | 15.2 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
| 0.8 | 4.2 | GO:0004782 | sulfinoalanine decarboxylase activity(GO:0004782) |
| 0.8 | 3.3 | GO:0035651 | AP-3 adaptor complex binding(GO:0035651) |
| 0.8 | 10.0 | GO:0032051 | clathrin light chain binding(GO:0032051) |
| 0.8 | 5.8 | GO:0050733 | RS domain binding(GO:0050733) |
| 0.8 | 2.4 | GO:0003968 | RNA-directed RNA polymerase activity(GO:0003968) |
| 0.8 | 34.2 | GO:0098641 | cadherin binding involved in cell-cell adhesion(GO:0098641) |
| 0.8 | 3.2 | GO:0035241 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) |
| 0.8 | 4.7 | GO:0046899 | nucleoside triphosphate adenylate kinase activity(GO:0046899) |
| 0.8 | 5.5 | GO:0046979 | TAP2 binding(GO:0046979) |
| 0.8 | 3.9 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
| 0.8 | 13.9 | GO:0008199 | ferric iron binding(GO:0008199) |
| 0.8 | 13.9 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
| 0.8 | 4.6 | GO:0043183 | vascular endothelial growth factor receptor 1 binding(GO:0043183) |
| 0.8 | 2.3 | GO:0008476 | protein-tyrosine sulfotransferase activity(GO:0008476) |
| 0.7 | 2.2 | GO:0008746 | NAD(P)+ transhydrogenase activity(GO:0008746) oxidoreductase activity, acting on NAD(P)H, NAD(P) as acceptor(GO:0016652) |
| 0.7 | 11.7 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
| 0.7 | 10.2 | GO:0004465 | lipoprotein lipase activity(GO:0004465) |
| 0.7 | 2.2 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
| 0.7 | 0.7 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
| 0.7 | 15.8 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) intronic transcription regulatory region DNA binding(GO:0044213) |
| 0.7 | 2.2 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
| 0.7 | 3.6 | GO:0008457 | beta-galactosyl-N-acetylglucosaminylgalactosylglucosyl-ceramide beta-1,3-acetylglucosaminyltransferase activity(GO:0008457) lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase activity(GO:0047256) |
| 0.7 | 14.2 | GO:0050700 | CARD domain binding(GO:0050700) |
| 0.7 | 2.1 | GO:0001226 | RNA polymerase II transcription corepressor binding(GO:0001226) |
| 0.7 | 2.8 | GO:0017095 | heparan sulfate 6-O-sulfotransferase activity(GO:0017095) |
| 0.7 | 6.4 | GO:0043426 | MRF binding(GO:0043426) |
| 0.7 | 7.6 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
| 0.7 | 32.6 | GO:0043236 | laminin binding(GO:0043236) |
| 0.7 | 2.8 | GO:0004031 | aldehyde oxidase activity(GO:0004031) |
| 0.7 | 3.4 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
| 0.7 | 22.1 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
| 0.7 | 16.6 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
| 0.7 | 2.0 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
| 0.7 | 3.3 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
| 0.7 | 5.2 | GO:0016314 | phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity(GO:0016314) |
| 0.6 | 3.2 | GO:0052829 | inositol-1,4-bisphosphate 1-phosphatase activity(GO:0004441) inositol-1,3,4-trisphosphate 1-phosphatase activity(GO:0052829) |
| 0.6 | 93.0 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
| 0.6 | 1.3 | GO:0046977 | TAP binding(GO:0046977) TAP1 binding(GO:0046978) |
| 0.6 | 1.9 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
| 0.6 | 3.2 | GO:0005011 | macrophage colony-stimulating factor receptor activity(GO:0005011) |
| 0.6 | 12.0 | GO:0019841 | retinol binding(GO:0019841) |
| 0.6 | 2.5 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
| 0.6 | 3.7 | GO:0052841 | endopolyphosphatase activity(GO:0000298) diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) bis(5'-adenosyl)-hexaphosphatase activity(GO:0034431) bis(5'-adenosyl)-pentaphosphatase activity(GO:0034432) inositol diphosphate tetrakisphosphate diphosphatase activity(GO:0052840) inositol bisdiphosphate tetrakisphosphate diphosphatase activity(GO:0052841) inositol diphosphate pentakisphosphate diphosphatase activity(GO:0052842) inositol-1-diphosphate-2,3,4,5,6-pentakisphosphate diphosphatase activity(GO:0052843) inositol-3-diphosphate-1,2,4,5,6-pentakisphosphate diphosphatase activity(GO:0052844) inositol-5-diphosphate-1,2,3,4,6-pentakisphosphate diphosphatase activity(GO:0052845) inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 1-diphosphatase activity(GO:0052846) inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity(GO:0052847) inositol-3,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity(GO:0052848) |
| 0.6 | 5.6 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) procollagen-proline dioxygenase activity(GO:0019798) |
| 0.6 | 2.5 | GO:0004644 | phosphoribosylamine-glycine ligase activity(GO:0004637) phosphoribosylformylglycinamidine cyclo-ligase activity(GO:0004641) phosphoribosylglycinamide formyltransferase activity(GO:0004644) |
| 0.6 | 1.9 | GO:0071633 | dihydroceramidase activity(GO:0071633) |
| 0.6 | 1.9 | GO:1904599 | advanced glycation end-product binding(GO:1904599) |
| 0.6 | 0.6 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
| 0.6 | 8.6 | GO:0048018 | receptor agonist activity(GO:0048018) |
| 0.6 | 1.8 | GO:0004823 | leucine-tRNA ligase activity(GO:0004823) |
| 0.6 | 9.6 | GO:0016018 | cyclosporin A binding(GO:0016018) |
| 0.6 | 13.7 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
| 0.6 | 11.9 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
| 0.6 | 3.0 | GO:0102008 | cytosolic dipeptidase activity(GO:0102008) |
| 0.6 | 1.8 | GO:0070538 | oleic acid binding(GO:0070538) |
| 0.6 | 2.4 | GO:0070012 | oligopeptidase activity(GO:0070012) |
| 0.6 | 1.8 | GO:0048030 | disaccharide binding(GO:0048030) |
| 0.6 | 3.5 | GO:0042015 | interleukin-20 binding(GO:0042015) |
| 0.6 | 1.7 | GO:0016768 | spermine synthase activity(GO:0016768) |
| 0.6 | 0.6 | GO:0005010 | insulin-like growth factor-activated receptor activity(GO:0005010) |
| 0.6 | 8.6 | GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) |
| 0.6 | 3.4 | GO:0050265 | RNA uridylyltransferase activity(GO:0050265) |
| 0.6 | 2.3 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
| 0.6 | 1.7 | GO:0060001 | minus-end directed microfilament motor activity(GO:0060001) |
| 0.6 | 0.6 | GO:0070878 | primary miRNA binding(GO:0070878) |
| 0.6 | 5.0 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
| 0.6 | 3.9 | GO:0036041 | long-chain fatty acid binding(GO:0036041) |
| 0.6 | 2.8 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
| 0.6 | 18.7 | GO:0042605 | peptide antigen binding(GO:0042605) |
| 0.6 | 3.9 | GO:0047894 | flavonol 3-sulfotransferase activity(GO:0047894) |
| 0.5 | 6.0 | GO:0034235 | GPI anchor binding(GO:0034235) |
| 0.5 | 11.5 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
| 0.5 | 1.6 | GO:0033906 | hyaluronoglucuronidase activity(GO:0033906) |
| 0.5 | 2.2 | GO:0005115 | receptor tyrosine kinase-like orphan receptor binding(GO:0005115) chemoattractant activity involved in axon guidance(GO:1902379) |
| 0.5 | 2.1 | GO:0034040 | lipid-transporting ATPase activity(GO:0034040) |
| 0.5 | 30.0 | GO:0042379 | chemokine receptor binding(GO:0042379) |
| 0.5 | 3.2 | GO:0048406 | nerve growth factor binding(GO:0048406) |
| 0.5 | 1.6 | GO:0005499 | vitamin D binding(GO:0005499) |
| 0.5 | 7.9 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
| 0.5 | 0.5 | GO:0019209 | kinase activator activity(GO:0019209) |
| 0.5 | 4.7 | GO:0000978 | RNA polymerase II core promoter proximal region sequence-specific DNA binding(GO:0000978) |
| 0.5 | 1.6 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
| 0.5 | 2.1 | GO:0008426 | protein kinase C inhibitor activity(GO:0008426) |
| 0.5 | 3.6 | GO:0044547 | DNA topoisomerase binding(GO:0044547) |
| 0.5 | 1.0 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
| 0.5 | 6.2 | GO:0036122 | BMP binding(GO:0036122) |
| 0.5 | 1.0 | GO:0035939 | microsatellite binding(GO:0035939) |
| 0.5 | 1.5 | GO:0098770 | FBXO family protein binding(GO:0098770) |
| 0.5 | 5.5 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
| 0.5 | 5.0 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
| 0.5 | 5.5 | GO:0005542 | folic acid binding(GO:0005542) |
| 0.5 | 2.5 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
| 0.5 | 2.0 | GO:0052810 | 1-phosphatidylinositol-5-kinase activity(GO:0052810) |
| 0.5 | 7.3 | GO:0045159 | myosin II binding(GO:0045159) |
| 0.5 | 5.3 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
| 0.5 | 6.8 | GO:0005537 | mannose binding(GO:0005537) |
| 0.5 | 3.4 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
| 0.5 | 6.7 | GO:0098599 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
| 0.5 | 2.4 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
| 0.5 | 9.0 | GO:0017049 | GTP-Rho binding(GO:0017049) |
| 0.5 | 1.4 | GO:0000384 | first spliceosomal transesterification activity(GO:0000384) |
| 0.5 | 13.7 | GO:0002162 | dystroglycan binding(GO:0002162) |
| 0.5 | 0.9 | GO:0008410 | CoA-transferase activity(GO:0008410) |
| 0.5 | 2.8 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
| 0.5 | 1.9 | GO:0003858 | 3-hydroxybutyrate dehydrogenase activity(GO:0003858) |
| 0.5 | 0.5 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
| 0.5 | 2.3 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
| 0.5 | 6.9 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
| 0.5 | 3.2 | GO:0051022 | GDP-dissociation inhibitor binding(GO:0051021) Rho GDP-dissociation inhibitor binding(GO:0051022) |
| 0.5 | 3.2 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
| 0.5 | 3.2 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
| 0.4 | 2.2 | GO:0016646 | oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor(GO:0016646) |
| 0.4 | 9.0 | GO:0044548 | S100 protein binding(GO:0044548) |
| 0.4 | 3.1 | GO:0050119 | N-acetylglucosamine deacetylase activity(GO:0050119) |
| 0.4 | 4.0 | GO:1904929 | coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway(GO:1904929) |
| 0.4 | 4.4 | GO:0030546 | receptor activator activity(GO:0030546) |
| 0.4 | 2.6 | GO:0043812 | phosphatidylinositol-4-phosphate phosphatase activity(GO:0043812) |
| 0.4 | 6.6 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
| 0.4 | 3.1 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
| 0.4 | 10.0 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
| 0.4 | 3.5 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
| 0.4 | 4.3 | GO:0030020 | extracellular matrix structural constituent conferring tensile strength(GO:0030020) |
| 0.4 | 1.7 | GO:0070991 | medium-chain-acyl-CoA dehydrogenase activity(GO:0070991) |
| 0.4 | 1.3 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
| 0.4 | 9.0 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
| 0.4 | 1.7 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
| 0.4 | 5.1 | GO:0004705 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
| 0.4 | 1.7 | GO:0015207 | ATP:ADP antiporter activity(GO:0005471) adenine transmembrane transporter activity(GO:0015207) |
| 0.4 | 4.2 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
| 0.4 | 1.7 | GO:0045131 | pre-mRNA branch point binding(GO:0045131) |
| 0.4 | 9.5 | GO:0004707 | MAP kinase activity(GO:0004707) |
| 0.4 | 2.1 | GO:0008267 | poly-glutamine tract binding(GO:0008267) |
| 0.4 | 5.7 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
| 0.4 | 1.6 | GO:0045127 | N-acetylglucosamine kinase activity(GO:0045127) |
| 0.4 | 2.5 | GO:0039552 | RIG-I binding(GO:0039552) |
| 0.4 | 4.1 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
| 0.4 | 2.8 | GO:0004609 | phosphatidylserine decarboxylase activity(GO:0004609) |
| 0.4 | 5.3 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
| 0.4 | 4.4 | GO:0015288 | porin activity(GO:0015288) |
| 0.4 | 0.8 | GO:0004047 | aminomethyltransferase activity(GO:0004047) |
| 0.4 | 1.6 | GO:0008336 | gamma-butyrobetaine dioxygenase activity(GO:0008336) |
| 0.4 | 2.8 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
| 0.4 | 4.3 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
| 0.4 | 18.5 | GO:0003785 | actin monomer binding(GO:0003785) |
| 0.4 | 2.7 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
| 0.4 | 3.9 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
| 0.4 | 1.2 | GO:0097027 | ubiquitin-protein transferase activator activity(GO:0097027) |
| 0.4 | 5.7 | GO:0046870 | cadmium ion binding(GO:0046870) |
| 0.4 | 1.5 | GO:0005003 | ephrin receptor activity(GO:0005003) |
| 0.4 | 1.1 | GO:0072544 | L-DOPA receptor activity(GO:0035643) L-DOPA binding(GO:0072544) |
| 0.4 | 1.1 | GO:0034353 | RNA pyrophosphohydrolase activity(GO:0034353) |
| 0.4 | 2.6 | GO:0001849 | complement component C1q binding(GO:0001849) |
| 0.4 | 4.1 | GO:0015143 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
| 0.4 | 4.5 | GO:0010385 | double-stranded methylated DNA binding(GO:0010385) |
| 0.4 | 3.0 | GO:0015119 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
| 0.4 | 18.0 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
| 0.4 | 5.1 | GO:1990459 | transferrin receptor binding(GO:1990459) |
| 0.4 | 3.3 | GO:0032183 | SUMO binding(GO:0032183) |
| 0.4 | 3.3 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
| 0.4 | 1.1 | GO:0043849 | Ras palmitoyltransferase activity(GO:0043849) |
| 0.4 | 0.7 | GO:0002046 | opsin binding(GO:0002046) |
| 0.4 | 0.4 | GO:0004438 | phosphatidylinositol-3-phosphatase activity(GO:0004438) phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity(GO:0052629) phosphatidylinositol monophosphate phosphatase activity(GO:0052744) |
| 0.4 | 12.6 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
| 0.4 | 3.6 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
| 0.4 | 3.6 | GO:0015501 | glutamate:sodium symporter activity(GO:0015501) |
| 0.4 | 7.5 | GO:0051400 | BH domain binding(GO:0051400) |
| 0.4 | 1.1 | GO:0004326 | tetrahydrofolylpolyglutamate synthase activity(GO:0004326) dihydrofolate synthase activity(GO:0008841) |
| 0.4 | 4.6 | GO:0031386 | protein tag(GO:0031386) |
| 0.4 | 19.6 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
| 0.4 | 0.7 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
| 0.4 | 4.9 | GO:0044877 | macromolecular complex binding(GO:0044877) |
| 0.4 | 2.8 | GO:0004784 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
| 0.4 | 2.5 | GO:0008481 | sphinganine kinase activity(GO:0008481) D-erythro-sphingosine kinase activity(GO:0017050) |
| 0.4 | 1.1 | GO:0016776 | phosphotransferase activity, phosphate group as acceptor(GO:0016776) |
| 0.3 | 6.3 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
| 0.3 | 1.0 | GO:0042731 | PH domain binding(GO:0042731) |
| 0.3 | 1.0 | GO:0019808 | polyamine binding(GO:0019808) |
| 0.3 | 2.8 | GO:0045545 | syndecan binding(GO:0045545) |
| 0.3 | 4.9 | GO:0019211 | phosphatase activator activity(GO:0019211) |
| 0.3 | 2.1 | GO:0034648 | histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
| 0.3 | 2.1 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
| 0.3 | 0.7 | GO:0050659 | N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity(GO:0050659) |
| 0.3 | 0.7 | GO:0001156 | TFIIIC-class transcription factor binding(GO:0001156) |
| 0.3 | 1.7 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
| 0.3 | 2.0 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
| 0.3 | 1.3 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
| 0.3 | 0.3 | GO:0016401 | palmitoyl-CoA oxidase activity(GO:0016401) |
| 0.3 | 1.3 | GO:0042954 | lipoprotein transporter activity(GO:0042954) |
| 0.3 | 1.3 | GO:0046538 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
| 0.3 | 3.0 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
| 0.3 | 7.6 | GO:0015643 | toxic substance binding(GO:0015643) |
| 0.3 | 1.3 | GO:1903135 | cupric ion binding(GO:1903135) |
| 0.3 | 4.3 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
| 0.3 | 1.3 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
| 0.3 | 5.9 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
| 0.3 | 1.3 | GO:0004310 | farnesyl-diphosphate farnesyltransferase activity(GO:0004310) squalene synthase activity(GO:0051996) |
| 0.3 | 2.0 | GO:0045174 | oxidoreductase activity, acting on a sulfur group of donors, quinone or similar compound as acceptor(GO:0016672) glutathione dehydrogenase (ascorbate) activity(GO:0045174) methylarsonate reductase activity(GO:0050610) |
| 0.3 | 13.7 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
| 0.3 | 1.6 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
| 0.3 | 6.1 | GO:0016864 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
| 0.3 | 10.6 | GO:0031489 | myosin V binding(GO:0031489) |
| 0.3 | 13.8 | GO:0038191 | neuropilin binding(GO:0038191) |
| 0.3 | 0.6 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
| 0.3 | 0.6 | GO:0004096 | catalase activity(GO:0004096) |
| 0.3 | 1.9 | GO:0016316 | phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity(GO:0016316) inositol-1,3,4-trisphosphate 4-phosphatase activity(GO:0017161) inositol-3,4-bisphosphate 4-phosphatase activity(GO:0052828) |
| 0.3 | 1.9 | GO:0080019 | fatty-acyl-CoA reductase (alcohol-forming) activity(GO:0080019) |
| 0.3 | 1.6 | GO:0004556 | alpha-amylase activity(GO:0004556) |
| 0.3 | 0.9 | GO:0008859 | exoribonuclease II activity(GO:0008859) |
| 0.3 | 2.2 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
| 0.3 | 4.3 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
| 0.3 | 1.2 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
| 0.3 | 2.5 | GO:0004331 | 6-phosphofructo-2-kinase activity(GO:0003873) fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) |
| 0.3 | 1.5 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
| 0.3 | 4.0 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
| 0.3 | 0.3 | GO:0005055 | laminin receptor activity(GO:0005055) |
| 0.3 | 0.9 | GO:0044549 | GTP cyclohydrolase binding(GO:0044549) |
| 0.3 | 1.2 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
| 0.3 | 2.4 | GO:0050543 | icosatetraenoic acid binding(GO:0050543) |
| 0.3 | 3.6 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
| 0.3 | 5.9 | GO:0001011 | transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting(GO:0001011) transcription factor activity, TFIIB-class binding(GO:0001087) |
| 0.3 | 6.7 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
| 0.3 | 1.2 | GO:0060422 | peptidyl-dipeptidase inhibitor activity(GO:0060422) |
| 0.3 | 2.6 | GO:0030267 | hydroxypyruvate reductase activity(GO:0016618) glyoxylate reductase (NADP) activity(GO:0030267) |
| 0.3 | 4.7 | GO:0045294 | alpha-catenin binding(GO:0045294) |
| 0.3 | 2.9 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
| 0.3 | 2.9 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
| 0.3 | 1.4 | GO:0004850 | uridine phosphorylase activity(GO:0004850) |
| 0.3 | 6.9 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
| 0.3 | 0.6 | GO:0050815 | phosphoserine binding(GO:0050815) |
| 0.3 | 1.4 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
| 0.3 | 0.3 | GO:0019956 | chemokine binding(GO:0019956) |
| 0.3 | 7.3 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
| 0.3 | 0.3 | GO:0032558 | adenyl deoxyribonucleotide binding(GO:0032558) dATP binding(GO:0032564) |
| 0.3 | 0.8 | GO:0070739 | protein-glutamic acid ligase activity(GO:0070739) tubulin-glutamic acid ligase activity(GO:0070740) |
| 0.3 | 0.8 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
| 0.3 | 1.7 | GO:0072320 | volume-sensitive chloride channel activity(GO:0072320) |
| 0.3 | 0.8 | GO:0016005 | phospholipase A2 activator activity(GO:0016005) |
| 0.3 | 0.8 | GO:0098808 | mRNA cap binding(GO:0098808) |
| 0.3 | 0.8 | GO:0004878 | complement component C5a receptor activity(GO:0004878) |
| 0.3 | 1.9 | GO:0003920 | GMP reductase activity(GO:0003920) oxidoreductase activity, acting on NAD(P)H, nitrogenous group as acceptor(GO:0016657) |
| 0.3 | 0.8 | GO:0032093 | SAM domain binding(GO:0032093) |
| 0.3 | 12.9 | GO:0004364 | glutathione transferase activity(GO:0004364) |
| 0.3 | 1.3 | GO:0070736 | protein-glycine ligase activity, initiating(GO:0070736) |
| 0.3 | 6.9 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
| 0.3 | 1.1 | GO:0005334 | norepinephrine:sodium symporter activity(GO:0005334) |
| 0.3 | 0.3 | GO:0047017 | prostaglandin-F synthase activity(GO:0047017) |
| 0.3 | 13.4 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
| 0.3 | 1.0 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
| 0.3 | 1.0 | GO:0004917 | interleukin-7 receptor activity(GO:0004917) |
| 0.3 | 1.0 | GO:0000026 | alpha-1,2-mannosyltransferase activity(GO:0000026) |
| 0.3 | 4.3 | GO:0005243 | gap junction channel activity(GO:0005243) |
| 0.3 | 0.8 | GO:0042356 | GDP-4-dehydro-D-rhamnose reductase activity(GO:0042356) GDP-L-fucose synthase activity(GO:0050577) |
| 0.3 | 7.3 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
| 0.3 | 2.8 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
| 0.3 | 0.5 | GO:0098640 | integrin binding involved in cell-matrix adhesion(GO:0098640) |
| 0.2 | 0.7 | GO:0001133 | RNA polymerase II transcription factor activity, sequence-specific transcription regulatory region DNA binding(GO:0001133) |
| 0.2 | 3.0 | GO:0047134 | protein-disulfide reductase activity(GO:0047134) |
| 0.2 | 5.5 | GO:0000339 | RNA cap binding(GO:0000339) |
| 0.2 | 1.5 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
| 0.2 | 1.2 | GO:0004105 | choline-phosphate cytidylyltransferase activity(GO:0004105) |
| 0.2 | 3.4 | GO:0004308 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) |
| 0.2 | 4.8 | GO:0042166 | acetylcholine binding(GO:0042166) |
| 0.2 | 1.0 | GO:0047006 | 17-alpha,20-alpha-dihydroxypregn-4-en-3-one dehydrogenase activity(GO:0047006) |
| 0.2 | 2.2 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
| 0.2 | 3.1 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
| 0.2 | 2.1 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
| 0.2 | 0.9 | GO:0004132 | dCMP deaminase activity(GO:0004132) |
| 0.2 | 0.2 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
| 0.2 | 1.6 | GO:0097157 | pre-mRNA intronic binding(GO:0097157) |
| 0.2 | 5.3 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
| 0.2 | 6.9 | GO:0001972 | retinoic acid binding(GO:0001972) |
| 0.2 | 1.6 | GO:0047288 | monosialoganglioside sialyltransferase activity(GO:0047288) |
| 0.2 | 4.8 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
| 0.2 | 1.2 | GO:0035500 | MH2 domain binding(GO:0035500) |
| 0.2 | 1.1 | GO:0005223 | intracellular cGMP activated cation channel activity(GO:0005223) |
| 0.2 | 2.5 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
| 0.2 | 2.3 | GO:0030348 | syntaxin-3 binding(GO:0030348) |
| 0.2 | 5.9 | GO:0032041 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
| 0.2 | 2.0 | GO:0089720 | caspase binding(GO:0089720) |
| 0.2 | 5.6 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
| 0.2 | 5.2 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
| 0.2 | 9.0 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
| 0.2 | 1.6 | GO:0047493 | sphingomyelin synthase activity(GO:0033188) ceramide cholinephosphotransferase activity(GO:0047493) |
| 0.2 | 1.1 | GO:0034584 | piRNA binding(GO:0034584) |
| 0.2 | 1.6 | GO:0004522 | ribonuclease A activity(GO:0004522) |
| 0.2 | 0.7 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
| 0.2 | 0.9 | GO:0022865 | transmembrane electron transfer carrier(GO:0022865) |
| 0.2 | 2.4 | GO:0005109 | frizzled binding(GO:0005109) |
| 0.2 | 3.3 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
| 0.2 | 6.1 | GO:0035198 | miRNA binding(GO:0035198) |
| 0.2 | 1.7 | GO:0050693 | LBD domain binding(GO:0050693) |
| 0.2 | 2.4 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
| 0.2 | 1.3 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
| 0.2 | 5.2 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) |
| 0.2 | 0.2 | GO:0031208 | POZ domain binding(GO:0031208) |
| 0.2 | 0.6 | GO:0004807 | triose-phosphate isomerase activity(GO:0004807) |
| 0.2 | 2.4 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
| 0.2 | 0.2 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
| 0.2 | 2.6 | GO:0090599 | alpha-glucosidase activity(GO:0090599) |
| 0.2 | 0.9 | GO:0004666 | prostaglandin-endoperoxide synthase activity(GO:0004666) |
| 0.2 | 3.2 | GO:0070061 | fructose binding(GO:0070061) |
| 0.2 | 5.3 | GO:0004065 | arylsulfatase activity(GO:0004065) |
| 0.2 | 0.6 | GO:0004527 | exonuclease activity(GO:0004527) |
| 0.2 | 0.4 | GO:0032217 | riboflavin transporter activity(GO:0032217) |
| 0.2 | 8.0 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
| 0.2 | 0.6 | GO:0043739 | G/U mismatch-specific uracil-DNA glycosylase activity(GO:0043739) |
| 0.2 | 0.2 | GO:0016623 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor(GO:0016623) |
| 0.2 | 0.4 | GO:0017099 | very-long-chain-acyl-CoA dehydrogenase activity(GO:0017099) |
| 0.2 | 2.7 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
| 0.2 | 0.4 | GO:0090631 | pre-miRNA transporter activity(GO:0090631) |
| 0.2 | 0.2 | GO:0001727 | lipid kinase activity(GO:0001727) |
| 0.2 | 1.6 | GO:1990239 | steroid hormone binding(GO:1990239) |
| 0.2 | 0.4 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
| 0.2 | 3.3 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
| 0.2 | 4.7 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
| 0.2 | 6.7 | GO:0019198 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
| 0.2 | 0.6 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
| 0.2 | 3.4 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
| 0.2 | 0.6 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
| 0.2 | 1.4 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
| 0.2 | 0.8 | GO:0042132 | fructose 1,6-bisphosphate 1-phosphatase activity(GO:0042132) |
| 0.2 | 7.5 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
| 0.2 | 2.0 | GO:0043176 | amine binding(GO:0043176) serotonin binding(GO:0051378) |
| 0.2 | 5.1 | GO:0005123 | death receptor binding(GO:0005123) |
| 0.2 | 0.6 | GO:0047025 | 3-oxoacyl-[acyl-carrier-protein] reductase (NADH) activity(GO:0047025) |
| 0.2 | 12.4 | GO:0018024 | histone-lysine N-methyltransferase activity(GO:0018024) |
| 0.2 | 0.2 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
| 0.2 | 3.1 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
| 0.2 | 9.2 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
| 0.2 | 5.7 | GO:0051721 | protein phosphatase 2A binding(GO:0051721) |
| 0.2 | 2.7 | GO:0032452 | histone demethylase activity(GO:0032452) |
| 0.2 | 2.7 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
| 0.2 | 12.3 | GO:0031490 | chromatin DNA binding(GO:0031490) |
| 0.2 | 0.6 | GO:0015928 | alpha-L-fucosidase activity(GO:0004560) fucosidase activity(GO:0015928) |
| 0.2 | 1.9 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
| 0.2 | 2.1 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
| 0.2 | 0.2 | GO:0031748 | D1 dopamine receptor binding(GO:0031748) |
| 0.2 | 2.9 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
| 0.2 | 0.6 | GO:0004342 | glucosamine-6-phosphate deaminase activity(GO:0004342) |
| 0.2 | 1.0 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
| 0.2 | 1.7 | GO:0030023 | extracellular matrix constituent conferring elasticity(GO:0030023) |
| 0.2 | 0.2 | GO:0003777 | microtubule motor activity(GO:0003777) |
| 0.2 | 1.1 | GO:0004793 | glycine hydroxymethyltransferase activity(GO:0004372) threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
| 0.2 | 13.9 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
| 0.2 | 22.4 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
| 0.2 | 0.6 | GO:0051538 | 3 iron, 4 sulfur cluster binding(GO:0051538) |
| 0.2 | 1.9 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
| 0.2 | 0.9 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
| 0.2 | 9.2 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
| 0.2 | 1.1 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
| 0.2 | 5.2 | GO:0031005 | filamin binding(GO:0031005) |
| 0.2 | 0.7 | GO:1904492 | Ac-Asp-Glu binding(GO:1904492) tetrahydrofolyl-poly(glutamate) polymer binding(GO:1904493) |
| 0.2 | 2.4 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
| 0.2 | 1.7 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
| 0.2 | 0.7 | GO:0071209 | U7 snRNA binding(GO:0071209) |
| 0.2 | 0.4 | GO:0016402 | pristanoyl-CoA oxidase activity(GO:0016402) |
| 0.2 | 6.9 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
| 0.2 | 0.2 | GO:0051380 | norepinephrine binding(GO:0051380) |
| 0.2 | 1.3 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
| 0.2 | 0.9 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
| 0.2 | 0.6 | GO:0070119 | ciliary neurotrophic factor binding(GO:0070119) |
| 0.2 | 0.5 | GO:0070410 | co-SMAD binding(GO:0070410) |
| 0.2 | 0.2 | GO:0030375 | thyroid hormone receptor activator activity(GO:0010861) thyroid hormone receptor coactivator activity(GO:0030375) |
| 0.2 | 1.1 | GO:0030275 | LRR domain binding(GO:0030275) |
| 0.2 | 0.9 | GO:0050509 | N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity(GO:0050509) |
| 0.2 | 0.5 | GO:0072591 | citrate-L-glutamate ligase activity(GO:0072591) |
| 0.2 | 1.4 | GO:0042826 | histone deacetylase binding(GO:0042826) |
| 0.2 | 0.2 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
| 0.2 | 0.4 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
| 0.2 | 0.7 | GO:0010348 | lithium:proton antiporter activity(GO:0010348) |
| 0.2 | 0.9 | GO:0004692 | cGMP-dependent protein kinase activity(GO:0004692) |
| 0.2 | 0.2 | GO:0071837 | HMG box domain binding(GO:0071837) |
| 0.2 | 0.9 | GO:0003963 | RNA-3'-phosphate cyclase activity(GO:0003963) |
| 0.2 | 0.9 | GO:1990189 | peptide-serine-N-acetyltransferase activity(GO:1990189) |
| 0.2 | 2.8 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
| 0.2 | 0.5 | GO:0004996 | thyroid-stimulating hormone receptor activity(GO:0004996) |
| 0.2 | 1.6 | GO:1904315 | neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential(GO:0099529) transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1904315) |
| 0.2 | 0.2 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
| 0.2 | 0.3 | GO:0038052 | RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding(GO:0038052) |
| 0.2 | 1.2 | GO:0016453 | C-acetyltransferase activity(GO:0016453) |
| 0.2 | 1.6 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
| 0.2 | 1.9 | GO:0030911 | TPR domain binding(GO:0030911) |
| 0.2 | 7.5 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
| 0.2 | 17.9 | GO:0008013 | beta-catenin binding(GO:0008013) |
| 0.2 | 0.7 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
| 0.2 | 4.6 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
| 0.2 | 3.0 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
| 0.2 | 1.8 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
| 0.2 | 0.8 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
| 0.2 | 14.3 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
| 0.2 | 0.5 | GO:0008241 | peptidyl-dipeptidase activity(GO:0008241) |
| 0.2 | 1.0 | GO:0017159 | pantetheine hydrolase activity(GO:0017159) |
| 0.2 | 1.1 | GO:0030377 | urokinase plasminogen activator receptor activity(GO:0030377) |
| 0.2 | 0.5 | GO:0016649 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
| 0.2 | 0.5 | GO:0004853 | uroporphyrinogen decarboxylase activity(GO:0004853) |
| 0.2 | 3.9 | GO:0005080 | protein kinase C binding(GO:0005080) |
| 0.2 | 1.4 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
| 0.2 | 2.1 | GO:0060090 | binding, bridging(GO:0060090) |
| 0.2 | 0.5 | GO:0036435 | K48-linked polyubiquitin binding(GO:0036435) |
| 0.2 | 0.5 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
| 0.2 | 0.5 | GO:0004828 | serine-tRNA ligase activity(GO:0004828) |
| 0.2 | 0.5 | GO:0031862 | prostanoid receptor binding(GO:0031862) |
| 0.2 | 0.3 | GO:0034046 | poly(G) binding(GO:0034046) |
| 0.2 | 1.7 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
| 0.2 | 3.9 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
| 0.2 | 0.2 | GO:0016015 | morphogen activity(GO:0016015) |
| 0.2 | 0.5 | GO:0019961 | interferon binding(GO:0019961) |
| 0.2 | 1.4 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
| 0.2 | 0.5 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
| 0.2 | 2.9 | GO:0008417 | fucosyltransferase activity(GO:0008417) |
| 0.2 | 4.4 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
| 0.2 | 0.2 | GO:0050613 | delta14-sterol reductase activity(GO:0050613) |
| 0.2 | 2.0 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
| 0.2 | 0.3 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
| 0.2 | 4.5 | GO:0070412 | R-SMAD binding(GO:0070412) |
| 0.1 | 0.3 | GO:0019864 | IgG binding(GO:0019864) |
| 0.1 | 0.7 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
| 0.1 | 0.4 | GO:0002060 | purine nucleobase binding(GO:0002060) |
| 0.1 | 3.2 | GO:0019789 | SUMO transferase activity(GO:0019789) |
| 0.1 | 0.9 | GO:0000309 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
| 0.1 | 73.6 | GO:0045296 | cadherin binding(GO:0045296) |
| 0.1 | 0.1 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
| 0.1 | 0.4 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
| 0.1 | 2.4 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
| 0.1 | 0.6 | GO:0046790 | virion binding(GO:0046790) |
| 0.1 | 0.1 | GO:0043532 | angiostatin binding(GO:0043532) |
| 0.1 | 0.8 | GO:0016505 | peptidase activator activity involved in apoptotic process(GO:0016505) |
| 0.1 | 2.4 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
| 0.1 | 1.7 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
| 0.1 | 0.8 | GO:0070728 | leucine binding(GO:0070728) |
| 0.1 | 0.4 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
| 0.1 | 3.8 | GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen(GO:0016712) |
| 0.1 | 1.3 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
| 0.1 | 0.5 | GO:0008670 | 2,4-dienoyl-CoA reductase (NADPH) activity(GO:0008670) |
| 0.1 | 0.5 | GO:0032184 | SUMO polymer binding(GO:0032184) |
| 0.1 | 0.1 | GO:0003943 | N-acetylgalactosamine-4-sulfatase activity(GO:0003943) |
| 0.1 | 1.7 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
| 0.1 | 0.5 | GO:0004510 | tryptophan 5-monooxygenase activity(GO:0004510) |
| 0.1 | 2.7 | GO:0042056 | chemoattractant activity(GO:0042056) |
| 0.1 | 1.0 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
| 0.1 | 0.9 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
| 0.1 | 1.3 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
| 0.1 | 0.6 | GO:0047374 | methylumbelliferyl-acetate deacetylase activity(GO:0047374) |
| 0.1 | 0.4 | GO:0051139 | metal ion:proton antiporter activity(GO:0051139) |
| 0.1 | 2.4 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
| 0.1 | 0.4 | GO:0016503 | pheromone receptor activity(GO:0016503) |
| 0.1 | 0.1 | GO:0004821 | histidine-tRNA ligase activity(GO:0004821) |
| 0.1 | 6.4 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
| 0.1 | 1.7 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
| 0.1 | 6.2 | GO:0004407 | histone deacetylase activity(GO:0004407) protein deacetylase activity(GO:0033558) |
| 0.1 | 0.1 | GO:0048257 | 3'-flap endonuclease activity(GO:0048257) |
| 0.1 | 0.5 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
| 0.1 | 2.4 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
| 0.1 | 3.1 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
| 0.1 | 0.6 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
| 0.1 | 0.7 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
| 0.1 | 1.3 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
| 0.1 | 1.2 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
| 0.1 | 1.1 | GO:0030971 | receptor tyrosine kinase binding(GO:0030971) |
| 0.1 | 0.4 | GO:0004827 | proline-tRNA ligase activity(GO:0004827) |
| 0.1 | 0.5 | GO:0003774 | motor activity(GO:0003774) |
| 0.1 | 0.8 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
| 0.1 | 0.3 | GO:0004817 | cysteine-tRNA ligase activity(GO:0004817) |
| 0.1 | 0.2 | GO:0008271 | secondary active sulfate transmembrane transporter activity(GO:0008271) |
| 0.1 | 5.6 | GO:0050699 | WW domain binding(GO:0050699) |
| 0.1 | 1.4 | GO:0003964 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
| 0.1 | 0.2 | GO:0043813 | phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity(GO:0043813) |
| 0.1 | 1.1 | GO:0070063 | RNA polymerase binding(GO:0070063) |
| 0.1 | 1.0 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
| 0.1 | 1.2 | GO:0010181 | FMN binding(GO:0010181) |
| 0.1 | 0.4 | GO:0033823 | procollagen-lysine 5-dioxygenase activity(GO:0008475) procollagen glucosyltransferase activity(GO:0033823) |
| 0.1 | 0.3 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
| 0.1 | 0.3 | GO:0016427 | tRNA (cytosine) methyltransferase activity(GO:0016427) |
| 0.1 | 0.3 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
| 0.1 | 0.2 | GO:0035240 | dopamine binding(GO:0035240) |
| 0.1 | 0.2 | GO:0001537 | N-acetylgalactosamine 4-O-sulfotransferase activity(GO:0001537) |
| 0.1 | 0.5 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
| 0.1 | 0.5 | GO:0015924 | mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity(GO:0004572) mannosyl-oligosaccharide mannosidase activity(GO:0015924) |
| 0.1 | 0.3 | GO:0051120 | hepoxilin A3 synthase activity(GO:0051120) |
| 0.1 | 0.5 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
| 0.1 | 0.5 | GO:0036080 | GDP-fucose transmembrane transporter activity(GO:0005457) purine nucleotide-sugar transmembrane transporter activity(GO:0036080) |
| 0.1 | 0.4 | GO:0003865 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) steroid dehydrogenase activity, acting on the CH-CH group of donors(GO:0033765) cholestenone 5-alpha-reductase activity(GO:0047751) |
| 0.1 | 0.7 | GO:0008310 | single-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008310) |
| 0.1 | 0.4 | GO:0051916 | granulocyte colony-stimulating factor binding(GO:0051916) |
| 0.1 | 2.1 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
| 0.1 | 0.6 | GO:0004906 | interferon-gamma receptor activity(GO:0004906) |
| 0.1 | 1.8 | GO:0008320 | protein transmembrane transporter activity(GO:0008320) |
| 0.1 | 2.4 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
| 0.1 | 0.3 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
| 0.1 | 0.6 | GO:0004945 | angiotensin receptor activity(GO:0001595) angiotensin type II receptor activity(GO:0004945) |
| 0.1 | 24.2 | GO:0044822 | mRNA binding(GO:0003729) poly(A) RNA binding(GO:0044822) |
| 0.1 | 0.8 | GO:0060698 | endoribonuclease inhibitor activity(GO:0060698) |
| 0.1 | 0.7 | GO:0051748 | UTP:glucose-1-phosphate uridylyltransferase activity(GO:0003983) UTP-monosaccharide-1-phosphate uridylyltransferase activity(GO:0051748) |
| 0.1 | 0.4 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
| 0.1 | 0.3 | GO:0004968 | gonadotropin-releasing hormone receptor activity(GO:0004968) |
| 0.1 | 1.1 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
| 0.1 | 2.4 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
| 0.1 | 9.2 | GO:0008307 | structural constituent of muscle(GO:0008307) |
| 0.1 | 2.4 | GO:0005326 | neurotransmitter transporter activity(GO:0005326) |
| 0.1 | 3.9 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
| 0.1 | 2.0 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
| 0.1 | 0.7 | GO:0061649 | ubiquitinated histone binding(GO:0061649) |
| 0.1 | 0.3 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
| 0.1 | 0.5 | GO:0030545 | receptor regulator activity(GO:0030545) |
| 0.1 | 1.5 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
| 0.1 | 0.5 | GO:0070324 | thyroid hormone binding(GO:0070324) |
| 0.1 | 1.5 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
| 0.1 | 1.2 | GO:0004875 | complement receptor activity(GO:0004875) |
| 0.1 | 0.9 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
| 0.1 | 0.4 | GO:0031628 | opioid receptor binding(GO:0031628) |
| 0.1 | 1.1 | GO:0016004 | phospholipase activator activity(GO:0016004) |
| 0.1 | 1.1 | GO:0004075 | biotin carboxylase activity(GO:0004075) |
| 0.1 | 0.3 | GO:0017130 | poly(C) RNA binding(GO:0017130) |
| 0.1 | 0.6 | GO:0038187 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
| 0.1 | 0.3 | GO:0004874 | aryl hydrocarbon receptor activity(GO:0004874) |
| 0.1 | 0.3 | GO:0052642 | lysophosphatidic acid phosphatase activity(GO:0052642) |
| 0.1 | 0.6 | GO:0050816 | phosphothreonine binding(GO:0050816) |
| 0.1 | 0.1 | GO:0035197 | siRNA binding(GO:0035197) |
| 0.1 | 2.4 | GO:0046875 | ephrin receptor binding(GO:0046875) |
| 0.1 | 0.9 | GO:0032451 | demethylase activity(GO:0032451) |
| 0.1 | 1.8 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
| 0.1 | 0.7 | GO:0008536 | Ran GTPase binding(GO:0008536) |
| 0.1 | 9.1 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
| 0.1 | 0.3 | GO:0004004 | ATP-dependent RNA helicase activity(GO:0004004) RNA-dependent ATPase activity(GO:0008186) |
| 0.1 | 1.1 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
| 0.1 | 0.9 | GO:0016274 | arginine N-methyltransferase activity(GO:0016273) protein-arginine N-methyltransferase activity(GO:0016274) |
| 0.1 | 1.2 | GO:0032052 | bile acid binding(GO:0032052) |
| 0.1 | 0.9 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
| 0.1 | 0.5 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
| 0.1 | 0.6 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
| 0.1 | 2.0 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
| 0.1 | 2.8 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
| 0.1 | 0.1 | GO:0015057 | thrombin receptor activity(GO:0015057) |
| 0.1 | 0.3 | GO:0030021 | extracellular matrix structural constituent conferring compression resistance(GO:0030021) structural constituent of tooth enamel(GO:0030345) |
| 0.1 | 0.3 | GO:0009041 | uridylate kinase activity(GO:0009041) |
| 0.1 | 0.3 | GO:0004993 | G-protein coupled serotonin receptor activity(GO:0004993) |
| 0.1 | 0.2 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
| 0.1 | 3.4 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
| 0.1 | 0.7 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
| 0.1 | 0.8 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
| 0.1 | 3.6 | GO:0045502 | dynein binding(GO:0045502) |
| 0.1 | 0.9 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
| 0.1 | 1.4 | GO:0004568 | chitinase activity(GO:0004568) |
| 0.1 | 0.5 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
| 0.1 | 0.4 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
| 0.1 | 0.1 | GO:0045125 | bioactive lipid receptor activity(GO:0045125) |
| 0.1 | 0.1 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
| 0.1 | 0.4 | GO:0015056 | corticotrophin-releasing factor receptor activity(GO:0015056) |
| 0.1 | 10.8 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
| 0.1 | 0.3 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
| 0.1 | 0.4 | GO:0035800 | deubiquitinase activator activity(GO:0035800) |
| 0.1 | 1.4 | GO:0036002 | pre-mRNA binding(GO:0036002) |
| 0.1 | 0.6 | GO:0008035 | high-density lipoprotein particle binding(GO:0008035) |
| 0.1 | 0.2 | GO:0008453 | alanine-glyoxylate transaminase activity(GO:0008453) |
| 0.1 | 0.1 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
| 0.1 | 1.5 | GO:0050840 | extracellular matrix binding(GO:0050840) |
| 0.1 | 0.8 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
| 0.1 | 1.3 | GO:0033613 | activating transcription factor binding(GO:0033613) |
| 0.1 | 0.2 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
| 0.1 | 0.6 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
| 0.1 | 0.1 | GO:0001160 | transcription termination site sequence-specific DNA binding(GO:0001147) transcription termination site DNA binding(GO:0001160) |
| 0.1 | 0.1 | GO:0015235 | cobalamin transporter activity(GO:0015235) |
| 0.1 | 0.2 | GO:0035663 | Toll-like receptor 2 binding(GO:0035663) |
| 0.1 | 0.2 | GO:0004852 | uroporphyrinogen-III synthase activity(GO:0004852) |
| 0.1 | 0.3 | GO:0019215 | intermediate filament binding(GO:0019215) |
| 0.1 | 0.1 | GO:0070644 | vitamin D response element binding(GO:0070644) |
| 0.1 | 0.4 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
| 0.1 | 0.2 | GO:0004960 | thromboxane receptor activity(GO:0004960) thromboxane A2 receptor activity(GO:0004961) |
| 0.1 | 0.3 | GO:0004530 | deoxyribonuclease I activity(GO:0004530) |
| 0.1 | 0.1 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
| 0.1 | 0.5 | GO:0015321 | sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
| 0.1 | 1.7 | GO:0042043 | neurexin family protein binding(GO:0042043) |
| 0.1 | 9.9 | GO:0017124 | SH3 domain binding(GO:0017124) |
| 0.1 | 0.4 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
| 0.1 | 0.9 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
| 0.1 | 1.8 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
| 0.1 | 0.1 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
| 0.1 | 0.4 | GO:0004144 | diacylglycerol O-acyltransferase activity(GO:0004144) |
| 0.1 | 1.4 | GO:0001223 | transcription coactivator binding(GO:0001223) |
| 0.1 | 0.2 | GO:0016517 | interleukin-12 receptor activity(GO:0016517) |
| 0.1 | 0.3 | GO:0050115 | myosin-light-chain-phosphatase activity(GO:0050115) |
| 0.1 | 1.0 | GO:0044390 | ubiquitin-like protein conjugating enzyme binding(GO:0044390) |
| 0.1 | 0.5 | GO:0016406 | carnitine O-acyltransferase activity(GO:0016406) |
| 0.1 | 0.1 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
| 0.1 | 0.2 | GO:0004379 | glycylpeptide N-tetradecanoyltransferase activity(GO:0004379) myristoyltransferase activity(GO:0019107) |
| 0.1 | 2.0 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
| 0.1 | 1.2 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
| 0.1 | 0.1 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
| 0.1 | 1.6 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
| 0.1 | 3.6 | GO:0002020 | protease binding(GO:0002020) |
| 0.1 | 0.3 | GO:0016918 | retinal binding(GO:0016918) |
| 0.1 | 0.2 | GO:1990699 | palmitoleyl hydrolase activity(GO:1990699) |
| 0.1 | 1.0 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
| 0.1 | 0.2 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
| 0.1 | 2.3 | GO:0042162 | telomeric DNA binding(GO:0042162) |
| 0.1 | 0.1 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
| 0.1 | 10.8 | GO:0050839 | cell adhesion molecule binding(GO:0050839) |
| 0.1 | 0.1 | GO:1902936 | phosphatidylinositol bisphosphate binding(GO:1902936) |
| 0.1 | 0.2 | GO:0004882 | androgen receptor activity(GO:0004882) |
| 0.1 | 11.1 | GO:0030674 | protein binding, bridging(GO:0030674) |
| 0.1 | 1.3 | GO:0070001 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
| 0.1 | 0.9 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
| 0.0 | 0.1 | GO:0047946 | glutamine N-acyltransferase activity(GO:0047946) |
| 0.0 | 0.3 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
| 0.0 | 0.4 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
| 0.0 | 0.1 | GO:0008193 | RNA guanylyltransferase activity(GO:0008192) tRNA guanylyltransferase activity(GO:0008193) |
| 0.0 | 0.5 | GO:0051219 | phosphoprotein binding(GO:0051219) |
| 0.0 | 0.1 | GO:0008502 | melatonin receptor activity(GO:0008502) |
| 0.0 | 0.1 | GO:0043199 | sulfate binding(GO:0043199) |
| 0.0 | 0.1 | GO:0004483 | mRNA (nucleoside-2'-O-)-methyltransferase activity(GO:0004483) |
| 0.0 | 1.6 | GO:0046961 | proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
| 0.0 | 1.5 | GO:0070888 | E-box binding(GO:0070888) |
| 0.0 | 0.2 | GO:0004447 | iodide peroxidase activity(GO:0004447) |
| 0.0 | 0.7 | GO:0033038 | bitter taste receptor activity(GO:0033038) |
| 0.0 | 0.0 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
| 0.0 | 0.5 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
| 0.0 | 0.1 | GO:0008174 | mRNA methyltransferase activity(GO:0008174) |
| 0.0 | 0.3 | GO:1990405 | protein antigen binding(GO:1990405) |
| 0.0 | 0.6 | GO:0001848 | complement binding(GO:0001848) |
| 0.0 | 1.2 | GO:0016303 | 1-phosphatidylinositol-3-kinase activity(GO:0016303) |
| 0.0 | 0.2 | GO:0035473 | lipase binding(GO:0035473) |
| 0.0 | 0.9 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
| 0.0 | 1.6 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
| 0.0 | 0.1 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
| 0.0 | 0.1 | GO:1901338 | catecholamine binding(GO:1901338) |
| 0.0 | 0.2 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
| 0.0 | 2.7 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
| 0.0 | 0.1 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
| 0.0 | 0.8 | GO:0001103 | RNA polymerase II repressing transcription factor binding(GO:0001103) |
| 0.0 | 0.2 | GO:0004723 | calcium-dependent protein serine/threonine phosphatase activity(GO:0004723) |
| 0.0 | 0.3 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
| 0.0 | 1.1 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
| 0.0 | 0.2 | GO:0001098 | basal transcription machinery binding(GO:0001098) basal RNA polymerase II transcription machinery binding(GO:0001099) |
| 0.0 | 0.5 | GO:0043021 | ribonucleoprotein complex binding(GO:0043021) |
| 0.0 | 0.0 | GO:0031543 | peptidyl-proline dioxygenase activity(GO:0031543) |
| 0.0 | 0.1 | GO:0019239 | deaminase activity(GO:0019239) |
| 0.0 | 0.5 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
| 0.0 | 0.1 | GO:0042007 | interleukin-18 binding(GO:0042007) |
| 0.0 | 0.2 | GO:0004489 | methylenetetrahydrofolate reductase (NAD(P)H) activity(GO:0004489) |
| 0.0 | 0.1 | GO:0005124 | scavenger receptor binding(GO:0005124) |
| 0.0 | 0.1 | GO:0015137 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
| 0.0 | 0.3 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
| 0.0 | 0.4 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
| 0.0 | 0.1 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
| 0.0 | 0.3 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
| 0.0 | 1.4 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
| 0.0 | 0.2 | GO:0015250 | water channel activity(GO:0015250) |
| 0.0 | 0.2 | GO:0008048 | calcium sensitive guanylate cyclase activator activity(GO:0008048) |
| 0.0 | 1.5 | GO:0005227 | calcium activated cation channel activity(GO:0005227) ion gated channel activity(GO:0022839) |
| 0.0 | 0.2 | GO:0016155 | formyltetrahydrofolate dehydrogenase activity(GO:0016155) |
| 0.0 | 0.5 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
| 0.0 | 0.7 | GO:0031369 | translation initiation factor binding(GO:0031369) |
| 0.0 | 0.1 | GO:0043141 | ATP-dependent 5'-3' DNA helicase activity(GO:0043141) |
| 0.0 | 0.3 | GO:0008171 | O-methyltransferase activity(GO:0008171) |
| 0.0 | 0.1 | GO:0032027 | myosin light chain binding(GO:0032027) |
| 0.0 | 0.1 | GO:0004977 | melanocortin receptor activity(GO:0004977) |
| 0.0 | 0.4 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
| 0.0 | 0.2 | GO:0001968 | fibronectin binding(GO:0001968) |
| 0.0 | 0.5 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
| 0.0 | 0.1 | GO:0005436 | sodium:phosphate symporter activity(GO:0005436) |
| 0.0 | 2.1 | GO:0005125 | cytokine activity(GO:0005125) |
| 0.0 | 0.1 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
| 0.0 | 0.3 | GO:0003996 | acyl-CoA ligase activity(GO:0003996) |
| 0.0 | 0.1 | GO:0050294 | steroid sulfotransferase activity(GO:0050294) |
| 0.0 | 0.3 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
| 0.0 | 0.2 | GO:0050682 | AF-2 domain binding(GO:0050682) |
| 0.0 | 0.1 | GO:0016900 | oxidoreductase activity, acting on the CH-OH group of donors, disulfide as acceptor(GO:0016900) vitamin-K-epoxide reductase (warfarin-sensitive) activity(GO:0047057) |
| 0.0 | 0.2 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
| 0.0 | 0.1 | GO:0004559 | alpha-mannosidase activity(GO:0004559) mannosidase activity(GO:0015923) |
| 0.0 | 0.0 | GO:0009374 | biotin binding(GO:0009374) |
| 0.0 | 0.4 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
| 0.0 | 0.1 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
| 0.0 | 0.1 | GO:1901611 | phosphatidylglycerol binding(GO:1901611) cardiolipin binding(GO:1901612) |
| 0.0 | 0.0 | GO:0004661 | protein geranylgeranyltransferase activity(GO:0004661) |
| 0.0 | 0.1 | GO:0034038 | deoxyhypusine synthase activity(GO:0034038) |
| 0.0 | 0.2 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
| 0.0 | 1.2 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
| 0.0 | 0.1 | GO:0046934 | phosphatidylinositol 3-kinase activity(GO:0035004) phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) phosphatidylinositol bisphosphate kinase activity(GO:0052813) |
| 0.0 | 0.9 | GO:0043022 | ribosome binding(GO:0043022) |
| 0.0 | 0.2 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
| 0.0 | 0.1 | GO:0070404 | NADH binding(GO:0070404) |
| 0.0 | 0.1 | GO:0047787 | enone reductase activity(GO:0035671) delta4-3-oxosteroid 5beta-reductase activity(GO:0047787) |
| 0.0 | 0.2 | GO:0004873 | asialoglycoprotein receptor activity(GO:0004873) |
| 0.0 | 0.3 | GO:0030247 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
| 0.0 | 0.0 | GO:0050211 | procollagen galactosyltransferase activity(GO:0050211) |
| 0.0 | 2.0 | GO:0051082 | unfolded protein binding(GO:0051082) |
| 0.0 | 0.1 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
| 0.0 | 0.1 | GO:0004985 | opioid receptor activity(GO:0004985) |
| 0.0 | 0.1 | GO:0003938 | IMP dehydrogenase activity(GO:0003938) |
| 0.0 | 0.0 | GO:0050254 | rhodopsin kinase activity(GO:0050254) |
| 0.0 | 0.0 | GO:0008378 | galactosyltransferase activity(GO:0008378) |
| 0.0 | 0.1 | GO:0030507 | spectrin binding(GO:0030507) |
| 0.0 | 7.4 | GO:0001228 | transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001228) |
| 0.0 | 0.0 | GO:0004958 | prostaglandin F receptor activity(GO:0004958) |
Gene overrepresentation in C2:CP category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.4 | 40.1 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
| 1.0 | 27.4 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
| 1.0 | 78.2 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
| 0.9 | 28.7 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
| 0.8 | 33.1 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
| 0.8 | 49.6 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
| 0.6 | 31.5 | PID IL1 PATHWAY | IL1-mediated signaling events |
| 0.6 | 1.2 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
| 0.6 | 25.3 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
| 0.6 | 1.1 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
| 0.5 | 3.8 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
| 0.4 | 18.6 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
| 0.4 | 0.9 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
| 0.4 | 38.1 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
| 0.4 | 0.4 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
| 0.4 | 17.1 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
| 0.4 | 0.8 | PID ERBB1 RECEPTOR PROXIMAL PATHWAY | EGF receptor (ErbB1) signaling pathway |
| 0.4 | 9.9 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
| 0.4 | 31.0 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
| 0.4 | 4.3 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
| 0.4 | 12.0 | ST G ALPHA S PATHWAY | G alpha s Pathway |
| 0.4 | 2.3 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
| 0.4 | 124.4 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
| 0.4 | 26.8 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
| 0.4 | 0.4 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
| 0.4 | 8.5 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
| 0.3 | 11.1 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
| 0.3 | 9.1 | PID ARF 3PATHWAY | Arf1 pathway |
| 0.3 | 14.2 | PID EPHB FWD PATHWAY | EPHB forward signaling |
| 0.3 | 5.6 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
| 0.3 | 16.5 | PID RHOA PATHWAY | RhoA signaling pathway |
| 0.3 | 21.2 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
| 0.3 | 11.5 | PID FOXO PATHWAY | FoxO family signaling |
| 0.3 | 12.5 | PID ALK1 PATHWAY | ALK1 signaling events |
| 0.3 | 3.8 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
| 0.3 | 1.4 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
| 0.3 | 29.2 | PID NOTCH PATHWAY | Notch signaling pathway |
| 0.3 | 3.4 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
| 0.3 | 4.6 | PID S1P S1P1 PATHWAY | S1P1 pathway |
| 0.3 | 50.7 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
| 0.2 | 3.2 | NABA COLLAGENS | Genes encoding collagen proteins |
| 0.2 | 1.2 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
| 0.2 | 4.5 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
| 0.2 | 7.6 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
| 0.2 | 7.6 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
| 0.2 | 1.9 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
| 0.2 | 2.4 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
| 0.2 | 0.5 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
| 0.2 | 0.5 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
| 0.2 | 14.0 | PID FGF PATHWAY | FGF signaling pathway |
| 0.2 | 1.3 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
| 0.2 | 5.6 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
| 0.2 | 6.5 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
| 0.2 | 5.7 | PID NECTIN PATHWAY | Nectin adhesion pathway |
| 0.2 | 0.4 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
| 0.2 | 2.1 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
| 0.2 | 9.1 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
| 0.2 | 3.7 | PID EPHA FWDPATHWAY | EPHA forward signaling |
| 0.2 | 0.5 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
| 0.2 | 3.3 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
| 0.2 | 5.3 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
| 0.2 | 6.4 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
| 0.2 | 3.9 | ST G ALPHA I PATHWAY | G alpha i Pathway |
| 0.2 | 4.9 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
| 0.1 | 8.6 | PID BCR 5PATHWAY | BCR signaling pathway |
| 0.1 | 17.2 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
| 0.1 | 6.1 | PID BMP PATHWAY | BMP receptor signaling |
| 0.1 | 1.7 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
| 0.1 | 0.6 | ST STAT3 PATHWAY | STAT3 Pathway |
| 0.1 | 12.0 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
| 0.1 | 34.1 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
| 0.1 | 45.9 | NABA MATRISOME ASSOCIATED | Ensemble of genes encoding ECM-associated proteins including ECM-affilaited proteins, ECM regulators and secreted factors |
| 0.1 | 1.8 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
| 0.1 | 1.5 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
| 0.1 | 6.4 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
| 0.1 | 1.8 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
| 0.1 | 3.6 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
| 0.1 | 8.6 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
| 0.1 | 5.7 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
| 0.1 | 0.5 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
| 0.1 | 2.3 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
| 0.1 | 2.8 | PID RAS PATHWAY | Regulation of Ras family activation |
| 0.1 | 1.9 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
| 0.1 | 4.5 | PID LKB1 PATHWAY | LKB1 signaling events |
| 0.1 | 1.8 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
| 0.1 | 0.4 | PID S1P S1P2 PATHWAY | S1P2 pathway |
| 0.1 | 0.1 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
| 0.1 | 3.6 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
| 0.1 | 2.4 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
| 0.1 | 3.5 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
| 0.1 | 0.1 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
| 0.1 | 1.5 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
| 0.1 | 1.0 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
| 0.1 | 1.1 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
| 0.1 | 0.4 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
| 0.1 | 3.8 | PID MTOR 4PATHWAY | mTOR signaling pathway |
| 0.1 | 4.6 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
| 0.1 | 0.2 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
| 0.1 | 4.0 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
| 0.1 | 2.3 | PID ARF6 PATHWAY | Arf6 signaling events |
| 0.1 | 2.0 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
| 0.1 | 13.8 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
| 0.1 | 0.6 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
| 0.0 | 2.2 | PID P53 REGULATION PATHWAY | p53 pathway |
| 0.0 | 1.1 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
| 0.0 | 0.8 | PID ERBB4 PATHWAY | ErbB4 signaling events |
| 0.0 | 1.0 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
| 0.0 | 0.7 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
| 0.0 | 0.1 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
| 0.0 | 0.2 | PID ENDOTHELIN PATHWAY | Endothelins |
| 0.0 | 0.4 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
| 0.0 | 2.2 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
| 0.0 | 0.4 | PID CD40 PATHWAY | CD40/CD40L signaling |
| 0.0 | 0.9 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
| 0.0 | 0.0 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
| 0.0 | 0.2 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
| 0.0 | 0.4 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
| 0.0 | 0.3 | PID CONE PATHWAY | Visual signal transduction: Cones |
| 0.0 | 1.2 | PID CDC42 PATHWAY | CDC42 signaling events |
| 0.0 | 0.5 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
| 0.0 | 0.6 | PID AP1 PATHWAY | AP-1 transcription factor network |
| 0.0 | 0.2 | PID IL23 PATHWAY | IL23-mediated signaling events |
Gene overrepresentation in C2:CP:REACTOME category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.2 | 27.7 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
| 1.1 | 11.2 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
| 1.1 | 1.1 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
| 1.0 | 1.9 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
| 0.9 | 32.1 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
| 0.9 | 18.9 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
| 0.8 | 34.9 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
| 0.8 | 19.9 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
| 0.8 | 13.1 | REACTOME FGFR2C LIGAND BINDING AND ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
| 0.8 | 15.9 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
| 0.7 | 127.2 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
| 0.7 | 18.6 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
| 0.7 | 26.6 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
| 0.7 | 19.8 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
| 0.6 | 11.3 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
| 0.6 | 16.3 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
| 0.6 | 12.4 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
| 0.6 | 61.6 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
| 0.5 | 38.6 | REACTOME G1 PHASE | Genes involved in G1 Phase |
| 0.5 | 22.2 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
| 0.5 | 16.6 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
| 0.5 | 11.8 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
| 0.5 | 8.8 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
| 0.5 | 19.0 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
| 0.5 | 1.0 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
| 0.5 | 7.7 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
| 0.5 | 10.0 | REACTOME SHC1 EVENTS IN EGFR SIGNALING | Genes involved in SHC1 events in EGFR signaling |
| 0.5 | 20.8 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
| 0.5 | 0.5 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
| 0.4 | 24.5 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
| 0.4 | 21.0 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
| 0.4 | 0.4 | REACTOME PEPTIDE HORMONE BIOSYNTHESIS | Genes involved in Peptide hormone biosynthesis |
| 0.4 | 8.5 | REACTOME TRAF6 MEDIATED INDUCTION OF TAK1 COMPLEX | Genes involved in TRAF6 mediated induction of TAK1 complex |
| 0.4 | 12.4 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
| 0.4 | 4.5 | REACTOME TCR SIGNALING | Genes involved in TCR signaling |
| 0.4 | 20.1 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
| 0.4 | 2.1 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
| 0.4 | 6.7 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
| 0.3 | 3.2 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
| 0.3 | 2.2 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
| 0.3 | 5.6 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
| 0.3 | 0.3 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
| 0.3 | 4.1 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
| 0.3 | 10.9 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
| 0.3 | 5.4 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
| 0.3 | 4.7 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
| 0.3 | 8.6 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
| 0.3 | 1.4 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
| 0.3 | 13.6 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
| 0.3 | 1.3 | REACTOME ADENYLATE CYCLASE INHIBITORY PATHWAY | Genes involved in Adenylate cyclase inhibitory pathway |
| 0.3 | 4.1 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
| 0.2 | 1.0 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
| 0.2 | 7.9 | REACTOME AMINO ACID AND OLIGOPEPTIDE SLC TRANSPORTERS | Genes involved in Amino acid and oligopeptide SLC transporters |
| 0.2 | 3.2 | REACTOME NFKB IS ACTIVATED AND SIGNALS SURVIVAL | Genes involved in NF-kB is activated and signals survival |
| 0.2 | 0.2 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
| 0.2 | 0.5 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
| 0.2 | 0.5 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
| 0.2 | 6.2 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
| 0.2 | 0.2 | REACTOME ADP SIGNALLING THROUGH P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
| 0.2 | 1.4 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
| 0.2 | 6.6 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
| 0.2 | 5.6 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
| 0.2 | 3.3 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
| 0.2 | 22.9 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
| 0.2 | 3.3 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
| 0.2 | 1.1 | REACTOME MRNA PROCESSING | Genes involved in mRNA Processing |
| 0.2 | 1.9 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
| 0.2 | 5.2 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
| 0.2 | 6.2 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
| 0.2 | 2.3 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
| 0.2 | 11.0 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
| 0.2 | 17.5 | REACTOME AMYLOIDS | Genes involved in Amyloids |
| 0.2 | 5.2 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
| 0.2 | 3.0 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
| 0.2 | 0.6 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
| 0.2 | 3.0 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
| 0.2 | 6.4 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
| 0.2 | 3.8 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
| 0.2 | 1.1 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
| 0.2 | 4.2 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
| 0.2 | 2.4 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
| 0.2 | 3.8 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
| 0.2 | 0.2 | REACTOME GLUCAGON SIGNALING IN METABOLIC REGULATION | Genes involved in Glucagon signaling in metabolic regulation |
| 0.2 | 2.5 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
| 0.2 | 4.0 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
| 0.2 | 2.7 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
| 0.2 | 2.2 | REACTOME VIRAL MESSENGER RNA SYNTHESIS | Genes involved in Viral Messenger RNA Synthesis |
| 0.2 | 2.3 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
| 0.2 | 2.9 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
| 0.1 | 5.2 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
| 0.1 | 6.0 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
| 0.1 | 0.6 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
| 0.1 | 1.3 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
| 0.1 | 2.9 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
| 0.1 | 0.5 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
| 0.1 | 3.4 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
| 0.1 | 3.2 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
| 0.1 | 4.7 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
| 0.1 | 2.0 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
| 0.1 | 4.4 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
| 0.1 | 5.8 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
| 0.1 | 0.5 | REACTOME SHC RELATED EVENTS | Genes involved in SHC-related events |
| 0.1 | 0.3 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
| 0.1 | 0.9 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
| 0.1 | 2.5 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
| 0.1 | 1.2 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
| 0.1 | 0.1 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
| 0.1 | 0.9 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
| 0.1 | 5.1 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
| 0.1 | 3.3 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
| 0.1 | 3.1 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
| 0.1 | 3.5 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
| 0.1 | 7.6 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
| 0.1 | 8.1 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
| 0.1 | 1.0 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
| 0.1 | 0.5 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
| 0.1 | 3.0 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
| 0.1 | 4.5 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
| 0.1 | 7.2 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
| 0.1 | 0.3 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
| 0.1 | 4.6 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
| 0.1 | 1.1 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
| 0.1 | 12.3 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
| 0.1 | 2.1 | REACTOME BOTULINUM NEUROTOXICITY | Genes involved in Botulinum neurotoxicity |
| 0.1 | 1.0 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
| 0.1 | 0.3 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
| 0.1 | 3.9 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
| 0.1 | 0.1 | REACTOME 3 UTR MEDIATED TRANSLATIONAL REGULATION | Genes involved in 3' -UTR-mediated translational regulation |
| 0.1 | 1.1 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
| 0.1 | 17.6 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
| 0.1 | 13.6 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
| 0.1 | 3.9 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
| 0.1 | 1.2 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
| 0.1 | 1.6 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
| 0.1 | 2.6 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
| 0.1 | 0.4 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
| 0.1 | 0.9 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
| 0.1 | 0.5 | REACTOME AQUAPORIN MEDIATED TRANSPORT | Genes involved in Aquaporin-mediated transport |
| 0.1 | 5.0 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
| 0.1 | 5.2 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
| 0.0 | 1.1 | REACTOME GAP JUNCTION TRAFFICKING | Genes involved in Gap junction trafficking |
| 0.0 | 0.1 | REACTOME OPSINS | Genes involved in Opsins |
| 0.0 | 0.5 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
| 0.0 | 2.5 | REACTOME DOWNSTREAM SIGNAL TRANSDUCTION | Genes involved in Downstream signal transduction |
| 0.0 | 20.2 | REACTOME GENERIC TRANSCRIPTION PATHWAY | Genes involved in Generic Transcription Pathway |
| 0.0 | 1.0 | REACTOME METABOLISM OF RNA | Genes involved in Metabolism of RNA |
| 0.0 | 1.8 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
| 0.0 | 0.2 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
| 0.0 | 2.4 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
| 0.0 | 1.8 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
| 0.0 | 0.4 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
| 0.0 | 3.5 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
| 0.0 | 0.5 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
| 0.0 | 0.5 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
| 0.0 | 0.3 | REACTOME SIGNALING BY EGFR IN CANCER | Genes involved in Signaling by EGFR in Cancer |
| 0.0 | 0.1 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
| 0.0 | 0.1 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
| 0.0 | 0.3 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
| 0.0 | 0.4 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
| 0.0 | 0.1 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |